Superior variety of rapeseed NS-B50027-4

Through genetic transformation and breeding, the rapeseed variety NS-B50027-4 was developed, which solved the problem of insufficient LC-ω3 fatty acid content in rapeseed and achieved stable production of high DHA content, suitable for human edible oil and aquaculture.

CN114836567BActive Publication Date: 2026-11-17NUSEED NUTRITIONAL AUSTRALIA PTY LTD
View PDF 42 Cites 0 Cited by

Patent Information

Application Number
CN202210541485.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2016-06-16
Filing Date
2017-06-16
Publication Date
2026-11-17
Estimated Expiration
2037-06-16

AI Technical Summary

Technical Problem

Existing rapeseed varieties lack long-chain ω-3 fatty acids (LC-ω3), especially DHA and EPA, making it difficult to meet the needs of humans and aquaculture, and there is a lack of stable and uniform breeding lines for commercial production.

Method used

Through genetic transformation and rigorous selection breeding, an inbred rapeseed line NS-B50027-4 was developed, which enhanced the content of ω3 and LC-ω3 fatty acids in its seeds, especially DHA, forming a stable and high-yielding breeding line. Multiple heterologous gene expression cassettes were integrated into its genome to improve the production of LC-PUFA.

Benefits of technology

It achieved a significant increase in ω3 and LC-ω3 fatty acids in rapeseed seeds, especially DHA content, which was significantly higher than that of conventional rapeseed, providing a reliable commercial source suitable for human edible oil, aquaculture, and animal feed additives.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114836567B_ABST
    Figure CN114836567B_ABST
Patent Text Reader

Abstract

This application relates to the elite rapeseed variety NS-B50027-4. Embodiments of the invention relate to the elite rapeseed variety NS-B50027-4, seeds and oil obtained from NS-B50027-4, progeny derived from NS-B50027-4, the genetic and phenotypic characteristics of NS-B50027-4, and compositions and methods for identifying the elite rapeseed variety NS-B50027-4. In particular, NS-B50027-4 is a transgenic rapeseed line capable of producing at least 5% DHA in its seed oil.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of the application filed on June 16, 2017, with application number 201780051945.8 and invention title "Superior Variety of Rapeseed NS-B50027-4".

[0002] Related applications

[0003] This application claims priority to U.S. Provisional Application No. 62 / 351,246, filed June 16, 2016, which is incorporated herein by reference in its entirety for all purposes.

[0004] sequence list

[0005] This application contains a sequence list that has been submitted via EFS-Web in ASCII format, and that sequence list is incorporated herein by reference in its entirety.

[0006] field

[0007] The embodiments of this invention relate to the fields of rapeseed breeding and agricultural products, specifically to the elite seed event NS-B50027-4. background

[0008] Rapeseed is an important oilseed crop grown in many parts of the world. Rapeseed oil is rich in both monounsaturated and polyunsaturated fatty acids, including short-chain omega-3 fatty acids, but lacks long-chain omega-3 fatty acids. Long-chain omega-3 fatty acids (LC-omega-3) have proven health benefits, but currently, they are mainly obtained directly from algae or from marine fish that consume algae. The recognition of dietary LC-omega-3 fatty acids, particularly docosahexaenoic acid (22:6n-3; DHA) and eicosapentaenoic acid (20:5n-3; EPA), has led to a dramatic increase in demand for edible fish oil. Therefore, there is a need for alternative, direct sources of LC-omega-3 fatty acids for human consumption. Furthermore, because farmed fish such as Atlantic salmon accumulate fatty acids in proportion to dietary fatty acids, it is necessary to maintain the level of LC polyunsaturated fatty acids (LC-PUFA) in fish feed and, consequently, ensure the presence of these fatty acids in farmed fish. Therefore, there is a need for LC-PUFA-rich sources that can be used in aquaculture. For example, there is a need for rapeseed varieties capable of producing LC-PUFAs, particularly LC-ω3 fatty acids such as DHA, for use in aquaculture and for direct human consumption. Despite advancements in plant breeding and molecular genetic manipulation, there are no commercially available sources of rapeseed oil with LC-PUFA content approaching that produced in wild fish. Furthermore, rapeseed cultivars (not F1 hybrids) should be homogeneous, homozygous, and propagable for reliable production of this economic crop. Therefore, there remains a need for rapeseed lines that can be grown as a sustainable crop, providing commercially viable amounts of LC-ω3 fatty acids such as DHA in their seeds. Summary of the Invention

[0009] The embodiments described herein provide an inbred recombinant rapeseed line, named NS-B50027-4, whose seeds contain beneficial levels of ω3 and LC-ω3 fatty acids, thus providing a renewable, terrestrial-based system for producing these valuable oils. A representative sample of seeds from the inbred rapeseed line NS-B50027-4 was deposited at the American Center for Type Culture Collection on June 9, 2016, under the Budapest Treaty. (Manassas, VA), and designated accession number PTA-123186 (see Appendix A). This paper also describes the cells, tissues, seeds, and oil of the inbred rapeseed line NS-B50027-4. Combinations of selection and breeding through transgenic manipulation enable the generation of variation in species where variation is absent. For example, the fatty acid profile of the rapeseed line NS-B50027-4 described herein is absent in native European rapeseed (B. napus); and the traits described herein, particularly the beneficial trait of DHA production, have been developed by humans using significant technological interventions.

[0010] One aspect of this invention provides seeds of the rapeseed (Brassica napus L.) strain NS-B50027-4, a genetically modified cultivar of the AVJade strain selected and bred into a stable, homogeneous breeding line, and whose seeds accumulate a high percentage of ω3 and LC-ω3 fatty acids relative to the total fatty acid content. The inbred strain NS-B50027-4 is developed to provide rapeseed plants that produce seeds containing LC-ω3 fatty acids, particularly DHA, at levels approaching those found in some wild fish oils. Edible oil derived from NS-B50027-4 has a significantly higher DHA content than other European rapeseed plants. The novel, homogeneous breeding line NS-B50027-4 is developed through genetic transformation, followed by rigorous selection and breeding of stable, high-yielding, morphologically adapted rapeseed lines.

[0011] Therefore, at least one embodiment described herein relates to seeds of the inbred rapeseed line NS-B50027-4; plants and parts thereof such as pollen, ovules or seeds bred from the seeds of the inbred rapeseed line NS-B50027-4; and methods for producing seeds from rapeseed plants by breeding the inbred rapeseed line NS-B50027-4, or by hybridizing the inbred rapeseed line NS-B50027-4 with itself or with another rapeseed line or Brassica line and obtaining seeds from the bred progeny.

[0012] At least one embodiment provides seeds from a rapeseed population produced by the methods described herein, wherein, on average, 10% to 100% of the alleles of said population are derived from the rapeseed line NS-B50027-4. Similarly, embodiments of the invention provide rapeseed line NS-B50027-4, sublines of NS-B50027-4, progeny of NS-B50027-4 or its sublines, or plants produced by crossing NS-B50027-4 with a second rapeseed or Brassica plant, for breeding or cultivating plants for the production of seeds, oil, meal, or protein.

[0013] At least one embodiment provides seeds of rapeseed plants (such as European rapeseed) whose genomes contain at least a portion of the genome of the inbred line NS-B50027-4. At least one embodiment provides a plant such as European rapeseed whose genomes contain at least a portion of the genome of the inbred line NS-B50027-4. At least one embodiment provides cells of rapeseed plants (such as European rapeseed) whose genomes contain at least a portion of the genome of the inbred line NS-B50027-4. Another embodiment provides genomic DNA of rapeseed plants (such as European rapeseed) containing at least a portion of the genome of the line NS-B50027-4. At least one embodiment also relates to seeds, cells, tissues, tissue cultures, progeny, and descendants of plants containing at least a portion of the genome of NS-B50027-4, which is preserved in [location missing]. The seeds were derived from accession number PTA-123186. Another embodiment also provides rapeseed plants containing at least a portion of the genome of NS-B50027-4 (such as those preserved in...). Plants that grow from seeds with the accession number PTA-123186 are available (e.g., through propagation or breeding).

[0014] At least one embodiment provides seeds of rapeseed plants (such as European rapeseed) containing the superior germplasm of the NS-B50027-4 cultivar in their genome. At least one embodiment provides a plant, such as European rapeseed, containing the superior germplasm of the inbred cultivar NS-B50027-4 in its genome. Another embodiment provides genomic DNA of rapeseed plants (such as European rapeseed) containing the superior germplasm of the NS-B50027-4 cultivar. At least one embodiment also relates to seeds, cells, tissues, tissue cultures, progeny, and offspring from plants containing germplasm preserved in [relevant sources]. The superior variety event NS-B50027-4, grown from seeds with accession number PTA-123186. Another embodiment also provides rapeseed plants containing superior variety events (such as those preserved in...). Plants that can be obtained from seeds of PTA-123186 (e.g., through propagation or breeding). The implementation also involves rapeseed plants containing the superior variety event NS-B50027-4.

[0015] The reference seed of the inbred strain NS-B50027-4 of this invention has been deposited with accession number PTA-123186. At least one embodiment provides seeds of NS-B50027-4 deposited under accession number PTA-123186, said seeds growing into rapeseed plants, said rapeseed plants containing, at conventional harvest, at least 5% by weight of total fatty acids of the seeds, about 6% of DHA, about 7% of DHA, about 8% of DHA, about 9% of DHA, about 10% of DHA, about 11% of DHA, about 12% of DHA, about 13% of DHA, about 14% of DHA, about 15% of DHA, about 16% of DHA, about 17% of DHA (including endpoints), or more of DHA.

[0016] In at least one implementation, The seeds with accession number PTA-123186 are seed batches consisting of at least about 95% inbred transgenic seeds, which are transgenic seeds with the superior seed event NS-B50027-4, and which grow into rapeseed plants containing at least 5% DHA, about 6% DHA, about 7% DHA, about 8% DHA, about 9% DHA, about 10% DHA, about 11% DHA, about 12% DHA, about 13% DHA, about 14% DHA, about 15% DHA, about 16% DHA, about 17% DHA (including endpoints), or more of the total fatty acids in the seeds. The seeds with accession number PTA-123186 are seed lots composed of transgenic seeds that are at least about 95% homozygous for transgenic DNA. These transgenic seeds contain the superior seed event NS-B50027-4. The transgenic seeds are grown into rapeseed plants whose seeds contain at least 5% LC-PUFA, about 6% LC-PUFA, about 7% LC-PUFA, about 8% LC-PUF, and about 9% LC-PUFA as a percentage of the total fatty acids (EPA, DPA, and DHA) of the seeds by weight. LC-PUFA, approximately 10% LC-PUFA, approximately 11% LC-PUFA, approximately 12% LC-PUFA, approximately 13% LC-PUFA, approximately 14% LC-PUFA, approximately 15% LC-PUFA, approximately 16% LC-PUFA, approximately 17% LC-PUFA, approximately 18% LC-PUFA, approximately 19% LC-PUFA, approximately 20% LC-PUFA, approximately 21% LC-PUFA (including endpoints), or more LC-PUFA.

[0017] In another embodiment, seeds or progeny seeds that are available or have been obtained from the preserved seeds (e.g., after hybridization with rapeseed or Brassica plants with the same or different genetic backgrounds) can be sown, and the resulting plants can have a phenotype substantially the same as that of NS-B50027-4. In at least one embodiment, at conventional harvest, the fatty acid content of NS-B50027-4 progeny seeds comprises at least 5% DHA, about 6%, about 7%, about 8%, about 9%, about 10%, about 11%, about 12%, about 13%, about 14%, about 15%, about 17%, about 18%, about 19%, about 20%, about 21%, about 22%, about 23%, about 24% DHA (including endpoints), or more DHA, based on the weight percent of the total fatty acids of the seeds. In at least one embodiment, at conventional harvest, the fatty acid content of NS-B50027-4 progeny seeds comprises, as a sum of EPA, DPA, and DHA, at least 5% by weight of LC-PUFA, approximately 6% by weight of LC-PUFA, approximately 7% by weight of LC-PUFA, approximately 8% by weight of LC-PUFA, approximately 9% by weight of LC-PUFA, approximately 10% by weight of LC-PUFA, approximately 11% by weight of LC-PUFA, approximately 12% by weight of LC-PUFA, and approximately 13% by weight of LC-PUFA. PUFA, approximately 14% LC-PUFA, approximately 15% LC-UFA, approximately 16% LC-PUFA, approximately 17% LC-PUFA, approximately 18% LC-PUFA, approximately 19% LC-PUFA, approximately 20% LC-PUFA, approximately 21% LC-PUFA, approximately 22% LC-PUFA, approximately 23% LC-PUFA, approximately 24% LC-PUFA, approximately 25% LC-PUFA (including endpoints), or more LC-PUFA.

[0018] The seeds of NS-B50027-4 also contain substantially more ω3ALA than conventional rapeseed varieties. In at least one embodiment, at conventional harvest, the fatty acid content of NS-B50027-4 progeny seeds comprises at least 15% ALA, about 16% ALA, about 17% ALA, about 18% ALA, about 19% ALA, about 20% ALA, about 21% ALA, about 22% ALA, about 23% ALA, about 24% ALA (including endpoints), or more, based on the weight percent of the total fatty acids of the seeds.

[0019] Another aspect of the present invention provides oils containing beneficial levels of ω3 fatty acids and LC-ω3 fatty acids, wherein the fatty acid contents contain a higher ω3:ω6 fatty acid ratio than that of ordinary rapeseed oil. For example, AV Jade does not contain EPA / DPA / DHA(ω3) compared to LA(ω6), and in one embodiment, seed oil from NS-B50027-4 has an EPA / DPA / DHA(ω3):LA(ω6) ratio of about 1 to about 7, such as about 1.25. The ω3:ω6 fatty acid ratio from NS-B50027-4 is particularly beneficial for palmitic acid. Oil from the parental line AV Jade does not contain DHA, and therefore there is no DHA:palmitate ratio; oil from NS-B50027-4 has, for example, a DHA:palmitate ratio of about 2.12; in contrast, oil from farmed salmon has a reported DHA:palmitate ratio of 0.59; and oil from wild salmon has a reported DHA:palmitate ratio of 1.02. In at least one embodiment, the ratio of ω3:ω6 fatty acids in the seed oil of NS-B50027-4 is about 3 to about 7, such as about 6.

[0020] In another aspect of the embodiments of the invention, oils, lipids, ω3-FA, LC-PUFA, or DHA from the seeds of the inbred strain NS-B50027-4 are used as feed (food or edible material, including beverages) for humans or animals, or as nutritional supplements (food additives) for humans or animals. In at least one embodiment, oils, lipids, ω3-FA, LC-PUFA, or DHA from the seeds of NS-B50027-4 are used as feed supplements or as feed additives in aquaculture. In at least one embodiment, oils, lipids, ω3-FA, LC-PUFA, or DHA from the seeds of NS-B50027-4 are used as pharmaceutical compositions or for use in pharmaceutical compositions. In at least one other embodiment, seed powder or protein obtained from seed concentration of NS-B50027-4 or its progeny is used as feed (food or edible material) or for use in feed (food or edible material), or as nutritional supplements (food additives) for humans or animals. In a specific implementation plan, the oil, lipids, crude flour, or protein from the seeds of NS-B50027-4 or its progeny are used as feed for aquaculture.

[0021] One aspect of the present invention provides a method for increasing LC-PUFA in plants by providing (e.g., through genetic transformation or breeding) more than one copy of a gene construct expressing some enzymes at the “front end” of the LC-PUFA biosynthetic pathway. For example, while not all enzymes such as Δ6-desaturase, Δ5-desaturase, Δ5-elongase, and ω3 / Δ15-desaturase can be exclusively considered front end enzymes, in certain embodiments, these genes are assembled in LC-PUFA-producing plants into artificial loci that increase the production of LC-PUFAs such as DHA. In certain implementations, artificial loci containing some front-end genes include Δ6-desaturases from Micromonas pusilla, Δ5-elongases from Pyramimonas cordata, Δ5-desaturases from Pavlova salina, and Δ15 / ω3-desaturases from Pichia pastoris.

[0022] One aspect of the described implementation provides a novel rapeseed breeding line, named NS-B50027-4, and rapeseed plants, such as European rapeseed, that contain the superior genetic event NS B50027 in their nuclear genome. Brassica plants containing the genetic event of the line NS-B50027-4 are capable of producing seed-specific fatty acids containing more unsaturated, longer chains than those produced in conventional rapeseed plants. The inbred rapeseed line NS-B50027-4 exhibits other agronomic traits substantially equivalent to those of non-transgenic isogenic rapeseed lines; however, these traits differ from other lines to provide a distinct line or cultivar. Representative samples of seeds from the inbred rapeseed line NS-B50027-4 have been deposited in [location missing]. The login number is PTA-123186.

[0023] At least one embodiment involves a transgenic rapeseed, its plant or plant part, tissue or cell, having at least one transgenic insert stably integrated into the genome, said transgenic insert comprising an expression cassette containing 16 heterologous genes, said transgene being codon-optimized for plant expression and encoding Δ4-desaturase, Δ5-desaturase from *Haloxylon ammodendron*, Δ5-elongase from *Pyramimonas cordata*, Δ6-desaturase from *Microcystis aeruginosa*, Δ12-desaturase from *Lachancea kluyveri*, Δ15 / ω3-desaturase from *Pichia pastoris*, and at least one matrix-binding region (MAR) and selectable marker gene from *Nicotiana tobacum*; and at least one transgenic insert comprising an expression cassette containing four heterologous genes, said transgene being codon-optimized for plant expression and encoding Δ6-desaturase from *Microcystis aeruginosa*, *Pyramimonas*, and *Lachancea kluyveri*. The transgenic strains include Δ5-elongase from *Cordata*, Δ5-desaturase from *Haloxylon ammodendron*, Δ15 / ω3-desaturase from *Pichia pastoris*, and at least one MAR from *Tobacco japonica*. The inbred transgenic line NS-B50027-4 illustrates this implementation, and representative samples of seeds possessing these heterologous genes have been deposited in [location missing]. The login number is PTA-123186.

[0024] Another aspect of the present invention provides isolated or purified genomic DNA obtained from rapeseed plants of the inbred rapeseed line NS-B50027-4 or superior species containing the line NS-B50027-4, the seeds of which have been deposited in ATCC, accession number PTA 123186. Such genomic DNA can be used, for example, as a reference control material in the identification assays described herein. At least one embodiment provides a genome of European rapeseed having a deletion in the 3'UTR of the HPP gene at positions 118589903-118591677 on the chrUn_random of the European rapeseed reference genome (2n=AACC; Darmor variant), and a deletion at positions 18569298-18571066 on chromosome A02 of the Brassica rapa reference genome (2n=AA, Chiifu variant), wherein the deletion is GTAGCACGACAAGTT (SEQ ID NO:38). The 15-bp deletion is located at positions 118589927-118589941 on chromosome chrUn_random of the European rapeseed reference genome and positions 18569316-18569330 on chromosome A02 of the Brassica rapa reference genome. At least one embodiment provides a European rapeseed plant with a deletion in the second exon of a gene encoding a Pto-interacting protein (PTI) located at positions 17267746-17270700 on chromosome A05 of the European rapeseed reference (Darmor variety) genome, which disrupts PTI expression, wherein the deletion is CACGGTGGAGGTCACCATGT (SEQ ID NO:39). These deletions are genomic characteristics of the inbred rapeseed line NS-B50027-4 and can be used to identify line NS-B50027-4 and its progeny.

[0025] Therefore, embodiments of the present invention also provide a method for identifying transgenic plants or their cells or tissues, including transgenic aspects (superior species events) of the inbred rapeseed line NS-B50027-4, based on the presence of a characterizing DNA molecule having a specific nucleotide sequence or encoding a specific amino acid. For example, such a characterizing DNA molecule contains a sequence of 15 base pairs (bp) containing the insertion fragment linking site of the event, at least 15 bp, 20 bp, at least 20 bp, at least 24 bp, at least 30 bp, or more than 30 bp (i.e., a portion of the inserted exogenous DNA containing an LC-ω3 fatty acid synthesis gene or (including a "gene" containing regulatory sequences for expression, etc.) and a portion of the rapeseed or Brassica genome adjacent thereto (both the 5' flanking region or 3' flanking region of each insertion), allowing for the specific identification of superior species events. For example, the 5' end linker sequence of the four-gene insert in chromosome A02 of NS-B50027-4 contains SEQ ID NO:43; the 3' end linker sequence of the four-gene insert in chromosome A02 contains SEQ ID NO:44; the 5' end linker sequence of the 16-gene insert in chromosome A05 of NS-B50027-4 contains SEQ ID NO:45; and the 3' end linker sequence of the 16-gene insert in chromosome A05 contains SEQ ID NO:46. The embodiments also relate to plants comprising superior species of the inbred rapeseed line NS-B50027-4 identified by such methods.

[0026] Another aspect of the present invention provides a nucleic acid molecule (e.g., a polynucleotide or DNA) comprising an insertion site for the NS-B50027-4 superiority event and a sufficient length of both rapeseed genomic DNA and transgenic DNA in a polynucleotide configuration for use in detecting the superiority event of the inbred line NS-B50027-4, and for characterizing plants containing the NS-B50027-4 superiority event or plants associated with the inbred line NS-B50027-4. Such a molecule may comprise, for example, at least nine nucleotides of rapeseed genomic DNA and a similar number of nucleotides of transgenic DNA, respectively, on each side of the linker site. For example, such a DNA molecule comprises at least nine nucleotides of rapeseed genomic DNA and a similar number of nucleotides of transgenic (exogenous) DNA, wherein the similar number of nucleotides of transgenic (exogenous) DNA comprises gene regions adjoining the insertion site in SEQ ID NO:40 (e.g., nucleotides 2081 to 2098 and nucleotides 14193 to 14210) and gene regions adjoining the insertion site in SEQ ID NO:41 (e.g., nucleotides 1151 to 1168 and nucleotides 47765 to 47782). In one aspect of the invention, a rapeseed plant comprising such a specific nucleic acid molecule is provided.

[0027] At least one embodiment involves a transgenic Brassica genus or rapeseed seed, or its plant cell, plant, plant part, or tissue, wherein the transgenic Brassica genus or rapeseed seed, or its plant cell, plant, plant part, or tissue, has at least one transgenic insert stably integrated into the genome, the transgenic insert comprising an expression cassette containing 16 heterologous genes, wherein the transgene is a plant codon-optimized Δ6-desaturase, Δ6-elongase, Δ5-elongase from Pyramimonas cordata, Δ5-desaturase from Haloxylon ammodendron, Δ15 / ω3-desaturase from Pichia pastoris, Δ4-desaturase from Haloxylon ammodendron, and Δ12-desaturase from Lachancea kluyveri, at least one matrix-binding region (MAR) from Nicotiana scabra, and an optional marker gene; 16 transgenic inserts, characterized by SEQ ID. Nucleotides 1268 to 47773 of NO:41; and at least one transgenic insert comprising expression cassettes of four heterologous genes, codon-optimized for plant expression and encoding a Δ6-desaturase from *Microcystis aeruginosa*, a Δ5-elongase from *Pyramimonas cordata*, a Δ5-desaturase from *Haloxylon ammodendron*, a Δ15 / ω3-desaturase from *Pichia pastoris*, and at least one MAR from *Nicotiana safflower*; the four-gene insert is characterized by nucleotides 2090 to 14201 of SEQ ID NO:40. In at least one embodiment, two expression cassettes are located on two different chromosomes in the plant genome.

[0028] Another embodiment provides a recombinant nucleic acid molecule having the nucleic acid sequences of SEQ ID NO:40, SEQ ID NO:41, or their complementary sequences. Another embodiment provides a recombinant nucleic acid molecule having the nucleic acid sequence from positions 2090 to 14201 of SEQ ID NO:40, or its complementary sequence. Another embodiment provides a recombinant nucleic acid molecule having the nucleic acid sequence from positions 1160 to 47773 of SEQ ID NO:41, or its complementary sequence. Embodiments of the invention also provide transgenic Brassica oleracea or rapeseed seeds, said seeds comprising a nucleic acid molecule having the nucleic acid sequence from nucleotides 2090 to 14201 of SEQ ID NO:40, or its complementary sequence; and Brassica oleracea or rapeseed seeds, said seeds comprising a nucleic acid molecule having the nucleic acid sequence from nucleotides 1160 to 47773 of SEQ ID NO:41, or its complementary sequence. Another embodiment provides seeds or cells comprising such nucleic acid molecules.

[0029] Another embodiment provides a DNA molecule comprising an artificial locus, said artificial locus sequentially comprising the following nucleotide sequences: (a) the nucleotide sequence of SEQ ID NO:40 from nucleotide 2747 to nucleotide 6250; (b) the nucleotide sequence of SEQ ID NO:40 from nucleotide 6257 to nucleotide 8414; (c) the nucleotide sequence of SEQ ID NO:40 from nucleotide 8415 to nucleotide 10374; (d) the nucleotide sequence of SEQ ID NO:40 from nucleotide 10375 to nucleotide 11544; (e) the nucleotide sequence of SEQ ID NO:40 from nucleotide 11545 to nucleotide 14049; (f) a molecule having at least 80%, 95%, 97%, 98%, 99%, or 99.5% sequence identity with nucleotide sequences (a) to (e); or (g) its complementary sequence. Related embodiments provide plant cells, plant material, or plant seeds comprising this artificial locus.

[0030] Another embodiment provides a DNA molecule comprising an artificial locus, the artificial locus sequentially comprising the following nucleotide sequences: (a) the nucleotide sequence of SEQ ID NO:41 from nucleotide 1268 to nucleotide 5317; (b) the nucleotide sequence of SEQ ID NO:41 from nucleotide 5324 to nucleotide 7481; (c) the nucleotide sequence of SEQ ID NO:41 from nucleotide 7482 to nucleotide 9443; (d) the nucleotide sequence of SEQ ID NO:41 from nucleotide 9444 to nucleotide 10611; (e) the nucleotide sequence of SEQ ID NO:41 from nucleotide 10612 to nucleotide 13116; (f) the nucleotide sequence of SEQ ID NO:41 from nucleotide 13117 to nucleotide 17000; (g) the nucleotide sequence of SEQ ID NO:41 from nucleotide 17001 to nucleotide 19606; (h) the nucleotide sequence of SEQ ID NO:41 from nucleotide 19607 to nucleotide 29773; (i) the nucleotide sequence of SEQ ID NO:41 from nucleotide 1268 to nucleotide 5317; (b) the nucleotide sequence of SEQ ID NO:41 from nucleotide 5324 to nucleotide 7481; (c) the nucleotide sequence of SEQ ID NO:41 from nucleotide 7482 to nucleotide 9443; (d) the nucleotide sequence of SEQ ID NO:41 from nucleotide 9444 to nucleotide 10611; (e) the nucleotide sequence of SEQ ID NO:41 from nucleotide 10612 to nucleotide 13116; (f) the nucleotide sequence of SEQ ID NO:41 from nucleotide 13117 to nucleotide 17000; (g) the nucleotide sequence of SEQ ID NO:41 from nucleotide 1700 (j) Nucleotide sequences from nucleotide 20783 to nucleotide 22987 of SEQ ID NO:41; (k) Nucleotide sequences from nucleotide 23011 to 24370 of SEQ ID NO:41; (l) Nucleotide sequences from nucleotide 25920 to nucleotide 25943 of SEQ ID NO:41; (m) Nucleotide sequences from nucleotide 28157 to nucleotide 29324 of SEQ ID NO:41; (n) Nucleotide sequences from nucleotide 29324 to nucleotide 31830 of SEQ ID NO:41; (p) Nucleotide sequences from nucleotide 31831 to nucleotide 35816 of SEQ ID NO:41; (q) Nucleotide sequences from nucleotide 35817 to nucleotide 38319 of SEQ ID NO:41; (r) SEQ ID NO:41; Nucleotide sequences from nucleotides 38320 to 39488 of SEQ ID NO:41; (s) nucleotide sequences from nucleotides 39489 to 41449 of SEQ ID NO:41; (t) nucleotide sequences from nucleotides 41450 to 43607 of SEQ ID NO:41; (u) nucleotide sequences from nucleotides 43614 to 47662 of SEQ ID NO:41; (v) molecules having at least 80%, 95%, 97%, 98%, 99%, or 99.5% sequence identity with nucleotide sequences (a) to (u), (a) to (j), and (k) to (u), or (w) their complementary sequences. Related embodiments provide plant cells, materials, or seeds containing this artificial gene locus.

[0031] Another embodiment provides a DNA molecule comprising an artificial locus, the artificial locus sequentially comprising the following nucleotide sequences: (a) the nucleotide sequence of SEQ ID NO:40 from nucleotide 2747 to nucleotide 4141; (b) the nucleotide sequence of the complementary sequence of the nucleotide sequence of SEQ ID NO:40 from nucleotide 7259 to nucleotide 8065; (c) the nucleotide sequence of SEQ ID NO:40 from nucleotide 8841 to nucleotide 10121; (d) the nucleotide sequence of SEQ ID NO:40 from nucleotide 12281 to nucleotide 13531; (e) a molecule having at least 80%, 95%, 97%, 98%, 99%, or 99.5% sequence identity with nucleotide sequences (a) to (d); or (f) its complementary sequence; wherein the artificial locus includes a regulatory region (e.g., promoter, leader sequence, terminator) to provide expression of (a) to (d) or (e) or (f). The relevant implementation scheme provides plant cells, plant materials, or plant seeds containing the artificial gene locus.

[0032] Another embodiment provides a DNA molecule comprising an artificial locus, the artificial locus sequentially comprising the following nucleotide sequences: (a) the nucleotide sequence of SEQ ID NO:41 from nucleotide 1820 to nucleotide 3208; (b) the nucleotide sequence of SEQ ID NO:41 from nucleotide 6326 to nucleotide 7126; (c) the nucleotide sequence of SEQ ID NO:41 from nucleotide 7908 to nucleotide 9192; (d) the nucleotide sequence of SEQ ID NO:41 from nucleotide 11352 to nucleotide 12596; (e) the nucleotide sequence of SEQ ID NO:41 from nucleotide 15216 to nucleotide 16556; (f) the nucleotide sequence of SEQ ID NO:41 from nucleotide 17619 to nucleotide 18866; (g) the nucleotide sequence of SEQ ID NO:41 from nucleotide 21895 to nucleotide 22647; (h) the nucleotide sequence of SEQ ID NO:41 from nucleotide 25943 to nucleotide 26283; (i) the nucleotide sequence of SEQ ID NO:41 from nucleotide 25943 to nucleotide 26283; (j) Nucleotide sequences from nucleotide 30066 to nucleotide 31313 of SEQ ID NO:41; (k) Nucleotide sequences from nucleotide 31831 to nucleotide 35816 of SEQ ID NO:41; (j) Nucleotide sequences from nucleotide 36335 to nucleotide 38319 of SEQ ID NO:41; (m) Nucleotide sequences from nucleotide 39749 to nucleotide 41023 of SEQ ID NO:41; (m) Nucleotide sequences from nucleotide 41805 to nucleotide 42605 of SEQ ID NO:41; (n) Nucleotide sequences from SEQ ID NO:41 to nucleotide 30066 to nucleotide 31313 of SEQ ID NO:41; (j) Nucleotide sequences from nucleotide 31831 to nucleotide 35816 of SEQ ID NO:41; (j) Nucleotide sequences from nucleotide 36335 to nucleotide 38319 of SEQ ID NO:41; (j) Nucleotide sequences from nucleotide 39749 to nucleotide 41023 of SEQ ID NO:41; (j) Nucleotide sequences from nucleotide 41805 to nucleotide 42605 of SEQ ID NO:41; (j) Nucleotide sequences from nucleotide 30066 to nucleotide 31313 of SEQ ID NO:41; (j) Nucleotide sequences from nucleotide 31831 to nucleotide 35816 ... NO:41 includes a nucleotide sequence from nucleotide 45724 to nucleotide 47111; (o) a molecule having at least 80%, 95%, 97%, 98%, 99%, or 99.5% sequence identity with nucleotide sequences (a) to (u), (a) to (j), and (k) to (u); or (p) its complementary sequence; wherein the artificial locus includes a regulatory region (e.g., promoter, leader sequence, terminator) to provide expression of (a) to (n) or (o) or (p). Related embodiments provide plant cells, plant material, or plant seeds containing this artificial locus.

[0033] In one embodiment, the transgenic strain NS-B50027-4, as described herein, has the nucleotide sequence from nucleotide positions 2090 to 14201 of SEQ ID NO:40 or its complementary sequence, or comprises a molecule or its complementary sequence having at least 80%, 95%, 97%, 98%, 99%, or 99.5% sequence identity with the nucleotide sequence from nucleotide positions 2090 to 14201 of SEQ ID NO:40. In another embodiment, the transgenic strain NS-B50027-4, as described herein, has the nucleotide sequence from nucleotide positions 1268 to 47662 of SEQ ID NO:41 or its complementary sequence, or comprises a molecule or its complementary sequence having at least 80%, 95%, 97%, 98%, 99%, or 99.5% sequence identity with the nucleotide sequence from nucleotide positions 1268 to 47662 of SEQ ID NO:41.

[0034] This document also provides Brassica spp. or rapeseed plants, plant cells, tissues, or seeds containing nucleic acid molecules in their genomes, said nucleic acid molecules comprising the nucleotide sequence from nucleotide positions 2090 to 14201 of SEQ ID NO:40 or its complementary sequence, or comprising a molecule or its complementary sequence having at least 95%, 97%, 98%, 99%, or 99.5% sequence identity with the nucleotide sequence from nucleotide positions 2090 to 14201 of SEQ ID NO:40. Another embodiment provides Brassica spp. or rapeseed plants, plant cells, tissues, or seeds containing nucleic acid molecules in their genomes, said nucleic acid molecules comprising the nucleotide sequence from nucleotide positions 1268 to 47662 of SEQ ID NO:41 or its complementary sequence, or comprising a molecule or its complementary sequence having at least 80%, 95%, 97%, 98%, 99%, or 99.5% sequence identity with the nucleotide sequence from nucleotide positions 1268 to 47662 of SEQ ID NO:41.

[0035] Another aspect of the present invention provides kits and methods for determining whether a rapeseed plant is an inbred variety NS-B50027-4 or related to an inbred variety NS-B50027-4, or whether it is a rapeseed plant comprising at least a portion of a genetically superior event containing the variety NS-B50027-4. This document describes compositions and methods of simple and well-defined techniques for identifying the superior event NS-B50027-4 in biological samples. For example, the kit includes at least one set of sense (forward) and antisense (reverse) primers specific to the linking of Brassica chromosomal DNA and inserted transgenes. For example, DNA ligases containing the sequences SEQ ID NO:43 (TGGAGGTGTTCAAACACT), SEQ ID NO:44 (ATAGTATTAGTATACAGA), SEQ ID NO:45 (GGCTAAGGTAACACTGAT), and SEQ ID NO:46 (CAGTGTTTGAAGGACAGA) are novel DNA sequences for the superior species event NS-B50027-4 and can be used for the diagnosis of rapeseed plant NS-B50027-4 and its progeny. More specifically, the ligase sequences in SEQ ID NO:43 and SEQ ID NO:44 represent 9 polynucleotides on each side of the insertion site of the transgenic sequence fragment and on the A02 DNA of the rapeseed genome chromosome; and the ligase sequences in SEQ ID NO:45 and SEQ ID NO:46 represent 9 polynucleotides on each side of the insertion site of the transgenic sequence fragment and on the A05 DNA of the rapeseed genome chromosome. Longer or shorter polynucleotides can be selected from the flanking regions described herein.

[0036] Embodiments of the present invention also provide a method for identifying a superior species event of the inbred rapeseed line NS-B50027-4 in a biological sample based on primers or probes that specifically recognize the 5' or 3' flanking region of a foreign DNA insert fragment containing the genetic event of the superior species event NS-B50027-4. More specifically, the example method includes amplifying nucleic acids present in a biological sample by polymerase chain reaction using at least two primers, one primer recognizing the 5' or 3' Brassica flanking region of the inserted foreign DNA (heterologous DNA or transgenic DNA) of the superior species event NS-B50027-4, and the other primer recognizing a sequence within the foreign DNA including, for example, a gene for a foreign desaturase or elongase, to obtain a DNA fragment between 100 bp and 800 bp. Primers or probes can identify NS-B50027-4 by recognizing the following sequences: the sequence in the 5' region of chromosome A02 flanked by the insert (or its complement) from positions 1 to 2089 of SEQ ID NO:40, or the sequence in the 3' region of chromosome A02 flanked by the insert (or its complement) from positions 14202 to 15006 of SEQ ID NO:40; the sequence in the 5' region of chromosome A05 flanked by the insert (or its complement) from positions 1 to 1159 of SEQ ID NO:41, or the sequence in the 3' region of chromosome A05 flanked by the insert (or its complement) from positions 47774 to 49789 of SEQ ID NO:41; and at least one sequence of exogenous DNA containing, for example, positions 2090 to 14201 (or its complement) of SEQ ID NO:40 or positions 1160 to 47773 (or its complement) of SEQ ID NO:41.

[0037] At least one embodiment also provides a composition that can be used for competitive allele-specific PCR (KASP) assays (where two allele-specific forward primers recognize SNPs), droplet digital PCR (ddPCR) assays, quantitative PCR (qPCR) assays, paralog-specific assays, or for incidental presence (AP) assays. Specific implementation schemes for primers that can be used for KASP assays to detect the genetic traits of NS-B50027-4, and are particularly suitable for gene introgression studies and hybrid development, include SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:3 ... At least 10 consecutive nucleotides, or their complementary sequences, of the primers ID NO:32, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, SEQ ID NO:36, and SEQ ID NO:37. The aforementioned primers or their complementary sequences may be included in a kit for identifying NS-B50027-4, its progeny, or other plants or plant materials containing at least a portion of the genome of NS-B50027-4. Related embodiments provide plant materials identified using such primers.

[0038] For example, at least one embodiment provides primer pairs for isolating DNA molecules, wherein the first primer contains at least 11 consecutive nucleotides from nucleotides 1 to 235 of the 5' rapeseed flanking genomic region of SEQ ID NO:47 or their complete complementary sequence, and the second primer contains at least 11 consecutive nucleotides from the transgenic region of nucleotides 236 to 470 of SEQ ID NO:47 or their complete complementary sequence, wherein when the primer pairs of the DNA molecules are used together in a DNA amplification reaction, they produce a diagnostic amplicon containing SEQ ID NO:43 for rapeseed event NS-B50027-4 or its progeny.

[0039] At least one embodiment provides a composition comprising isolated primer pairs of DNA molecules, wherein the first primer comprises at least 11 consecutive nucleotides from nucleotide 1 to 235 of the transgenic region of SEQ ID NO:48 or a completely complementary sequence thereof, and the second primer comprises at least 11 consecutive nucleotides from nucleotide 236 to 470 of the 3' rapeseed flanking genomic DNA region of SEQ ID NO:48 or a completely complementary sequence thereof, wherein when the primer pairs of the DNA molecules are used together in a DNA amplification reaction, they produce a diagnostic amplicon comprising SEQ ID NO:44 for rapeseed event NS-B50027-4 or its progeny.

[0040] At least one embodiment provides primer pairs for isolating DNA molecules, wherein the first primer contains at least 11 consecutive nucleotides from nucleotide 1 to 235 of the 5' rapeseed flanking genomic region of SEQ ID NO:49 or a completely complementary sequence thereof, and the second primer contains at least 11 consecutive nucleotides from nucleotide 236 to 470 of the transgenic region of SEQ ID NO:49 or a completely complementary sequence thereof, wherein when the primer pairs of the DNA molecules are used together in a DNA amplification reaction, they produce a diagnostic amplicon containing SEQ ID NO:45 for rapeseed event NS-B50027-4 or its progeny.

[0041] At least one embodiment provides primer pairs for isolating DNA molecules, wherein the first primer contains at least 11 consecutive nucleotides from nucleotide 1 to 235 of the transgenic region of SEQ ID NO: 50 or a completely complementary sequence thereof, and the second primer contains at least 11 consecutive nucleotides from nucleotide 236 to 470 of the 3' rapeseed flanking genomic DNA region of SEQ ID NO: 50 or a completely complementary sequence thereof, wherein the primer pairs of the DNA molecules, when used together in a DNA amplification reaction, produce a diagnostic amplicon containing SEQ ID NO: 46 for rapeseed event NS-B50027-4 or its progeny.

[0042] In addition, DNA event primer pairs can also be used to generate amplicons for diagnosing the NS-B50027-4 event. These event primer pairs include, for example, AATTTGTTGGAGGTGTTCAAACACT (SEQ ID NO:51) and CGGAATCACAATCCCTGAATGATT (SEQ ID NO:52) or their complementary sequences. The amplicons generated by SEQ ID NO:51 and SEQ ID NO:52 are approximately 250 polynucleotides long. Besides these primer pairs, any primer pair derived from SEQ ID NO:47, SEQ ID NO:48, SEQ ID NO:49, or SEQ ID NO:50 or their complementary sequences, when used in DNA amplification reactions to generate amplicons for diagnosing the NS-B50027-4 event, is an aspect of this invention.

[0043] Another embodiment provides at least one set of primers for one of the following: a Δ4-desaturase from *Haloxylon ammodendron*, a Δ5-desaturase from *Haloxylon ammodendron*, a Δ5-elongase from *Pyramimonas cordata*, a Δ6-desaturase from *Microcystis aeruginosa*, a Δ6-elongase from *Pyramimonas cordata*, a Δ12-desaturase from *Lachancea kluyveri*, and a Δ15 / ω3-desaturase from *Pichia pastoris*; and at least one set of primers specific for a 5' link between the insert and native *Brassica oleracea* chromosome A02 DNA, such as the link of nucleotides 2033 to 2132 of SEQ ID NO:40, comprising a 43 bp insert and a 100 bp region of 57 bp of *Brassica oleracea* chromosome A02 DNA, or at least one set of primers specific for a 3' link between the insert and native *Brassica oleracea* chromosome A02 DNA, such as the link of SEQ ID NO:40. The link of SEQ ID NO:40 from nucleotides 14156 to 14255 comprises a 46 bp insert and a 100 bp region of 54 bp Brassica chromosome A02 DNA; or at least one set of primers specific for the 5' link between the insert and the native Brassica chromosome A05 DNA, such as the link of SEQ ID NO:41 from nucleotides 1110 to 1209 comprising a 50 bp insert and a 100 bp region of 50 bp Brassica chromosome A05 DNA, or at least one set of primers specific for the 3' link between the insert and the native Brassica chromosome A05 DNA, such as the link of SEQ ID NO:41 from nucleotides 47724 to 47823 comprising a 50 bp insert and a 100 bp region of 50 bp Brassica chromosome A05 DNA.

[0044] Another embodiment provides primers for recognizing sequences within exogenous DNA of NS-B50027-4, said exogenous DNA comprising, for example, Δ6-desaturase DNA or its complementary sequence from *Microcystis aeruginosa* having sequences of SEQ ID NO:57 and SEQ ID NO:58; Δ5-elongase or its complementary sequence from *Pyramimonas cordata* having sequences of SEQ ID NO:63 and SEQ ID NO:64; Δ5-desaturase or its complementary sequence from *Haloxylon ammodendron* having sequences of SEQ ID NO:61 and SEQ ID NO:62; Δ15 / ω3-desaturase or its complementary sequence from *Pichia pastoris* having sequences of SEQ ID NO:55 and SEQ ID NO:56; Δ4-desaturase or its complementary sequence from *Haloxylon ammodendron* having sequences of SEQ ID NO:65 and SEQ ID NO:66; and nucleotide sequences from *Lachancea* having sequences of SEQ ID NO:53 and SEQ ID NO:54. At least one primer is provided for a Δ12-desaturase derived from kluyveri or its complementary sequence; or a Δ6-elongase derived from Pyramimonas cordata having sequences of SEQ ID NO:59 or SEQ ID NO:60. Therefore, embodiments of the present invention provide specific primers and specific DNA amplified using such primers, as well as primers that can be derived from the sequence information provided herein.

[0045] According to the method for identifying NS-B50027-4 and its progeny, in addition to primers that specifically identify the 5' or 3' flanking region of the superior species event NS-B50027-4, the kit may also contain a second primer that specifically identifies a sequence within exogenous DNA for use in a PCR identification protocol, wherein the exogenous DNA comprises at least one of the following: Δ6-desaturase from *Microcystis aeruginosa*, Δ5-elongase from *Pyramimonas cordata*, Δ5-desaturase from *Haloxylon ammodendron*, Δ15 / ω3-desaturase from *Pichia pastoris*, Δ4-desaturase from *Haloxylon ammodendron*, Δ6-elongase from *Pyramimonas cordata*, or Δ12-desaturase from *Lachancea kluyveri*. The kit may contain at least two specific primers, one recognizing a sequence within the 5' flanking region of the superior species event NS-B50027-4, and the other recognizing a sequence within exogenous DNA containing at least one of the following: Δ6-desaturase from *Microcystis aeruginosa*, Δ5-elongase from *Pyramimonascordata*, Δ5-desaturase from *Haloxylon ammodendron*, Δ15 / ω3-desaturase from *Pichia pastoris*, Δ4-desaturase from *Haloxylon ammodendron*, or Δ12-desaturase from *Lachancea kluyveri*.

[0046] The present invention also relates to a kit for identifying superior species event NS-B50027-4 in biological samples, the kit comprising PCR primers comprising nucleotide sequences of SEQ ID NO:1 to SEQ ID NO:37 or their complementary sequences, or substantially consisting of nucleotide sequences of SEQ ID NO:1 to SEQ ID NO:37 or their complementary sequences, for use in the superior species event NS-B50027-4 identification protocol described herein.

[0047] At least one embodiment involves a transgenic rapeseed, its plant or plant part, tissue or cell, said transgenic rapeseed, its plant or plant part, tissue or cell having at least one transgenic insert stably integrated into the genome, said transgenic insert comprising an expression cassette containing 16 heterologous genes, said transgene being a plant codon-optimized Δ6-desaturase from *Microcystis aeruginosa*, a Δ5-elongase from *Pyramimonas cordata*, a Δ5-desaturase from *Haloxylon ammodendron*, a Δ15 / ω3-desaturase from *Pichia pastoris*, a Δ4-desaturase from *Haloxylon ammodendron*, a Δ6-elongase from *Pyramimonas cordata*, and a Δ12-desaturase from *Lachancea kluyveri*, at least one matrix-binding region (MAR) and selectable marker gene from *Tobacco japonica*; and at least one transgenic insert comprising an expression cassette containing four heterologous genes, said genes being codon-optimized for plant expression and encoding a Δ6-desaturase from *Microcystis aeruginosa*, a *Pyramimonas*, a *Haloxylon ammodendron ...Pyramimonas*, The four gene expression cassettes are characterized by nucleotides 2090 to 14201 of SEQ ID NO:40, comprising a Δ5-elongase from *Cordata*, a Δ5-desaturase from *Haloxylon ammodendron*, a Δ15 / ω3-desaturase from *Pichia pastoris*, and at least one MAR from *Tobacco denudata*. In at least one embodiment, two expression cassettes are located on two different chromosomes of the plant genome.

[0048] Another implementation provides with Figure 5 A recombinant nucleic acid molecule containing the nucleic acid sequence (SEQ ID NO:40) or its complementary sequence. Another embodiment provides a recombinant nucleic acid molecule having... Figure 6The document describes recombinant nucleic acid molecules containing the nucleic acid sequence (SEQ ID NO:41) or its complementary sequence. In one embodiment, a transgenic inbred line NS-B50027-4 as described herein has the nucleotide sequence from nucleotide positions 2090 to 14201 of SEQ ID NO:40 or its complementary sequence, or a molecule containing at least 95%, 97%, 98%, 99%, or 99.5% sequence identity with the nucleotide sequence from nucleotide positions 2090 to 14201 of SEQ ID NO:40 or its complementary sequence. The document also provides rapeseed plants, plant cells, tissues, or seeds containing nucleic acid molecules in their genomes, said nucleic acid molecules containing the nucleotide sequence from nucleotide positions 2090 to 14201 of SEQ ID NO:40 or its complementary sequence, or a molecule containing at least 95%, 97%, 98%, 99%, or 99.5% sequence identity with the nucleotide sequence from nucleotide positions 2090 to 14201 of SEQ ID NO:40 or its complementary sequence. In another embodiment, a transgenic line of the inbred strain NS-B50027-4 described herein has the nucleotide sequence from nucleotide positions 1268 to 47662 of SEQ ID NO:41 or its complementary sequence, or a molecule comprising at least 95%, 97%, 98%, 99%, or 99.5% sequence identity with the nucleotide sequence from nucleotide positions 1268 to 47662 of SEQ ID NO:41 or its complementary sequence. This document also provides a rapeseed plant, plant cell, tissue, or seed containing a nucleic acid molecule in its genome, said nucleic acid molecule comprising the nucleotide sequence from nucleotide positions 1268 to 47662 of SEQ ID NO:41 or its complementary sequence, or a molecule comprising at least 95%, 97%, 98%, 99%, or 99.5% sequence identity with the nucleotide sequence from nucleotide positions 1268 to 47662 of SEQ ID NO:41 or its complementary sequence.

[0049] Another aspect of the present invention provides for determining whether a rapeseed plant is an inbred strain NS-B50027-4 or is associated with an inbred strain NS-B50027-4, or is a rapeseed plant comprising at least a portion of a genetically superior event containing strain NS-B50027-4. This document describes compositions and methods of simple and well-defined techniques for identifying the genetically superior event NS-B50027-4 in biological samples. For example, a kit includes at least one set of sense (forward) and antisense (reverse) primers specific to the linking of Brassica chromosomal DNA and inserted transgenes. For example, DNA links containing the sequences SEQ ID NO:43 (TGGAGGTGTTCAAACACT), SEQ ID NO:44 (ATAGTATTAGTATACAGA), SEQ ID NO:45 (GGCTAAGGTAACACTGAT), and SEQ ID NO:46 (CAGTGTTTGAAGGACAGA) are novel DNA sequences for the NS-B50027-4 event and can be used to diagnose rapeseed plant NS-B50027-4 and its progeny. The linker sequences in SEQ ID NO:43 and SEQ ID NO:44 represent 9 polynucleotides on each side of the insertion site of the transgenic sequence fragment and on the rapeseed genome chromosome A02 DNA; and the linker sequences in SEQ ID NO:45 and SEQ ID NO:46 represent 9 polynucleotides on each side of the insertion site of the transgenic sequence fragment and on the rapeseed genome chromosome A05 DNA. Longer or shorter polynucleotides can be selected from the flanking regions described herein.

[0050] In addition, DNA event primer pairs can also be used to generate amplicons for diagnosing the NS-B50027-4 event. These event primer pairs include, for example, AATTTGTTGGAGGTGTTCAAACACT (SEQ ID NO:51) and CGGAATCACAATCCCTGAATGATT (SEQ ID NO:52), or their complementary sequences. The amplicons generated by SEQ ID NO:51 and SEQ ID NO:52 are approximately 250 polynucleotides long. Besides these primer pairs, any primer pair derived from SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45, or SEQ ID NO:46, or their complementary sequences, when used in DNA amplification reactions to generate amplicons for diagnosing the NS-B50027-4 event, is an aspect of this invention.

[0051] Another embodiment provides at least one set of primers for one of the following: a Δ6-desaturase from the microalga *Microcystis spp.*, a Δ5-elongase from the microalga *Pyramimonas cordata*, a Δ6-elongase from the microalga *Pyramimonas cordata*, a Δ5-desaturase from the marine microalga *Haloxylon ammodendron*, a Δ15 / ω3-desaturase from the yeast *Pichia pastoris*, a Δ4-desaturase from *Pyramimonas ammodendron*, and a Δ12-desaturase from the yeast *Lachancea kluyveri*; and at least one set of primers specific for a 5' link between the insert and the native *Brassica oleracea* chromosome A02 DNA, such as the link of SEQ ID NO:40 from nucleotides 2033 to 2132, comprising a 43 bp insert and a 100 bp region of 57 bp of *Brassica oleracea* chromosome A02 DNA; or at least one set of primers specific for a 3' link between the insert and the native *Brassica oleracea* chromosome A02 DNA, such as the link of SEQ ID NO:40. The link of SEQ ID NO:40 from nucleotides 14156 to 14255 comprises a 46 bp insert and a 100 bp region of 54 bp Brassica chromosome A02 DNA; or at least a set of primers specific for the 5' link between the insert and the native Brassica chromosome A05 DNA, such as the link of SEQ ID NO:41 from nucleotides 1110 to 1209 comprising a 50 bp insert and a 100 bp region of 50 bp Brassica chromosome A05 DNA, or at least a set of primers specific for the 3' link between the insert and the native Brassica chromosome A05 DNA, such as the link of SEQ ID NO:41 from nucleotides 47724 to 47823 comprising a 50 bp insert and a 100 bp region of 50 bp Brassica chromosome A05 DNA.

[0052] Another aspect of the embodiments described herein provides a kit for identifying NS-B50027-4 superior species events in biological samples, the kit comprising at least one primer or probe that specifically recognizes the 5' or 3' Brassica genus region flanked by exogenous DNA, and at least one primer or probe that specifically recognizes at least one of the following inserted DNAs: a Δ6 desaturase derived from *Microcystis aeruginosa*, which may contain the nucleotide sequences GAGCACCTTGTAGTTGAGTCC (SEQ ID NO:57), AGTCTGAGGATGCTCCTATGC (SEQ ID NO:58) or their complementary sequences; a Δ5-elongase derived from *Pyramimonas cordata*, which may contain the nucleotide sequences TGCTGGAACTCTTGGATACG (SEQ ID NO:63), CTGGGTGATGTACTTCTTCC (SEQ ID NO:64) or their complementary sequences; or a Δ5-desaturase derived from *Haloxylon ammodendron*, which may contain the nucleotide sequences GCTACCGATGCTTACAAGCA (SEQ ID NO:61), TAGTGAAGTCCGTGCTTCTC (SEQ ID NO:62), or TAGTGAAGTCCGTGCTTCTC (SEQ ID NO:63). SEQ ID NO:62) or its complementary sequence; Δ15 / ω3-desaturase from *Pichia pastoris*, which may contain the nucleotide sequences GACGCCTATCCCTAAGCACTGT (SEQ ID NO:55), GTCCACTCTTGAGCATCGTA (SEQ ID NO:56) or their complementary sequences; Δ4-desaturase from *Haloxylon ammodendron*, which may contain the nucleotide sequences GGCTTTCAGATCTGAGCATC (SEQ ID NO:65), CTCACCTTAACAAGAGGAG (SEQ ID NO:66) or their complementary sequences; Δ12-desaturase from *Lachancea kluyveri*, which may contain the nucleotide sequences TGGAGCTATCCCTCATGAGT (SEQ ID NO:53), GATCCTAGAACAGTAGTGGTG (SEQ ID NO:54) or their complementary sequences; Δ6-elongase from *Pyramimonas* CS0140, which may contain the nucleotide sequence TGTTGCTATGGCTCAAGAGC (SEQ ID NO:62) or its complementary sequence. NO:59), CTAGCGTGGTGCTTCATGTA (SEQ ID NO:60), or their complementary sequences.

[0053] The kit of this embodiment may contain: primers that specifically recognize at least one of the 5' or 3' flanking regions of the superior species event NS-B50027-4; and other primers that specifically recognize sequences within exogenous DNA for use in PCR identification, said exogenous DNA comprising at least one of the following: Δ6-desaturase from *Microcystis aeruginosa*, Δ5-elongase from *Pyramimonas cordata*, Δ5-desaturase from *Haloxylon ammodendron*, Δ15 / ω3-desaturase from *Pichia pastoris*, Δ4-desaturase from *Haloxylon ammodendron*, Δ6-elongase from *Pyramimonas cordata*, or Δ12-desaturase from *Lachancea kluyveri*. The kit may contain at least two specific primers, one primer recognizing a sequence within the 5' flanking region of the superior species event NS-B50027-4, and the other primer recognizing a sequence within exogenous DNA containing at least one of the following: Δ6-desaturase from *Microcystis aeruginosa*, Δ5-elongase from *Pyramimonas cordata*, Δ5-desaturase from *Haloxylon ammodendron*, Δ15 / ω3-desaturase from *Pichia pastoris*, Δ4-desaturase from *Haloxylon ammodendron*, Δ6-elongase from *Pyramimonas cordata*, or Δ12-desaturase from *Lachancea kluyveri*.

[0054] The relevant parties have provided genomic DNA obtained from or derived from plants, said genomic DNA containing at least a portion of the superior phenotypic events of the strain NS-B50027-4. Such genomic DNA can be used as reference control material in the identification assays described herein.

[0055] This application provides the following:

[0056] 1. Seeds of the inbred rapeseed line NS-B50027-4, the representative seeds of which have been deposited with ATCC accession number PTA-123186.

[0057] 2. A rapeseed plant or a portion thereof, said rapeseed plant or a portion thereof being produced by growing seeds as described in item 1.

[0058] 3. Pollen from the plants described in Project 2.

[0059] 4. Ovules of plants as described in Project 2.

[0060] 5. A rapeseed plant or a part thereof, said rapeseed plant or a part thereof having all the physiological and morphological characteristics of the plant described in item 2.

[0061] 6. Tissue cultures of regenerative cells produced from rapeseed plants as described in Project 2.

[0062] 7. The tissue culture according to Project 6, wherein the cells or protoplasts are tissues selected from the group consisting of leaves, pollen, embryos, roots, root tips, pods, flowers, ovules and stems.

[0063] 8. A tissue culture of regenerable cells of rapeseed plant according to Project 2, wherein the tissue regeneration is capable of expressing all the morphological and physiological characteristics of the plant according to Project 2.

[0064] 9. A method for producing rapeseed seeds, the method comprising growing a crop as described in item 2 to produce seeds and harvesting the seeds.

[0065] 10. The method as described in item 9, wherein the growth is carried out in a greenhouse.

[0066] 11. The method as described in item 9, wherein the growth is carried out in a tent.

[0067] 12. The method as described in Project 9, wherein the growth is carried out outdoors.

[0068] 13. A method for producing rapeseed oil, the method comprising obtaining seeds of the plant as described in item 2 and processing the seeds to obtain rapeseed oil.

[0069] 14. The method of item 13, further comprising the step of harvesting the plant of item 2 to obtain the seed.

[0070] 15. The rapeseed plant or a portion thereof as described in Item 5, wherein the plant or portion thereof has been transformed such that its genetic material contains one or more transgenes in addition to the transgene present in the rapeseed line NS-B50027-4, the one or more transgenes being operatively linked to one or more regulatory elements.

[0071] 16. A method for producing rapeseed plants, said rapeseed plants containing one or more transgenes in their genetic material in addition to the transgene of the inbred rapeseed line NS-B50027-4, said method comprising hybridizing the rapeseed plant as described in item 15 with a second plant of another rapeseed line, or with a rapeseed plant of the inbred rapeseed line NS-B50027-4, such that the genetic material of the offspring produced by the hybridization expresses the additional transgene.

[0072] 17. The method of Item 16, wherein the additional transgene confers herbicide resistance, insect resistance, bacterial disease resistance, fungal disease resistance, viral disease resistance, or sterility.

[0073] 18. The rapeseed plant or part thereof as described in Item 5, wherein the plant or part thereof is the product of conventional breeding techniques and has not been modified by recombination, mutagenesis or other genetic modifications except for the superior species event associated with NS-B50027-4.

[0074] 19. A method for producing rapeseed plants, said rapeseed plants having at least one desired trait in addition to the traits of the inbred rapeseed line NS-B50027-4, said method comprising hybridizing the rapeseed plant as described in item 18 with a plant of another rapeseed line, or with a plant of the inbred rapeseed line NS-B50027-4, such that the genetic material of the offspring produced by the hybridization expresses the desired additional trait.

[0075] 20. The method of Item 19, wherein the additional trait confers herbicide resistance, insect resistance, bacterial disease resistance, fungal disease resistance, viral disease resistance, or sterility.

[0076] 21. A method for producing rapeseed plants derived from the rapeseed variety NS-B50027-4, the method comprising:

[0077] (a) Crossing the rapeseed line NS-B50027-4 with a second rapeseed plant to produce progeny rapeseed seeds; and

[0078] (b) The progeny rapeseed seeds are grown under plant growth conditions to produce rapeseed plants derived from the rapeseed line NS-B50027-4.

[0079] 22. The method as described in item 21, further comprising:

[0080] (a) Crossing rapeseed plants from the rapeseed cultivar NS-B50027-4 with itself or another rapeseed plant to produce offspring rapeseed seeds from the rapeseed cultivar NS-B50027-4.

[0081] (b) Allowing the progeny rapeseed seeds from step (a) to grow under plant growth conditions to produce rapeseed plants derived from the additional rapeseed strain NS-B50027-4; and

[0082] (c) Repeat the hybridization and growth steps of (a) and (b) 0 to 7 times to generate rapeseed plants derived from an additional rapeseed line NS-B50027-4, wherein the additional rapeseed plants derived from the additional rapeseed line NS-B50027-4 express a combination of at least two NS-B50027-4 traits selected from DHA production and at least one other agronomically desired trait.

[0083] 23. Rapeseed plants or parts thereof derived from the rapeseed line NS-B50027-4 produced by the method described in Project 21.

[0084] 24. Rapeseed plants or parts thereof derived from rapeseed NS-B50027-4 produced by the method described in Project 22.

[0085] 25. A method for producing rapeseed seeds, the method comprising hybridizing a first parent rapeseed plant with a second parent rapeseed plant and harvesting the resulting first-generation rapeseed seeds, wherein the first parent rapeseed plant or the second parent rapeseed plant is the rapeseed plant as described in Project 2.

[0086] 26. The method according to item 25, wherein the first parent rapeseed plant is different from the second parent rapeseed plant, and wherein the obtained first-generation rapeseed seeds are first-generation (F1) hybrid rapeseed seeds.

[0087] 27. A method for obtaining inbred lines of rapeseed, the method comprising:

[0088] (a) Planting a seed collection containing hybrid seeds, one of the parents of the hybrid seeds being a rapeseed plant according to item 2, or a rapeseed plant having all the physiological and morphological characteristics of a rapeseed plant according to item 2, the seed collection also including seeds of the rapeseed inbred line.

[0089] (b) Growing rapeseed plants from the seed collection;

[0090] (c) Identification of inbred plants from the said rapeseed inbred lines;

[0091] (d) Select the aforementioned inbred plants; and

[0092] (e) Pollination is controlled in a manner that maintains the homozygosity of the inbred plants.

[0093] 28. According to the method described in Project 27, one of the parents has all the physiological and morphological characteristics of the inbred rapeseed line NS-B50027-4, the seeds of which have been deposited with ATCC accession number PTA-123186.

[0094] 29. Cells of rapeseed line NS-B50027-4, and representative samples of its seeds are deposited with ATCC accession number PTA-123186.

[0095] 30. A method for detecting the presence of event NS-B50027-4 in a sample containing plant DNA, wherein the method comprises contacting the sample with:

[0096] (a) A first primer that binds to the flanking linker region of the Brassica genome, the first primer being selected from the primer set consisting of: GAAGGTGACCAAGTTCATGCTTGTTCTTGGGTGGGTCTGTCCTTC (SEQ ID NO: 17; A05 insert linker 1); GAAGGTCGGAGTCAACGGATTGTGTTCTTGGGTGGGTCTGTCCTTA (SEQ ID NO: 18, A05 insert linker 1); ATCCACTAGCAGATTGTCGTTTCCC (SEQ ID NO: 19, A05 insert linker 1); GTTGGCTAAGGTCACGGTGGAG (SEQ ID NO: 20, A05 insert linker 1); GAAGGTGACCAAGTTCATGCTCCGCCTTCAGTTTAAACTATCAGTGTT (SEQ ID NO: 21, A05 insert linker 1); GAAGGTCGGAGTCAACGGATTGGTCACGGTGGAGGTCACCA (SEQ ID NO: 17; A05 insert linker 1); GAAGGTCGGAGTCAACGGATTGGTCACGGTGGAGGTCACCA (SEQ ID NO: 18; A05 insert linker 1); GAAGGTCGGAGTCAACGGATTGGTCACGGTGGAGGTCACCA (SEQ ID NO: 19 ... NO: 22, A05 insert fragment link 1), GGTGTGTTCTTGGGTGGGTCTG (SEQ ID NO: 23, A05 insert fragment link 1); GAAGGTGACCAAGTTCATGCTACTTTTTTTTCAACTGTTGGCTAAGGTA (SEQ ID NO: 24, A05 insert fragment link 2); GAAGGTCGGAGTCAACGGATTACTTTTTTTTCAACTGTTGGCTAAGGTC (SEQ ID NO: 25, A05 insert fragment link 2), GTGTGTTCTTGGGTGGGTCTG (SEQ ID NO: 26, A05 insert fragment link 2); GTCGTTTCCCGCCTTCAGTTT (SEQ ID NO: 27, A05 insert fragment link 2); GAAGGTGACCAAGTTCATGCTAAACTATCAGTGTTTGAACACCTCC (SEQ ID NO: 28, A05 insert fragment link 2); GAAGGTGACCAAGTTCATGCTAAACTATCAGTGTTTGAACACCTCC (SEQ ID NO: 29, A05 insert fragment link 2); GAAGGTGACCAAGTTCATGCTAAACTATCAGTGTTTGAACACCTCC (SEQ ID NO: 20 ...CAGTTCATGCTAAACTATCAGTGTTTGAACACCTCC (SEQ ID NO: 20, A05 insert fragment link 2); GAAGGTGACCCAGTTCATGCTAAACTATCAGTGTTTGA NO: 28, A02 insert fragment link 1); GAAGGTCGGAGTCAACGGATTACAACTTGTCGTGCTACACACCT (SEQ ID NO: 29, A02 insert fragment link 1); GGTTGTGTGAAAACGTGTGAGC (SEQ ID NO: 30, A02 insert fragment link 1); GAAGGTGACCAAGTTCATGCTCTTTTAGCTAAATAAGAGGTTCTGTATACT (SEQ ID NO: 31, A02 insert fragment link 2);GAAGGTCGGAGTCAACGGATTCTTTTAGCTAAATAAGAGGTTCTGTATACA (SEQ ID NO: 32, A02 insert fragment link 2); GATTGTGATTCCGGGCAGT (SEQ ID NO: 33, A02 insert fragment link 2); GTGTGAAAACGTGTGAGCAAT (SEQ ID NO: 34, A02 insert fragment link 2); GAAGGTGACCAAGTTCATGCTTTGTGATTCCGGGCAGTAG (SEQ ID NO: 35, A02 insert fragment link 2); GAAGGTCGGAGTCAACGGATTTGTGAGCAATTGTTGGAGGT (SEQ ID NO: 36, A02 insert fragment link 2); TCTTATCAACATTAAGAACATAATCTTTTAG (SEQ ID NO: 37, A02 insert fragment link 2); at least 10 consecutive nucleotides of any of the aforementioned primers; and their complementary sequences; and;

[0097] (b) A smooth-walled scaffold with a smooth surface, a smooth-moving scaffold: GAAGGT GACCAAGTTCATGCTCCAAGCACCGTAGTAAGAGAGCA(SEQ ID NO:1,Micopu-Δ6D):GCTAAGAAGTGGGGACTCAACTACAA(SEQ ID NO:2,Micopu-Δ6D):GAAGGTGACCAAGTTCATGCTGCTCTTGCTGGAACTCTTGG(SEQ ID NO:3,Pyrco-Δ5E):GGGTTAGCCACATTGTAGGTAACGTA(SEQ IDNO:4,Pyrco-Δ5E):GAAGGTGACCAAGTTCATGCTTAAGACACCCTGGTGGAAAGA(SEQ ID NO:5,Pavsa-Δ5D)TAGCATCAGTTCCAACTTGGTAAGCAAT(SEQ ID NO:6,Pavsa-Δ5D)GAAGGTGACCAAGTTCATGCTGAACACGTAAGCAGACCAAGCAG(SEQ ID NO:7,Picpa-ω3D):CCCTCTTCTCCCTAACGAATTCCTT(SEQ ID NO:8,Picpa-ω3D):GAAGGTGACCAAGTTCATGCTGAGGAACCTGTTGCTGCTGATGA(SEQ ID NO:9,Pavsa-Δ4D):GCGATCCTAGCACAAAGTTGAAGGTA(SEQ IDNO:10,Pavsa-Δ4D):GAAGGTGACCAAGTTCATGCTGGATGGATCGCTTACCTCTTCGT(SEQ ID NO:11,Lack1-Δ12D):CAGGGTAAGGTTGTCCTGTAACGTT(SEQ ID NO:12,Lackl-Δ12D):GAAGGTGACCAAGTTCATGCTCTATTGGATGGGGACTCAAGC(SEQ ID NO:13,Pyrco-Δ6E):GGGAGATCCTTAGTAGCAGAAGAGAT(SEQ ID NO:14,Pyrco-Δ6E):GAAGGTGACCAAGTTCATGCTCCTGAGAGGCGTCCTGTTGAAAT(SEQ ID NO:15,PAT)AACAGCAGCCATATCAGCAGCAGTA(SEQ ID NO:16,PAT)TGGAGCTATCCCTCATGAGT (SEQ ID NO: 53); GATCCTAGAACAGTAGTGGTG (SEQ ID NO: 54, Δ12 desaturase); GACGCTATCCCTAAGCACTGT (SEQ ID NO: 55); GTCCACTCTTGAGCATCGTA (SEQ ID NO: 56, Δ15 / ω3 desaturase); GAGCACCTTGTAGTTGAGTCC (SEQ ID NO: 57); AGTCTGAGGATGCTCCTATGC (SEQ ID NO: 58, Δ6 desaturase); TGTTGCTATGGCTCAAGAGC (SEQ ID NO: 59); CTAGCGTGGTGCTTCATGTA (SEQ ID NO: 60, Δ6 elongation enzyme); GCTACCGATGCTTACAAGCA (SEQ ID NO: 61); TAGTGAAGTCCGTGCTTCTC (SEQ ID NO: 62, Δ5 desaturase); TGCTGGAACTCTTGGATACG (SEQ ID NO: 53); NO: 63); CTGGGTGATGTACTTCTTCC (SEQ ID NO: 64, Δ5 elongase); GGCTTTCAGATCTGAGCATC (SEQ ID NO: 65); CTCAGCCCTTAACAAGAGGAG (SEQ ID NO: 66, Δ4 desaturase); at least 10 consecutive nucleotides of any one of the aforementioned primers; and their complementary sequences; subjecting the sample to a polymerase chain reaction; and determining the amplicon generated between the primers.

[0098] 31. The method as described in item 30, wherein the determination is KASP TM Genotyping.

[0099] 32. Plants, plant materials, or plant-derived materials identified by the methods described in Item 30 or Item 31.

[0100] 33. A kit comprising components for carrying out the method described in item 30 or item 31.

[0101] 34. A kit comprising a forward primer AATTTGTTGGAGGTGTTCAAACACT (SEQ ID NO: 51) and a reverse primer CGGAATCACAATCCCTGAATGATT (SEQ ID NO: 52), or their complementary sequences, wherein the primers provide an amplicon of about 250 nucleotides for diagnosing the superior species event NS-B50027-4.

[0102] 35. Genomic DNA of the inbred rapeseed line NS-B50027-4, whose representative seeds have been deposited with ATCC accession number PTA-123186.

[0103] 36. A method for producing DHA in the seeds of a plant, the method comprising culturing a plant having more than one copy of at least one of a transgene of Δ6-desaturase, Δ5-elongase, Δ5-desaturase and Δ15 / ω3-desaturase in its genome, wherein the transgene is capable of being expressed in the seeds of the plant.

[0104] 37. Seeds of plants cultured as described in item 35.

[0105] 38. A plant cell comprising (a) SEQ ID NO: 43 (TGGAGGTGTTCAAACACT) and SEQ ID NO: 44 (ATAGTATTAGTATACAGA), sequences having at least 95% identity with these, or complementary sequences thereof; (b) SEQ ID NO: 45 (GGCTAAGGTAACACTGAT) and SEQ ID NO: 46 (CAGTGTTTGAAGGACAGA), sequences having at least 95% identity with these, or complementary sequences thereof; or (c) both (a) and (b).

[0106] 39. A plant cell comprising (a) SEQ ID NO: 47 and SEQ ID NO: 48, sequences having at least 95% identity with these, or complementary sequences thereof; (b) SEQ ID NO: 49 and SEQ ID NO: 50, sequences having at least 95% identity with these, or complementary sequences thereof; or (c) both (a) and (b).

[0107] 40. A recombinant Brassica genome, wherein chromosomes A02 and A05 are characterized by: (a) a deletion in chromosome A02, wherein the deletion is GTAGCACGACAAGTT (SEQ ID NO: 38); and (b) a deletion in chromosome A05, wherein the deletion is CACGGTGGAGGTCACCATGT (SEQ ID NO: 39).

[0108] 41. A plant cell comprising (a) SEQ ID NO: 40; (b) SEQ ID NO: 41; or (c) both (a) and (b).

[0109] 42. Seeds of NS-B50027-4, said seeds containing at least 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, or 16% DHA, including the endpoints, in weight percent of total fatty acids in the seed.

[0110] 43. The seeds of NS-B50027-4, said seeds containing at least 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, or 17% of long-chain polyunsaturated fatty acids, calculated as the sum of EPA, DPA, and DHA as weight percent of total fatty acids in the seeds.

[0111] 44. A collection of seeds comprising at least 95% of NS-B50027-4 seeds, wherein the seeds contain at least 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, or 16% DHA, including the endpoints, in weight percent of total fatty acids in the seeds.

[0112] 45. A seed collection comprising at least 95% of NS-B50027-4 seeds, wherein the seeds contain at least about 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, or 16% long-chain polyunsaturated fatty acids (LC-PUFAs), including the endpoints, wherein the LC-PUFAs are the sum of EPA, DPA, and DHA, as a percentage of the total fatty acids in the seeds by weight.

[0113] 46. ​​A composition comprising the seeds of any one of items 42-45, wherein the seeds have been crushed to provide seed oil and seed powder.

[0114] 47. The composition as described in item 46, wherein the seed oil is an edible seed oil.

[0115] 48. Seed oil extracted from the seeds of strain NS-B50027-4, wherein the fatty acid content of the seed oil has an ω-3 / ω-6 fatty acid ratio of at least 3.

[0116] 49. Seed oils as described in item 46, wherein the ratio of ω-3 to ω-6 fatty acids is in the range of 3 to 20.

[0117] 50. Seed oil as described in item 48 or 49, wherein the seed oil is crude oil.

[0118] 51. Seed oil as described in item 48 or 49, wherein the seed oil is a refined oil.

[0119] 52. The seed oil as described in item 48 or 49, wherein the seed oil is a concentrated oil.

[0120] 53. The seed oil of any one of items 50-53, wherein the seed oil is edible.

[0121] 54. A composition comprising seed oil as described in item 53.

[0122] 55. The composition as described in item 54, wherein the composition is a food.

[0123] 56. The composition as described in item 55, wherein the food is intended for human consumption.

[0124] 57. The composition as described in item 55, wherein the composition is an edible oil or salad oil.

[0125] 58. The composition as described in item 54, wherein the composition is an emulsion.

[0126] 59. The composition as described in item 54, wherein the composition is a dry component.

[0127] 60. The composition as described in item 54, wherein the feed is a source of nutrition for aquaculture.

[0128] 61. The composition as described in item 60, wherein the feed is a solid fish feed.

[0129] 62. The composition as described in item 60, wherein the feed is a liquid fish feed.

[0130] 63. The composition as described in item 46, wherein the seed powder is an ingredient in the food.

[0131] 64. The composition as described in item 54, wherein the composition is a pharmaceutical composition.

[0132] 65. Oil obtained from the seeds of NS-B50027-4 or its progeny, wherein the lipids of the oil have been treated to enrich DHA fractions and the enriched lipids contain at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, or at least 90% DHA.

[0133] 66. A method for preparing rapeseed oil containing DHA, the method comprising the following steps:

[0134] (a) Introducing the DHA trait gene of NS-B50027-4 into a superior male-sterile Brassica genus line;

[0135] (b) Introducing the DHA trait gene of NS-B50027-4 into a fertile second superior Brassica genus line;

[0136] (c) Cross two strains (a) and (b) to obtain hybrid offspring;

[0137] (d) Cultivating seeds of hybrid offspring;

[0138] (e) Harvesting the grains produced from the bred hybrid offspring; and

[0139] (f) Extracting oil from the offspring of the hybrid seeds. Brief description of the attached diagram

[0140] Figure 1 A schematic diagram (map) of the GA7-modB converter box is provided.

[0141] Figure 2 This is a plasmid map of the binary vector pJP3416.

[0142] Figure 3 Yield plots for predicted DHA (kg / ha) were created at eight cultivation sites. ◆ represents DHAK g / ha; -- represents linear DHAK g / ha; y = 29.296x + 2.8315; R² = 0.8567.

[0143] Figure 4 Yield plots for predicted LC-PUFA (EPA, DPA, and DHA) (in kg / ha) were plotted at eight sites. ◆ represents LC-PFU kg / ha; -- represents linear LC-PUF kg / ha; y = 34.043x + 3.4049; R² = 0.8636.

[0144] Figure 5 The DNA sequence of the four-gene transgenic insert and its flanking European rapeseed sequence (bold) are shown (SEQ ID NO:40).

[0145] Figure 6 The DNA sequence of the 16-gene insert and its flanking European rapeseed sequence (bold) is shown (SEQ ID NO:41). Detailed description

[0146] It should be understood that the present invention is not limited to the specific methods, schemes, and reagents described herein, and therefore can be varied. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to limit the scope of the invention, which is defined only by the claims.

[0147] All patents and other publications cited are incorporated herein by reference for the purpose of describing and disclosing, for example, methods that may be used in connection with the present invention, but without providing definitions of terms inconsistent with those presented herein. These publications are provided individually only for their disclosures prior to the filing date of this application. In this respect, nothing should be construed as disqualifying the inventor from reliance on prior inventions or for any other reason prior to such disclosures. All statements regarding dates or the contents of these documents are based on information available to the applicant and do not constitute an admission of the accuracy of the dates or contents of these documents.

[0148] As used herein and in the claims, the singular forms “a,” “an,” and “the” include plural indicators unless the context clearly indicates otherwise. Unless otherwise stated, “comprise,” “comprises,” and “comprising” are used inclusively, not exclusively, throughout the specification, such that the integer or group of integers may include one or more other unstated integers or groups of integers. Unless modified, for example, by “either,” the term “or” is inclusive. Therefore, unless the context otherwise indicates, the word “or” means any member of a particular list, and also includes any combination of members of that list.

[0149] All values ​​are approximations because fatty acid composition can vary due to environmental conditions. Values ​​are typically expressed as a percentage of total fatty acid weight, or a percentage of total seed weight. Therefore, except in operational examples or where otherwise indicated, all figures representing amounts or reaction conditions used herein should be understood to be modified by the term “about” in all cases.

[0150] Recombinant DNA technology can be performed according to standard protocols known in the art. See: Sambrook et al., MOLECULAR CLONING: LAB. MANUAL (2nd edition, Cold Spring Harbor Lab. Press, NY (1989); Ausubel et al., CURRENT PROTOCOLS MOLEC. BIOL. (1994 and later); DNA CLONING: PRACTICAL APPROACH, vols. 1–4 (edited by Glover & Hames, IRL Press 1995, 1996); Croy, PLANTMOLEC. BIOL. LABFAX (BIOS Sci. Pub. Ltd. & Blackwell Sci. Pub., UK, 1993); WO2015089587.

[0151] The headings are provided for convenience only and should not be construed as limiting the invention in any way. Unless otherwise defined, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to limit the scope of the invention, which is defined only by the claims. To facilitate a better understanding of this disclosure, certain terms are defined first. Further definitions are set forth throughout the detailed description.

[0152] A “strain” is a group of plants that exhibit very little overall variation among individuals sharing the name. A “strain” also refers to a homogeneous combination of plants carrying substantially the same genetic material, where at least one trait of said substantially the same genetic material exhibits little or no genetic variation among individuals. “Variety” or “cultivated species” can be used interchangeably with “strain,” but generally the first two terms refer to strains suitable for commercial production. For example, the “genetically derived” used in the phrase “genetically derived from parental lines” means that the characteristic in question is determined wholly or partially by one aspect of the genetic makeup of the plant in question.

[0153] As used in this article, "Brassica" refers to plants in the family Brassicaceae. A species of Brassica can be one of the following: rapeseed, brassica (or Brassica campestris), or mustard (B. juncea). Alternatively, the plant can be derived from a species that has hybridized these Brassica species, such as B. napocampestris, or from a species that has been artificially hybridized with another species in the family Cruciferacea. Plloidy refers to whether the cultivated variety exhibits a diploid or tetraploid chromosome number. Because rapeseed is an allotetraploid (double diploid) resulting from the cross-fertilization and preservation of two genomes, Brassica oleracea (formerly Brassica napus) and Brassica oleracea, rapeseed containing the transgenic event NS-B50027-4 can be used to introduce the NS-B50027-4 event and thus introduce the “trait” of producing LC-ω3 fatty acids described herein into other members of the Brassica genus. Therefore, examples of members of the Brassica genus that can be used to implement embodiments of the present invention include, but are not limited to, mustard, Brassica napus napus, Brassica oleracea, Ethiopian mustard (B. carinata), rapeseed, Brassica napus, and Brassica oleracea, as well as any other plant belonging to the Brassica genus that allows for breeding between species. Generally, “oilseed plant” refers to any one of the species rapeseed, Brassica napus (or Brassica oleracea), or mustard.

[0154] European rapeseed is commonly referred to as rapeseed or oilseed rape, and certain cultivars may be called canola. As used herein, the term "rapeseed" or "rapeseed plant" refers to any Brassica genus plant capable of producing rapeseed oil (i.e., oil that meets the specific quality requirement of containing less than 2% erucic acid) and includes the following varieties: European rapeseed, *B. napobrassica*, *Brassica rapa*, mustard, and *Brassica oleracea*. Rapeseed is a didiploid (also known as an allotetraploid), an interspecific hybrid with complete diploid chromosome sets from each parental form, possessing a genome with AACC.

[0155] "Rapeseed" and "rapeseed plant" generally refer to European rapeseed, but include all plant varieties that can be crossbred with rapeseed. "Rapeseed" and "rapeseed plant" also include the plant parts. "Rapeseed oil" must contain less than 2% erucic acid; and 1 gram of air-dried, oil-free solid rapeseed seeds must contain less than 30 micromoles of 3-butenylglucose isothiocyanate, 4-pentenylglucose isothiocyanate, 2-hydroxy-3-butenylglucose isothiocyanate, 2-hydroxy-4-pentenylglucose isothiocyanate, or mixtures thereof. See, for example, CODEX ALIMENTARIUS: FATS, OILS & RELATED PRODUCTS, Volume 8 (2nd edition, Food & Agriculture Org. United Nations, Rome, Italy, 2001).

[0156] "Plant parts" include plant cells, plant organs, plant protoplasts, plant cell tissue cultures from which plants can regenerate, plant callus, plant masses, and intact plant cells in a plant or plant part, such as embryos, pollen, ovules, seeds, pods, leaves, flowers, branches, fruits, stems, roots, root tips, anthers, cotyledons, hypocotyls, radicles, single cells, gametes, cell cultures, tissue cultures, etc. A cotyledon is a type of seed leaf leaf; a small leaflet contained on a plant embryo. Cotyledons contain food storage tissue for the seed. An embryo is a small plantlet contained within a mature seed. "Plant cells" also include non-regenerative plant cells. Progeny, derivatives, variants, and mutants of regenerated plants are also included within the scope of this invention, provided that these parts contain the NS-B50027-4 nucleic acid molecule. This invention also relates to the use of the superior NS-B50027-4 transgenic species in plant cell and tissue cultures. The implementation scheme includes plants and plant parts from the superior cultivar NS-B50027-4, as well as other plants produced by the methods described herein.

[0157] An "allelic gene" is any one or more alternative forms of a gene associated with a trait or characteristic. In a diploid cell or organism, the two alleles of a given gene occupy corresponding loci on a pair of homologous chromosomes.

[0158] A locus confers one or more traits, such as modified fatty acid metabolism, modified phytic acid metabolism, modified carbohydrate metabolism, male sterility, herbicide tolerance, insect resistance, disease resistance, or modified protein metabolism. Traits can be conferred by, for example, naturally occurring genes introduced into the genome of a strain through backcrossing, natural or induced mutations, or transgenes introduced through genetic transformation techniques. A locus may contain one or more alleles integrated at a single chromosomal location. A quantitative trait locus (QTL) is a genetic locus that controls, at least to some extent, a trait that is typically continuously distributed and can be represented numerically.

[0159] An "event" is an artificial locus of exogenous DNA carrying at least one copy of the gene of interest, as a result of genetic manipulation. The typical allelic state of an event is the presence or absence of exogenous DNA. Events can be characterized phenotypically by the expression of one or more transgenes. At the genetic level, an event is part of the plant's genetic makeup. At the molecular level, an event is characterized by a restriction map (e.g., determined by DNA imprinting) or upstream or downstream flanking sequences of the transgene, or the molecular conformation of the transgene. Transformation of plant cells or parts with transforming DNA typically results in multiple events, each unique.

[0160] The term "gene" refers to a DNA molecule that typically contains several operatively linked DNA regions, such as a promoter and a 5' untranslated region (5'UTR or 5' non-coding sequence), which together form the promoter region; a coding region (which may or may not encode a protein); and a non-translated 3' region (3'UTR or 3' non-coding sequence) containing polyadenylation sites. Typically in plant cells, the 5'UTR, coding region, and 3'UTR are transcribed into an RNA molecule, which, in the case of a protein-coding gene, is translated into a protein. Therefore, a "coding sequence" refers to the nucleotide sequence in a DNA molecule that provides the codons for translating a specific amino acid sequence. Genes may include additional DNA regions, such as, for example, introns. A "genotype" refers to the genetic makeup of a cell or organism. A "locus" is typically the location of a given gene within the plant genome.

[0161] The term "transgenic" refers to a gene of interest integrated into the genome of a plant. Therefore, a "transgenic plant" contains at least one transgenic gene in the genome of all its cells. The transgenic gene of embodiments of the present invention contains at least one copy of the gene of interest, and more specifically, at least one copy of a Δ4-desaturase derived from *Pyramimonas halophila*, a Δ5-desaturase derived from the marine microalga *Pyramimonas halophila*, a Δ5-elongation enzyme derived from the microalga *Pyramimonas cordata*, a Δ6-desaturase derived from the microalga *Microcystis aeruginosa*, a Δ6-elongation enzyme derived from *Pyramimonas cordata*, a Δ12-desaturase derived from the yeast *Lachancea kluyveri*, and a Δ15 / ω3-desaturase derived from the yeast *Pichia pastoris*; and at least one additional copy of a Δ6-desaturase derived from the microalga *Microcystis aeruginosa*, a Δ5-elongation enzyme derived from the microalga *Pyramimonas cordata*, a Δ5-desaturase derived from the marine microalga *Pyramimonas halophila*, and a Δ15 / ω3-desaturase derived from the yeast *Pichia pastoris*. The transgene is arranged in a binary configuration within an expression cassette that includes a suitable regulatory region. The transgenes described above are artificial because they were designed using a codon optimization strategy, and therefore do not originally exist in nature. The transgene expression cassette may include at least one matrix-binding region (MAR) from safflower tobacco. The transgene cassette may also include an optional marker gene. See U.S. Patent No. 8,816,111.

[0162] When referring to genes or DNA molecules in relation to a plant species, "exogenous" or "heterogeneous" means that the gene or DNA molecule or a portion thereof (e.g., a specific region) cannot be found naturally in that plant species, or cannot be found naturally at a locus in that plant species. The term "exogenous DNA" also refers to a DNA molecule that will be integrated into or has already been integrated into the genome of a plant due to transformation. In the context of this disclosure, a transgene, transgene cassette, or transgene expression cassette contains at least one exogenous or heterologous DNA.

[0163] When referring to a gene or DNA molecule, the term "chimeric" is used to indicate that the gene or DNA molecule contains at least two functionally related DNA regions (such as promoters, 5'UTRs, coding regions, 3'UTRs, introns) that are naturally unassociated with each other and originate from different sources, such that at least one DNA region is foreign to the other DNA region in the chimeric molecule.

[0164] The terms "plasmid" and "vector" refer to extrachromosomal elements that typically carry genes that are not part of the cell's central metabolism, and are usually in the form of circular double-stranded DNA fragments. Such elements can be autonomously replicating sequences, genome-integrated sequences, phage sequences, or nucleotide sequences derived from any source of linear or circular single-stranded or double-stranded DNA or RNA, many of which have been ligated or reassembled into a unique construct capable of introducing a promoter fragment and DNA sequence of a selected gene product, along with a suitable 3' untranslated sequence, into the cell. In the context of transgenic plants, such plasmids or vectors may contain T-DNA regions to facilitate the insertion of transgenes into the plant genome.

[0165] An "expression cassette" is a genetic construct that contains a transgene and has elements other than the exogenous gene that allow the gene to be expressed in a foreign host; it can refer to the cassette before and after insertion into the plant's genome. In other words, the transgene insertion fragment constitutes the expression cassette.

[0166] "Transforming DNA" refers to recombinant DNA molecules used for transformation, such as expression vectors. Transforming DNA typically contains at least one "gene of interest" (e.g., a chimeric gene) that can confer one or more specific characteristics to the transformed plant.

[0167] "Transformation" refers to the transfer of nucleic acid molecules into a host organism, resulting in genetically stable inheritance. For example, the nucleic acid molecule can be a self-replicating plasmid, or it can integrate into the host organism's genome. A host organism containing the transformed nucleic acid fragment is called a "transgenic," "recombinant," or "transformed" organism.

[0168] The term "recombinant DNA molecule" is used illustratively and can therefore include isolated nucleic acid molecules, which can be DNA and can be obtained through recombination or other processes such as synthetic DNA synthesis or PCR. PCR (polymerase chain reaction) is a reaction in which primers consisting of "upstream" and "downstream" primers and a polymerization catalyst (such as DNA polymerase), typically a thermostable polymerase, are used to prepare replicated copies of a target polynucleotide. Methods used for PCR are known in the art. See, for example, PCR (edited by McPherson & Moller, BIOS Sci. Publ. Ltd., Oxford, 2000). PCR can be performed on genomic DNA or cDNA.

[0169] "Intercalated DNA" refers to heterologous DNA introduced into plant material through transformation methods, and includes DNA that is different from the original DNA used for such transformations described herein. Intercalated DNA is typically a transgenic expression cassette. "Superior Species Event NS-B50027-4 Intercalated Nucleic Acid" and "Event NS-B50027-4 Intercalated DNA" refer to nucleic acid molecules characterized by a sequence of nucleotides 2090 to 14201 of SEQ ID NO:1 or their complementary sequences; and nucleic acid molecules characterized by containing nucleotide positions 987 to 1894 of SEQ ID NO:2, or sequences 1 to 910 of SEQ ID NO:3 or their complementary sequences.

[0170] "Suitable regulatory sequences" refer to nucleotide sequences located upstream (e.g., 5'UTR), inside, or downstream (3'UTR) of a coding sequence; said nucleotide sequences affect transcription, RNA processing or stability, or the translation of the related coding sequence. Regulatory sequences may include promoters, enhancer elements, translational leader sequences, introns, polyadenylation recognition sequences, RNA processing sites, effector binding sites, and stem-loop structures.

[0171] A promoter is a DNA sequence that controls the expression of a coding sequence or functional RNA. Typically, the coding sequence is located at the 3' end of the promoter sequence. Promoters can be derived entirely from a natural gene, or comprise different elements derived from different promoters found in nature, or even comprise synthetic DNA segments. Those skilled in the art understand that different promoters can direct gene expression in different tissues or cell types, or at different stages of development, or in response to different environmental or physiological conditions. Promoters that cause gene expression in most cell types most of the time are generally referred to as "constitutive promoters." It is also recognized that DNA fragments of different lengths can have the same promoter activity because the exact boundaries of the regulatory sequence are not fully determined in most cases.

[0172] The terms "3' non-coding sequence" and "transcription terminator" refer to DNA sequences located downstream of coding sequences. This includes polyadenylation recognition sequences and other sequences encoding regulatory signals that can affect mRNA processing or gene expression. Polyadenylation signals are typically characterized by influencing the addition of polyadenylic acid tracts to the 3' end of mRNA precursors. The 3' region can affect transcription, RNA processing or stability, or the translation of related coding sequences.

[0173] The term "operably linked" refers to the association of nucleic acid sequences on a single nucleic acid fragment, such that the function of one nucleic acid sequence is influenced by another. For example, when a promoter can regulate the expression of a coding sequence, the promoter is operably linked to that coding sequence (i.e., the coding sequence is under the transcriptional control of the promoter). The coding sequence can be operably linked to the regulatory sequence in a sense or antisense direction.

[0174] As used herein, the term "expression" refers to the transcription and stable accumulation of meaningful (mRNA) derived from the nucleic acids of this invention. Expression can also refer to the translation of mRNA into a polypeptide.

[0175] Unless otherwise stated or clearly indicated from the context, references to cells include plant cells, whether isolated, in tissue cultures, or integrated into a plant or plant part.

[0176] "Offspring" refers to all descendants, including plant offspring or derivatives, and encompassing the first, second, third, and subsequent generations; they can be produced through self-pollination or hybridization with plants of the same or different genotypes, and can be modified through a range of suitable genetic engineering techniques. Cultigen typically refers to plants that have been intentionally altered and selected by humans. "T0" refers to the first generation of transformed plant material, "T1" refers to the seeds produced on T0 plants, T1 seeds produce plants that produce T2 seeds, and subsequent Tx generations.

[0177] "Breeding" encompasses all methods for developing or propagating plants, including intraspecific and interspecific hybridization, intra-line and inter-line hybridization, and all suitable conventional and artificial breeding techniques. Desired traits (e.g., the DHA trait in NS-B50027-4) can be transferred to other rapeseed or European rapeseed lines, cultivars, or cultigens; or through conventional breeding methods and also through interspecific hybridization to other Brassica species such as mustard and Brassica rapa. Conventional breeding methods, interspecific hybridization methods, and other methods for transferring genetic material between plants are well known in the art.

[0178] "Backcrossing" is a method in which breeders repeatedly cross hybrid offspring back into the parent line, for example, crossing the first-generation hybrid F1 with a parent genotype of the F1 hybrid.

[0179] "Fatty acid composition" or "fatty acid content" typically refers to the weight percentage of various fatty acids present in the endogenously formed oil of mature, intact, partially dried seeds. A common industry practice is to report fatty acid composition as an area percentage (area normalized) rather than an absolute amount. Area percentages are easy to calculate and readily comparable to results from many others in the industry that report in the same manner. Area percentages differ from, but are approximations of, absolute weight percentages. Absolute results can be calculated based on mg / kg using separate reference standards and internal standards of known concentrations. However, it is also possible to calculate the mass of fatty acids without using separate fatty acid standards, although an internal standard may still be necessary. Typically, fatty acid content is determined by crushing the seeds and extracting the fat as fatty acid methyl esters (FAMEs), which can be analyzed using various techniques to generate area percentages or from which data on area percentages can be derived. Examples of analytical methods include gas chromatography (GC), GC-MS, liquid chromatography-mass spectrometry (LC-MS), nuclear magnetic resonance (NMR), or near-infrared reflectance spectroscopy. Total lipids can be separated into purified fractions using techniques known in the art, such as TAG fractions. Other methods for characterizing fatty acid composition are known to those skilled in the art. See, for example, Tinoco et al., 3 Anal. Biochem. 514 (1962); CANALA: CHEMISTRY, PRODUCTION, PROCESSING & UTILIZATION (edited by Daun et al., AOCS Press, Urbana, IL, 2011) (Daun et al., 2011); US 2015 / 0166928; US20160002566.

[0180] Similarly, "oil content" is the typical weight percentage of oil present in mature, intact, partially dried seeds (typically containing about 6% or 7% moisture). The percentage of oil is calculated as the weight of the oil divided by the weight of the seed at 0% moisture. Oil content can be characteristic of different varieties. It can be determined using various analytical techniques, such as NMR (MQC, Oxford Instruments), NIR, and Soxhlet extraction. For example, rapeseed oil content can be measured using nuclear magnetic resonance (Rossell & Pritchar, ANALYSIS OF OILSEEDS, FATS & FATTY FOODS 48-53 (Elsevier Sci. Pub. Ltd, London, 1991) or by pulsed-wave NMS 100 Minispec (Balker Pty Ltd Scientific Instruments, Germany), while simultaneously measuring moisture content. Seed oil content can also be measured by near-infrared reflectance (NIR) spectroscopy. Li et al. 67 Phytochem. 904 (2006).

[0181] The phrases “extracted plant lipids,” “isolated plant lipids,” “extracted lipids,” etc., refer to compositions comprising lipids extracted from, for example, crushed plants or plant parts (such as seeds). The extracted lipids can be relatively crude compositions obtained, for example, by crushing plant material (such as seeds); or more purified compositions in which most (if not all) of the water, nucleic acids, proteins, or carbohydrates derived from the plant material have been removed from the oil. Examples of purification methods are known in the art. In some embodiments, the extracted or isolated plant lipids comprise at least about 60%, at least about 70%, at least about 80%, at least about 90%, or at least about 95% (w / w) of lipids by weight of the composition. The extracted lipids can be solid or liquid at room temperature, the latter being considered “oil.” In some embodiments, the extracted lipids are not mixed with another lipid from another source, such as DHA (e.g., DHA from fish oil). In some embodiments, the ratios of oleic acid to DHA, palmitic acid to DHA, linoleic acid to DHA, or total ω6 fatty acids to total ω3 fatty acids are not significantly altered (e.g., no more than 10% or 5% change) after extraction compared to the ratios in whole seeds or cells. In other words, the extracted lipids are not enriched with specific fatty acids, such as DHA. In other embodiments, the extracted plant lipids have not been exposed to processes such as hydrogenation or fractionation, which alter the ratios of oleic acid to DHA, palmitic acid to DHA, linoleic acid to DHA, or total ω6 fatty acids to total ω3 fatty acids compared to the ratios in whole seeds or cells. That is, the extracted lipids are not enriched with specific fatty acids, such as DHA. When the extracted plant lipids of the embodiments of the present invention are oils, the oils also contain non-fatty acid molecules such as sterols.

[0182] As described above, the phrases "extracted plant oil" and "isolated plant oil" refer to compositions comprising extracted or isolated plant lipids that are liquid at room temperature. The oil is obtained from a plant or a part thereof, such as seeds. The extracted or isolated oil can be a relatively crude composition obtained, for example, by crushing plant seeds; or a more purified composition in which most (if not all) of the water, nucleic acids, proteins, or carbohydrates derived from the plant material have been removed from the oil. The composition may contain other components that can be lipids or non-lipids, such as non-fatty acid molecules such as sterols. In embodiments, the oil composition comprises at least about 60%, at least about 70%, at least about 80%, at least about 90%, or at least about 95% (w / w) of extracted plant lipids. In embodiments, the oil extracted according to the present invention is not mixed with another oil or fatty acid such as DHA (e.g., DHA from fish oil) from another source. In one embodiment, the ratio of fatty acids does not change significantly (e.g., no more than 10% or 5% change) after extraction compared to the ratio in whole seeds or cells; the extracted vegetable oil has also not been exposed to processes such as hydrogenation or fractionation, which significantly alter the ratio of fatty acids in the extract compared to the ratio in whole seeds or cells. That is, the extracted oil is not enriched with specific fatty acids, such as DHA.

[0183] As used herein, "oil" is a composition that primarily comprises lipids and is liquid at room temperature. For example, the oils of the present invention preferably contain at least 75%, at least 80%, at least 85%, or at least 90% lipids by weight. Typically, purified vegetable oils contain at least 90% triglycerides (TAGs) by weight of the lipids in the oil. Trace components of the oil, such as diacylglycerides (DAGs), free fatty acids (FFAs), phospholipids, or sterols, may be present in the oil.

[0184] As used herein, the term "fatty acid" refers to a carboxylic acid, typically with a long aliphatic tail, whether saturated or unsaturated. Generally, fatty acids have carbon-carbon bonds of at least 8 carbon atoms, such as at least 12, 16, 18, 20, or 22 carbon atoms. Most naturally occurring fatty acids have an even number of carbon atoms because their biosynthesis involves acetates with two carbon atoms. Fatty acids can be in a free state (non-esterified); in esterified forms such as triglycerides (TAG), diacylglycerols (DAG), or part of monoacylglycerols; or in an acyl-CoA (thioester) or other bound form. Fatty acids can be esterified into phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, phosphatidylinositol, or diphosphatidylglycerol.

[0185] "Saturated fatty acids" do not contain carbon-carbon double bonds (olefins) or other functional groups along their chain. "Saturated" means that hydrogen is present at all possible carbons (except for the carboxylic acid [-COOH] group). In other words, in saturated fatty acids, the omega (ω-terminus) of the fatty acid (also called the n-terminus) contains three hydrogens (-CH3), and each carbon in the chain contains two hydrogens (-CH2-).

[0186] Unsaturated fatty acids share a similar backbone with saturated fatty acids, except that they contain at least one olefinic group (-CH=CH-) in their carbon chain. The two side carbon atoms (bonded to either side of the olefinic group) can be in either cis or trans configuration. A monounsaturated fatty acid is a fatty acid with at least 12 carbon atoms in its carbon chain but only one olefinic group. A polyunsaturated fatty acid, or "PUFA," is a fatty acid with at least 12 carbon atoms and at least two olefinic groups in its carbon chain. Long-chain polyunsaturated fatty acids (LC-PUFAs) and "LC-PUFAs" are fatty acids with at least 20 carbon atoms in their carbon chain and at least two olefinic groups. Very long-chain polyunsaturated fatty acids (VLC-PUFAs) and "VLC-PUFAs" are fatty acids with at least twenty-two carbon atoms and at least three olefinic groups in their carbon chain. Mentions of LC-PUFAs include VLC-PUFAs. Generally, the number of carbon atoms in the carbon chain of a fatty acid refers to the unbranched carbon chain. If the carbon chain is branched, the number of carbon atoms does not include those in the side groups.

[0187] In one embodiment, LC-PUFA is an ω3 fatty acid: it has a desaturated (olefinic group) at the third carbon-carbon bond of the fatty acid counting from the methyl terminus. In another embodiment, LC-PUFA is an ω6 fatty acid: it has a desaturated (olefinic group) at the sixth carbon-carbon bond of the fatty acid counting from the methyl terminus. The position of the olefin (double bond) in the fatty acid chain is also annotated using Δ (or δ), where the position of the olefin refers to the carboxyl terminus number of the fatty acid. For example, linoleic acid can also be referred to as "cis-Δ9, cis-Δ12 octadecadienoic acid" or Δ 9,12 Octadectopadienoic acid. Fatty acids can also be identified using the "C:D" lipid ratio, where C represents the number of carbon atoms and D represents the number of double bonds in the carbon backbone. For example, arachidonic acid can be labeled as 20:4Δ. 5,8,11,14 The name "arachidonic acid" refers to an 20-carbon chain with four olefin groups at the carbons 5, 8, 11, and 14 at the carboxyl terminus of the fatty acid. The name also indicates that arachidonic acid is an ω6 fatty acid because if there are 20 carbons and an olefin at C14 from the carboxyl terminus, the first olefin from the methyl terminus must be at C6.

[0188] In another embodiment, LC-PUFA is selected from the group consisting of: arachidonic acid (ARA, 20:4Δ) 5,8,11,14;ω6), eicosatetraenoic acid (ETA, 20:4Δ 8,11,14,17 ;ω3), eicosapentaenoic acid (EPA, 20:5Δ 5,8,11,14,17 ;ω3), eicosapentaenoic acid (DPA, 22:5Δ 7,10,13,16,19 ;ω3), or docosahexaenoic acid (DHA, 22:6Δ 4,7,10,13,16,19 LC-PUFA can also be di-high-γ high-linolenic acid (DGLA) or eicosatrienoic acid (ETrA, 20:3Δ). 11,14,17 ; ω3). The LC-PUFA prepared according to embodiments of the present invention may be any or all of the above mixtures, and may include other LC-PUFAs or derivatives of any of these LC-PUFAs. However, LC-PUFAs produced in superior rapeseed varieties are generally purer than LC-PUFAs derived from fish oil. In at least one embodiment, the ω3 fatty acid is DHA; DPA and DHA; or at least one of EPA, DPA, and DHA.

[0189] Furthermore, as described above, LC-PUFA and VLC-PUFA can be free fatty acids (non-esterified), esterified, or in another bound form. Therefore, the LC-PUFA of the embodiments of the present invention can be present in the form of a mixture of cellular lipids, extracted lipids, or purified oils. In at least one embodiment, the oil contains at least 75% or at least 85% triglycerides, with the remainder present in other forms of lipids, such as those mentioned, wherein the triglycerides contain at least one LC-PUFA. The oil can then be further purified or processed, for example by hydrolysis with a strong base to release free fatty acids, or by distillation or similar methods.

[0190] Therefore, "total ω3 fatty acids," "total ω3 fatty acid content," etc., refer to the sum of all esterified and non-esterified ω3 fatty acids extracted from lipids, oils, recombinant cells, plant parts, or seeds (as determined by context), usually expressed as a percentage of total fatty acid content. These ω3 fatty acids include ALA, SDA, ETrA, ETA, EPA, DPA, or DHA, and do not include any ω6 fatty acids or monounsaturated fatty acids. "New ω3 fatty acids," "new ω3 fatty acid content," etc., refer to the sum of all esterified and non-esterified ω3 fatty acids, excluding ALA, extracted from lipids, oils, recombinant cells, plant parts, or seeds (as determined by context), expressed as a percentage of total fatty acid content. These new ω3 fatty acids are fatty acids produced in cells, plants, plant parts, and seeds of embodiments of the present invention through the expression of superior transgenic constructs, and if present, include SDA, ETrA, ETA, EPA, DPA, or DHA, but do not include ALA, any ω6 fatty acids, or monounsaturated fatty acids. Exemplary total ω3 fatty acid content and novel ω3 fatty acid content can be determined by converting fatty acids in the sample to FAME and performing GC analysis using methods known in the art. See, for example, American Oilseed Chemists' Society (AOCS) method Celd-91.

[0191] Similarly, "total ω6 fatty acids," "total ω6 fatty acid content," etc., refer to the sum of all esterified and non-esterified ω6 fatty acids in extracted lipids, oils, recombinant cells, plant parts, or seeds (as determined by context), expressed as a percentage of total fatty acid content. "Total ω6 fatty acids," if present, may include LA, GLA, DGLA, ARA, EDA, or ω6-DPA, but excludes any ω3 fatty acids or monounsaturated fatty acids. "New ω6 fatty acids," "new ω6 fatty acid content," etc., refer to the sum of all esterified and non-esterified ω6 fatty acids other than LA in extracted lipids, oils, recombinant cells, plant parts, or seeds (as determined by context), expressed as a percentage of total fatty acid content. These new ω6 fatty acids are fatty acids produced through transgenic expression in cells, plants, plant parts, or seeds as described herein, and may include GLA, DGLA, ARA, EDA, or ω6-DPA, but exclude LA, ω3 fatty acids, or monounsaturated fatty acids.

[0192] "Half-seed analysis" is the process of analyzing the fatty acids of one of the two cotyledons (half a seed), and the remaining seedling carrying the second cotyledon forms a plant.

[0193] "Protein content" is the typical weight percentage of protein in oil-free crude flour of mature, fully dried seeds, determined by methods known in the art. See, for example, Daun et al., 2011; AOCS Official Meth. Ba 4e-93 Combustion Meth. Determination Crude Protein.

[0194] Mature seeds produced by commercial growers for purposes other than growing or propagating a species are sometimes referred to as "seeds".

[0195] Genetic events

[0196] The phenotypic expression of transgenes in rapeseed is determined by both the structure of the transgene cassette itself and its insertion location in the plant genome: the presence of a transgene at a specific location in the plant genome can affect transgene expression and the overall phenotype of the plant. Successfully introducing commercially interesting traits into plants agriculturally or industrially through genetic manipulation can be a lengthy process dependent on various factors. The actual transformation and regeneration of genetically transformed plants is only the first step in a series of selection steps that include extensive genetic characterization, breeding, and field trial evaluation, ultimately leading to the selection of superior varieties.

[0197] An aspect of this invention relates to expressible transgenes with an astonishing copy number in the plant genome. “Expressible” refers to the primary structure of the DNA molecule, i.e., the coding sequence of the transgene, indicating that the gene encodes an active protein. However, expressible coding sequences may fail to be expressed because “gene silencing” occurs in vivo through various mechanisms of homologous transgene inactivation. Homologous transgene inactivation has been described in plants where the transgene is inserted in a meaningful orientation, with the unintended result that both the gene and the transgene are downregulated. (Napoli et al., 2 Plant Cell 279 (1990)). Possible mechanisms of homologous gene sequence inactivation include transcriptional inactivation via methylation, where the replicated DNA region signals endogenous mechanisms for gene silencing and post-transcriptional silencing, where the combined levels of mRNA from both the endogenous gene and the transgene trigger threshold-induced degradation of both signals. (van Bokland et al., 6 Plant J.861 (1994)). Surprisingly, despite the presence of several transgenes with at least three copies in NS-B50027-4, some of which are oriented in the same direction, NS-B50027-4 exhibits synergistic DHA expression.

[0198] Superior seed events can be characterized by the location and conformation of the site where recombinant DNA molecules are incorporated into the plant genome. The site in the plant genome where the recombinant DNA cassette is inserted is also called the "insertion site" or "target site." A "flanking region" or "flanking sequence" is a region of DNA in the plant genome located immediately upstream of and contiguous with the transgenic cassette, or immediately downstream of and contiguous with the transgenic cassette; for example, at least 20 base pairs, at least 50 base pairs, or up to 5,000 base pairs. Transformations that result in random integration of exogenous DNA produce transformants with different flanking regions, which are characteristic and unique to each transformant (superior seed event).

[0199] Typically, when a transgene is introduced into a plant via conventional hybridization, its insertion site and flanking regions in the plant genome remain unchanged. An "insertion region" refers to a region corresponding to at least 40 base pairs, such as at least 100 base pairs, or up to more than 10,000 base pairs, which is surrounded by upstream and downstream flanking regions of the transgene in the (untransformed) plant genome and includes the insertion site (and possibly a target site deletion). Considering the minute differences due to mutations within a species, the insertion region can maintain at least 85%, such as 90%, 95%, or 100%, sequence identity with the upstream and downstream flanking regions of the exogenous DNA in a given plant of that species. However, the insertion of a transgene cassette into the plant genome can sometimes be accompanied by deletions of plant DNA (referred to as "target site deletions").

[0200] Expression of the gene of interest refers to the fact that a transgene confers one or more phenotypic traits (e.g., production of LC-ω3 fatty acids) to a plant, said phenotypic traits being intended to be conferred by the introduction of transforming DNA (based on the structure and function of some or all of the genes of interest). In embodiments of the invention, several transgenes provide a biosynthetic pathway for the production of LC-ω3 fatty acids in transformed plants.

[0201] As used herein, a “superior species event” is an event selected from a set of events obtained through transformation with the same transforming DNA or through backcrossing with plants obtained through such transformation, based on the expression and stability of the transgenic construct, the compatibility of the transgenic construct with the optimal agronomical characteristics of the plant containing it, and the realization of the desired phenotypic trait. Therefore, the criteria for selecting a superior species event are at least one of the following, and preferably all of them:

[0202] (a) The presence of genetic modification does not excessively impair other desired characteristics of the plant, such as those related to agronomic performance or commercial value;

[0203] (b) The event is characterized by a well-defined molecular conformation that is stably inherited and for which appropriate diagnostic tools with identity control can be developed;

[0204] (c) The gene of interest in the transgenic box demonstrates correct, appropriate, and stable spatial and temporal expression at commercially acceptable levels under heterozygous (or hemizygous) and homozygous conditions of the event, in which plants carrying the event may be exposed to a range of environmental conditions under normal agronomic use. Exogenous DNA can also be associated with locations in the plant genome that allow for gene introgression into further desired commercial genetic contexts.

[0205] The status of an event as a superior seed event can be confirmed by gene introgression of the superior seed event in different relevant genetic backgrounds, and compliance can be observed using at least one criterion, such as (a), (b), and (c) above. Alternatively, the selection of a superior seed event can also be determined based on compatibility, more specifically, by crosses between plants carrying the superior seed event NS-B50027-4 and plants carrying at least one other event, such that the offspring carry two events. Therefore, a "superior seed event" refers to a locus containing a transgenic cassette that meets the above criteria. Plants, seeds, plant materials, or offspring may contain one or more superior seed events in their genome.

[0206] The superior seed event NS-B50027-4 was selected as a superior seed event in the development of rapeseed, producing LC-PUFAs, particularly LC-ω3 fatty acids, and even more particularly DHA. The incorporation of recombinant DNA molecules into the plant genome is typically caused by cell or tissue transformation (or another genetic manipulation). The specific site of incorporation can be random (a matter of chance) or predetermined (if a targeted integration method is used). As described herein, the rapeseed line NS-B50027-4 is a stable and homogeneous breeding line. It was bred with attention to the homogeneity of plant types. The line has increased with continued observation of homogeneity. At the time of patent filing for line NS-B50027-4, the rapeseed line NS-B50027-4 was not a parent of any other commercially available rapeseed cultivar.

[0207] The emergence of new molecular biology techniques has allowed for the isolation and characterization of genetic elements with specific functions, such as encoding specific protein products. Scientists in the field of plant biology have developed a strong interest in engineering plant genomes to include and express exogenous genetic elements, or other versions or modified versions of natural or endogenous genetic elements, thereby altering plant traits in specific ways. Any DNA molecule inserted into the genome of a species using transformation, whether from a different species or the same species, is collectively referred to herein as a “transgenic”. The process of “transformation” is the insertion of DNA into the genome. Several methods for producing transgenic plants have been developed, and in a particular embodiment, the present invention also relates to a transformed version of the claimed rapeseed line NS-B50027-4.

[0208] Numerous methods have been developed for plant transformation, including biological and physical plant transformation protocols. Furthermore, expression vectors and in vitro culture methods for plant cell or tissue transformation and plant regeneration are available. See, for example, Miki et al., Procedures for introducing foreign DNA into plants, METH. PLANT MOLEC. BIOL. & BIOTECHNOL., p. 63 (edited by Glick & Thompson, CRC Press, Boca Raton, 1993); Gruber et al., Vectors for plant transformation, ibid., R p. 89; Genetic transformation for the improvement of Canola, PROC. WORLD CONF. BIOTECHNOL. FATS & OILS INDUS., pp. 43-46 (Am. Oil. Chem. Soc., Champaign, IL, 1988).

[0209] The most common type of plant transformation involves the construction of expression vectors. Such vectors contain DNA molecules with coding regions controlled by regulatory regions (e.g., promoters) or coding regions operatively linked to regulatory regions (e.g., promoters). Vectors may contain one or more genes and one or more regulatory elements. At least one coding region and its respective regulatory element may be arranged in opposite directions within the vector, providing a binary vector. Theoretically, arranging genes sensitive to gene silencing in a binary manner can minimize gene silencing.

[0210] For example, the initial transformation cassette, pJP3416_GA7-modB, includes seven genes that promote the accumulation of ω-3 fatty acids in rapeseed seeds, as well as a selectable marker gene to facilitate the in vitro selection of presumed transgenic plants. See WO2013 / 185184; U.S. Patent Publication No. 2015 / 0374654; U.S. Patents Nos. 8,816,111 and 8,946,460; Petrie et al., 6 Plant Meth. 8 (2010).

[0211] The expressed genes are all synthetic—codon-optimized and synthesized—and therefore no transgenic DNA molecules have been found in any natural organism. The original sequences used as templates for codon optimization are described. See Petrie et al., 12 Metab. Eng'g 233 (2010a); Petrie et al., 11 Plant Methods 6 (2010b); Petrie et al., 21 Transgenic Res. 139 (2012).

[0212] As is well known in the art, functional gene promoters are DNA regions important for gene transcription but do not encode functional products such as peptides. For example, common promoters used for constitutive expression are derived from Cauliflower Mosaic Virus (Kay et al., 236 Science 1299 (1987); Coutu et al., 16 Transgenic Res. 771 (2007). Termination regions including polyadenylation signals are essential for the production of intact and stable mRNA molecules. For example, the Agrobacterium tumefaciens carmine synthase (NOS) terminator provides a useful terminator. Bevan, 12 Nucl. Acid Res. 8711 (1984); Rogers et al., in BIOTECHNOL. PLANT SCI., p. 219 (Acad. Press, Inc., New York, NY, 1985); Sanders et al., 15 Nucl. Acids Res. 1543 (1987). A combination of regulatory sequences is used to drive and terminate transcription of various expression cassettes. Seed-specific promoters used in GA7-modB have been previously described: Arabidopsis thaliana FAE1 (Rossack et al., 46 Plant Molec. Biol. 717 (2001)); Flax (L. usitatissimum) Cnl1 and Cnl2 (Chaudhary et al., WO 2001 / 016340); and a truncated rapeseed protein promoter (Stalberg et al., 23 Plant Molec. Biol. 671 (1993)). See also U.S. Patent No. 8,816,111.

[0213] A more detailed description of the transgenes containing open reading frame 5' and 3' regulatory regions and other non-coding regions of the transgene expression cassette used to introduce the LC-PUFA pathway into rapeseed is shown in Table 1.

[0214]

[0215]

[0216] Therefore, to determine whether a biological sample contains at least a portion of the LC-PUFA pathway as present in NS-B50027-4, primers and probes can be used to detect transgenes. Specific primers useful for detecting transgenes are shown in Table 2, where each primer has an annealing temperature of 62°C, and size (bp) refers to the number of base pairs in the PCR product.

[0217]

[0218] Initial transformants cultured from European rapeseed (v. AV Jade) lines showed significant variation in fatty acid production levels, particularly EPA and DHA. For the second and third generations, selection was primarily based on the DHA and EPA content of the transgenic seeds. In some cases, particularly the T2 or T3 generations, segregation patterns (determined by growing twenty to forty individual seeds from a single plant into twenty to forty progeny and then measuring the DHA and EPA content of the individual seeds of those progeny) also showed dispersed results, indicating the occurrence of compound or multiple copies of the insertion. Consequently, many initial T2 or T3 generation plants were discarded. Initially, it was concluded that multiple copies of the transgenic insert would produce unstable transformants and also exhibit the classic gene silencing seen in homozygous genotypes. Therefore, if PCR analysis of the transformed plants indicated a copy number >1, those transformants were frequently discarded.

[0219] Surprisingly, the superior strain NS-B50027-4 was found to contain multiple copies: 16 gene insertions, including two cassettes with eight-gene T-DNA boundaries arranged in a binary (inverted) left-to-left pattern (similar to a large palindromic structure); and a separate, smaller four-gene cassette; and this combination of transgenic insertions synergistically contributed to DHA production in the inbred line NS-B50027-4. More specifically, a combination of hybridization, backcrossing, and self-crossing segregated the 16-gene insertions onto chromosome A05 (also known as N05) and the four-gene insertions onto chromosome A02 (also known as N02). The contribution of each transgenic chromosome was determined by breeding each segregant to obtain homozygous lines for each event. For example, in one experiment, isolates containing 16 gene inserts produced approximately 4% DHA; and isolates containing four gene inserts did not produce DHA; however, when isolates were cultured to combine transgenic chromosome A02 and transgenic chromosome A05 loci, the combination of the two transgenic inserts provided plants producing at least approximately 7% to at least approximately 14% DHA (including the endpoints) in their seeds. This result was unexpected. As noted, despite the unusual genetic composition of the superior strain NS-B50027-4, the line has demonstrated stable and consistent fatty acid production.

[0220] Regarding the smaller four-gene insert located on A02, this insert replaces approximately 15 bp of the 3'UTR region of a gene with unknown function (HPP gene). Partial insertions and their flanking European rapeseed sequences are fully characterized in this paper. The four-gene insert includes transgenes of Δ6-desaturase, Δ5-elongase, Δ5-desaturase, and Δ15 / ω3-desaturase; but excludes the Δ4-desaturase, Δ12-desaturase, and Δ6-elongase genes, as well as the genetic selection marker PAT. Since Δ4-desaturase is required for DHA production in plant seed cells, it is unexpected and surprising that the four-gene insert synergistically contributes to DHA production in the transgenic line NS-B50027-4. The four-gene insert on A02 and its flanking European rapeseed regions are... Figure 5 The diagram shows (SEQ ID NO:40). Specifically, nucleotides 1 to 2089 of SEQ ID NO:40 are the 5' (upstream) flanking region of the insertion site of the small insert fragment; nucleotides 2090 to 14201 of SEQ ID NO:40 provide a heterologous nucleic acid from the transgenic cassette; and nucleotides 14202 to 15006 of SEQ ID NO:40 are the 808 bp 3' (downstream) region of the insertion site. Nucleotides 1 to 2089 and 14202 to 15006 of SEQ ID NO:40 are natural for the European rapeseed chromosome A02. Genetic analysis comparing the natural European rapeseed sequence with the insertion site revealed the following insertion / deletion: the transgenic insertion fragment replaced a 15-bp fragment (GTAGCACGACAAGTT; SEQ ID NO:38) located at positions 118589927-118589941 of chrUn_random in the reference genome of the European rapeseed cultivar Darmor (2n=AACC) and positions 18569316-18569330 of chromosome A02 in the reference genome of the Brassica rapa cultivar Chiifu (2n=AA). See Chalhoub et al., 345 Sci. 950 (2014); NCBI Ref. Seq. NC_024796.1; Wang et al., 43 Nat. Genet. 1035 (2011); NCBI Ref. Seq. XM_009130638.

[0221] The insertion fragments of 16 genes have been confirmed to be located in Brassica genes encoding Pto-interacting proteins (PTIs), serine-threonine kinases originally involved in hypersensitive response-mediated signal transduction. The PTI genes are located at positions 17267746-17270700 on chromosome A05 of the reference genome, specifically in rapeseed (Carmonia lanceolata). This large insertion fragment, accompanied by an insertion-deletion, replaces a 20-bp stretch of DNA in the second exon of the PTI protein (CACGGTGGAGGTCACCATGT; SEQ ID NO:39), thereby disrupting PTI expression. This 20-bp deletion is located at positions 17269790-17269809 on chromosome A05 of the reference genome. The DNA sequences of the 16 gene insertion fragments on A05 and their flanking rapeseed regions are... Figure 6 The sequence is shown in (SEQ ID NO:41). Specifically, nucleotides 1 to 1159 of SEQ ID NO:41 are the 5' (upstream) flanking region of the insertion site of the large insert; nucleotides 47774 to 49789 of SEQ ID NO:41 are the 3' (downstream) flanking region of the insertion site. Nucleotides 1 to 1159 and 47774 to 49789 of SEQ ID NO:41 are natural for the European rapeseed chromosome A05.

[0222] Therefore, another embodiment provides a DNA molecule comprising an artificial binary locus, said locus containing the following nucleotide sequences in sequence (arrows indicate the transcription direction with respect to a reference 5' to 3' DNA sequence):

[0223] (a) The nucleotide sequence from nucleotide 2747 to nucleotide 6250 of SEQ ID NO:40 (Micpu-d6D ← including PRO, leader sequence, TER);

[0224] (b) The nucleotide sequence from nucleotide 6257 to nucleotide 8414 of SEQ ID NO:40 (→Pyrco-d5E, including PRO, leader sequence, TER);

[0225] (c) The nucleotide sequence of SEQ ID NO:40 from nucleotide 8415 to nucleotide 10374 (→Pavsa-d5D, including PRO, leader sequence, TER);

[0226] (d) The nucleotide sequence from nucleotide 10375 to nucleotide 11544 of SEQ ID NO:40 (→MAR); and

[0227] (e) The nucleotide sequence of SEQ ID NO:40 from nucleotide 11545 to nucleotide 14049 (Picpa-w3 / d15D←, including PRO, leader sequence, TER);

[0228] (f) Molecules having at least 80%, 95%, 97%, 98%, 99%, or 99.5% sequence identity with nucleotide sequences (a) through (e); or

[0229] (g) Its complementary sequence.

[0230] The relevant implementation scheme provides plant cells, plant materials, or plant seeds containing the artificial binary locus.

[0231] Another embodiment provides a DNA molecule comprising an artificial binary locus, the locus molecule comprising the following nucleotide sequence in sequence:

[0232] (a) The nucleotide sequence from nucleotide 1268 to nucleotide 5317 of SEQ ID NO:41 (Cn12 PRO via leader sequence via coding region of Micpu-d6D ← via TER);

[0233] (b) The nucleotide sequence from nucleotide 5324 to nucleotide 7481 of SEQ ID NO:41 (PRO via → Pyrco-d5E via TER);

[0234] (c) The nucleotide sequence from nucleotide 7482 to nucleotide 9443 of SEQ ID NO:41 (PRO via leader sequence and →Pavsa-d5D via TER);

[0235] (d) The nucleotide sequence from nucleotide 9444 to nucleotide 10611 of SEQ ID NO:41 (→MAR);

[0236] (e) The nucleotide sequence from nucleotide 10612 to nucleotide 13116 of SEQ ID NO:41 (PRO via leader sequence and Picpa-w3 / d15D← via TER);

[0237] (f) The nucleotide sequence from nucleotide 13117 to nucleotide 17000 of SEQ ID NO:41 (PRO via → Pavsa d4D via TER);

[0238] (g) The nucleotide sequence from nucleotide 17001 to nucleotide 19606 of SEQ ID NO:41 (PRO via → Lack-d12D via TER);

[0239] (h) The nucleotide sequence of SEQ ID NO:41 from nucleotide 19607 to nucleotide 29773 (→MAR);

[0240] (i) The nucleotide sequence from nucleotide 20783 to nucleotide 22987 of SEQ ID NO:41 (PRO via → Pyrco-d6E via TER);

[0241] (j) The nucleotide sequence from nucleotides 23011 to 24370 of SEQ ID NO:41 (PRO through → PAT through TER);

[0242] (k) The nucleotide sequence from nucleotide 42561 to nucleotide 25920 of SEQ ID NO:41 (PRO via PAT ← via TER);

[0243] (1) The nucleotide sequence from nucleotide 25943 to nucleotide 29324 of SEQ ID NO:41 (PRO via Pyrco-d6E ← via TER);

[0244] (m)nucleotide sequence from nucleotide 28157 to nucleotide 29324 of SEQ ID NO:41 (MAR←);

[0245] (n) The nucleotide sequence from nucleotide 29324 to nucleotide 31830 of SEQ ID NO:41 (PRO via Lack-d12D ← via TER);

[0246] (p) The nucleotide sequence from nucleotide 31831 to nucleotide 35816 of SEQ ID NO:41 (PRO via Pavsad4D ← via TER);

[0247] (q) The nucleotide sequence from nucleotide 35817 to nucleotide 38319 of SEQ ID NO:41 (PRO via leader sequence and →Picpa-w3 / d15D via TER);

[0248] (r) The nucleotide sequence of SEQ ID NO:41 from nucleotide 38320 to nucleotide 39488 (MAR←);

[0249] (s) The nucleotide sequence from nucleotide 39489 to nucleotide 41449 of SEQ ID NO:41 (PRO via Pavsa-d5D ← via TER);

[0250] (t) The nucleotide sequence of SEQ ID NO:41 from nucleotide 41450 to nucleotide 43607 (PRO via Pyrco-d5E ← via TER);

[0251] (u) The nucleotide sequence from nucleotide 43614 to nucleotide 47662 of SEQ ID NO:41 (PRO→Micpu-d6D via TER);

[0252] (v) Molecules having at least 80%, 95%, 97%, 98%, 99%, or 99.5% sequence identity with nucleotide sequences (a) to (u), (a) to (j), and (k) to (u); or

[0253] (w) its complementary sequence.

[0254] The relevant implementation plan provides plant cells, materials, or seeds containing the artificial binary locus.

[0255] Another embodiment provides a DNA molecule comprising an artificial binary locus, the locus sequentially comprising the following nucleotide sequences:

[0256] (a) The nucleotide sequence from nucleotide 2747 to nucleotide 4141 of SEQ ID NO:40 (Micpu-d6D←);

[0257] (b) The nucleotide sequence of the complementary sequence of the nucleotide sequence from nucleotide 7259 to nucleotide 8065 of SEQ ID NO:40 (→Pyrco-d5E);

[0258] (c) The nucleotide sequence from nucleotide 8841 to nucleotide 10121 of SEQ ID NO:40 (→Pavsa-d5D);

[0259] (d) The nucleotide sequence from nucleotide 12281 to nucleotide 13531 of SEQ ID NO:40 (Picpa-w3 / d15D←);

[0260] (e) A molecule having at least 80%, 95%, 97%, 98%, 99%, or 99.5% sequence identity with nucleotide sequences (a) to (d); or

[0261] (f) Its complementary sequence;

[0262] The artificial gene locus includes regulatory regions (e.g., promoters, leader sequences, terminators) to provide expression of (a) through (d) or (e) or (f). Related implementations provide plant cells, plant materials, or plant seeds containing this artificial binary gene locus.

[0263] Another embodiment provides a DNA molecule comprising an artificial binary locus, the locus sequentially comprising the following nucleotide sequences:

[0264] (a) The nucleotide sequence from nucleotide 1820 to nucleotide 3208 of SEQ ID NO:41 (Micpu-d6D←);

[0265] (b) The nucleotide sequence from nucleotide 6326 to nucleotide 7126 of SEQ ID NO:41 (→Pyrco-d5E);

[0266] (c) The nucleotide sequence of SEQ ID NO:41 from nucleotide 7908 to nucleotide 9192 (→Pavsa-d5D);

[0267] (d) The nucleotide sequence from nucleotide 11352 to nucleotide 12596 of SEQ ID NO:41 (Picpa-w3 / d15D←);

[0268] (e) The nucleotide sequence from nucleotide 15216 to nucleotide 16556 of SEQ ID NO:41 (→Pavsa d4D);

[0269] (f) The nucleotide sequence from nucleotide 17619 to nucleotide 18866 of SEQ ID NO:41 (→Lack-d12D);

[0270] (g) The nucleotide sequence from nucleotide 21895 to nucleotide 22647 of SEQ ID NO:41 (→Pyrco-d6E);

[0271] (h) The nucleotide sequence from nucleotide 25943 to nucleotide 26283 of SEQ ID NO:41 (Pyrco-d6E←);

[0272] (i) The nucleotide sequence from nucleotide 30066 to nucleotide 31313 of SEQ ID NO:41 (Lack-d12D←);

[0273] (j) The nucleotide sequence of SEQ ID NO:41 from nucleotide 31831 to nucleotide 35816 (Pavsa-d4D←);

[0274] (k) The nucleotide sequence of SEQ ID NO:41 from nucleotide 36335 to nucleotide 38319 (→Picpa-w3 / d15D);

[0275] (l) The nucleotide sequence from nucleotide 39749 to nucleotide 41023 of SEQ ID NO:41 (Pavsa-d5D←);

[0276] (m) The nucleotide sequence from nucleotide 41805 to nucleotide 42605 of SEQ ID NO:41 (Pyrco-d5E←);

[0277] (n) The nucleotide sequence from nucleotide 45724 to nucleotide 47111 of SEQ ID NO:41 (→Micpu-d6D);

[0278] (o) a molecule having at least 80%, 95%, 97%, 98%, 99%, or 99.5% sequence identity with nucleotide sequences (a) to (u), (a) to (j), (k) to (u), or

[0279] (p) Its complementary sequence;

[0280] The artificial gene locus includes regulatory regions (e.g., promoters, leader sequences, terminators) to provide (a) to (n) or (o) or (p) expression. Related implementations provide plant cells, plant materials, or plant seeds containing this artificial binary gene locus.

[0281] Genetic traits engineered into a specific rapeseed plant using transformation techniques such as those described herein can be transferred into another rapeseed or Brassica genus line using conventional breeding techniques well-known in the field of plant breeding. For example, plants possessing the superior species event NS-B50027-4 can be obtained, for instance, from seeds preserved at the ATCC. Such plants can be further propagated and / or used according to conventional breeding protocols to introduce the superior species event NS-B50027-4 into other cultivars of the same plant species. The preserved seeds belong to the species *Raphanus chinensis*. However, methods for introducing alleles or transgenes located on the A or C genome from *Raphanus chinensis* into mustard are well-known in the art and include repeated backcrosses. Backcrossing can be used to transfer transgenes from transformed rapeseed plants to superior inbred lines, and the resulting offspring include the transgene. Furthermore, if inbred lines are used for transformation, the transgenic plants can be hybridized with different lines to produce transgenic hybrid rapeseed plants. As used herein, “hybridization” can refer to a simple X-Y hybridization or the process of backcrossing, depending on the context. Transformation can be used to further introduce various genetic elements into the plant genome. These elements include, but are not limited to, genes; coding sequences; inducible promoters, constitutive promoters and tissue-specific promoters; enhancement sequences; and signaling and targeting sequences.

[0282] Inbred rapeseed line NS-B50027-4

[0283] As described in this article, the rapeseed strain NS-B50027-4 is a stable and homogeneous breeding strain. It was developed with a strong emphasis on plant type homogeneity, and the strain has increased with observations of uniformity. NS-B50027-4 is distinguished by the production of LC-PUFAs, particularly LC-ω3 fatty acids, and even more so DHA, in its seeds. At the time of patent filing for strain NS-B50027-4, it was not a parent of any other commercially available rapeseed cultivar.

[0284] The inbred transgenic rapeseed line NS-B50027-4 exhibits the following morphological and physiological characteristics (primarily based on data and averages collected from eight different sites in Australia in 2015):

[0285]

[0286]

[0287] Another aspect provides a method for producing seeds, such as those from the European rapeseed plant or a portion thereof, of NS-B50027-4, comprising hybridization with the aforementioned European rapeseed plant or a portion thereof, including obtaining the aforementioned Brassica genus and growing the plant under Brassica genus growth conditions. Another aspect provides a method for growing the European rapeseed line NS-B50027-4 (representative seeds of which have been deposited with ATCC accession number PTA-123186), a subline of NS-B50027-4, progeny of NS-B50027-4 or a subline, or a plant produced by hybridization of NS-B50027-4 with a second rapeseed or Brassica genus, the method comprising: obtaining the aforementioned Brassica genus seeds and growing the plant under Brassica genus growth conditions. Another aspect provides a method for producing seeds, such as those from the European rapeseed plant or a portion thereof, of NS-B50027-4, comprising hybridization of the European rapeseed plant or a portion thereof.

[0288] LC-ω3 fatty acids

[0289] Using the rapeseed line NS-B50027-4 according to embodiments of the present invention, LC-ω3 fatty acids can be produced from NS-B50027-4 rapeseed seeds in commercial quantities. Therefore, the selection and propagation techniques for transforming plants have yielded a plurality of plants possessing the advantageous traits of NS-B50027-4, which are harvested in a conventional manner and the fatty acids are extracted from tissues of interest such as seeds.

[0290] As mentioned above, "fatty acid content" or "fatty acid composition" generally refers to the weight percentage of various fatty acids present in the endogenously formed oil of mature, whole, partially dried seeds (typically containing about 6% or 7% moisture), said weight percentage as a percentage of a specific fatty acid normalized to area; or relative to a known standard; or calculated as the fatty acid weight ratio per gram of seed (e.g., mg DHA / g seed).

[0291] Industrial practice typically reports fatty acid composition as an area percentage (area normalization) rather than an absolute amount. For example, chromatography often generates data based on peaks, integrating the area under each peak and expressing it as a percentage of the total area under all fatty acid peaks in the chromatogram. Area percentages are easy to calculate and compare with results reported by others in the industry who also report area percentages. Area percentages are not absolute but provide an acceptable approximation. For example, absolute mg / kg results can be calculated by including reference standards and internal standards of known concentrations. Correction factors can also be used to calculate the mass of fatty acids.

[0292] For example, when determining fatty acid content, seeds can be crushed, oil triacylglycerols (TAG) extracted, and then saponified and methylated with methanol and sodium methoxide, or by reacting with 1.25% 3-(trifluoromethyl)phenyl-trimethylammonium hydroxide (Meth Prep II) in methanol. TM The reaction (Fischer Scientific Cat#AT18007) forms fatty acid methyl esters. The resulting fatty acid methyl esters (FAME) can be analyzed by gas-liquid chromatography (GLC) using a capillary column based on unsaturation and fatty acid chain length to separate FAME. FAME can also be analyzed by, for example, GC, LC-MS, GC-MS, NMR, or near-infrared reflectance spectroscopy. Fatty acid composition can also be determined from the whole seed, for example by crushing the seed coat and subjecting the crushed seed to direct methylation. Total lipids can be separated to purify fractions, such as TAG fractions, using techniques known in the art. For example, thin-layer chromatography (TLC) can be performed on an analytical scale to separate TAG from other lipid fractions such as DAG, acyl-CoA, or phospholipids to determine fatty acid composition, particularly TAG. Many other analytical techniques can be used as known to those skilled in the art. See, for example, Tinoco et al., 3 Anal. Biochem. 514 (1962); CANOLA: CHEMISTRY, PRODUCTION, PROCESSING & UTILIZATION (edited by Daun et al., AOCS Press, Urbana, IL, 2011) (Daun et al., 2011); US2015 / 0166928; US 20160002566.

[0293] In another embodiment, the extracted plant lipids can be processed to increase the level of DHA as a percentage of the total fatty acid content. For example, the processing includes hydrolyzing esterified fatty acids to produce free fatty acids, or transesterification. For instance, rapeseed oil can be processed to convert the fatty acids in the oil into alkyl esters such as methyl or ethyl esters, and then the alkyl esters can be purified or fractionated to enrich the lipids or oil for DHA. In embodiments, the fatty acid composition of such processed lipids comprises at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, or at least 90% DHA.

[0294] Embodiments of the present invention also include progeny and offspring of these novel European rapeseed lines, NS-B5002-4. Progeny or offspring can be developed using breeding or tissue culture methods known to those skilled in the art. For example, progeny or offspring can contain rapeseed fatty acid profiles developed in these lines. Thus, progeny or offspring can possess any number of genes from the developed lines. Progeny or offspring may include only those genes that provide the rapeseed fatty acid phenotypes provided herein, or additional genes. This can be determined using molecular analytical methods known to those skilled in the art.

[0295] One aspect provides a method for developing European rapeseed seeds with the same phenotype as NS-B50027-4. For example, the DHA fatty acid content of NS-B50027-4 seeds comprises at least about 7%, at least about 8%, at least about 8%, at least about 10%, at least about 11%, at least about 12%, at least about 13%, at least about 14%, at least about 15%, or more DHA (% fatty acids). For example, the LC-PUFA fatty acid content of NS-B50027-4 seeds comprises at least about 10%, at least about 11%, at least about 12%, at least about 13%, at least about 14%, at least about 15%, at least about 16%, at least about 17%, at least about 18%, or more LC-PUFA (as a percentage of fatty acids, the sum of EPA, DPA, and DHA).

[0296] Another aspect provides a homogeneous assembly of crushed rapeseed seeds produced by the plants described herein, wherein the crushed rapeseed seeds have a total fatty acid content of at least about 30%, at least about 35%, such as about 36% to about 40% (including endpoints) by weight (% seed weight). In a particular embodiment, for example, the fatty acid content in the homogeneous assembly of crushed rapeseed seeds comprises at least about 7%, at least about 8%, at least about 9%, at least about 10%, at least about 11%, at least about 12%, at least about 13%, at least about 14%, at least about 15%, or more (% fatty acids). In specific embodiments, for example, the fatty acid content of a homogeneous aggregate of crushed rapeseed contains at least about 8% LC-PUFA, at least about 9% LC-PUFA, at least about 10% LC-PUFA, at least about 11% LC-PUFA, at least about 12% LC-PUFA, at least about 13% LC-PUFA, at least about 14% LC-PUFA, at least about 15% LC-PUFA, at least about 16% LC-PUFA, at least about 17% LC-PUFA, at least about 18% or more LC-PUFA (as a percentage of the total fatty acids EPA, DPA, DHA). Oil and coarse flour from such crushed seeds are also provided.

[0297] It also provides a homogeneous aggregate of crushed seeds of the NS-B50027-4 strain, or a homogeneous aggregate of crushed European rapeseed seeds from the progeny or descendants of NS-B50027-4, wherein the crushed seeds have a DHA content of at least about 7%, at least about 8%, at least about 9%, at least about 10%, at least about 11%, at least about 12%, at least about 13%, at least about 14%, at least about 15% or more of DHA (% fatty acids). For example, a homogeneous aggregate of crushed rapeseed seeds of NS-B50027-4, or a homogeneous aggregate of crushed rapeseed seeds from the progeny or descendants of NS-B50027-4, wherein the homogeneous aggregate of crushed seeds contains at least about 8%, at least about 9%, at least about 10%, at least about 11%, at least about 12%, at least about 13%, at least about 14%, at least about 15%, at least about 16%, at least about 17%, at least about 18% or more of LC-PUFA (as a percentage of fatty acids, the sum of EPA, DPA, and DHA). Oil and flour from such crushed seeds are also provided.

[0298] Another aspect described herein provides a method for producing oil or crude powder from the European rapeseed strain NS-B50027-4 (a representative seed of which has been deposited with ATCC accession number PTA-123186), sublines of NS-B50027-4, progeny of NS-B50027-4 or its sublines, or from plants produced by hybridization of NS-B50027-4 with a second rapeseed or Brassica plant, the method comprising: growing the aforementioned crop under Brassica growing conditions; harvesting the seeds; and extracting the oil or crude powder.

[0299] Another aspect described herein provides a method for producing oil from a plant derived from the European rapeseed strain NS-B50027-4 (representative seeds of which have been deposited with ATCC accession number PTA-123186), a subline of NS-B50027-4, progeny of NS-B50027-4 or a subline, or a plant produced by crossing NS-B50027-4 with a second Brassica genus, the method comprising: crushing seeds of the NS-B50027-4 strain (representative seeds of which have been deposited with ATCC accession number PTA-123186), a subline of NS-B50027-4, progeny of NS-B50027-4 or a subline, or a plant produced by crossing NS-B50027-4 with a second rapeseed or Brassica genus; and extracting oil from the seeds.

[0300] Another aspect provides crude flour and protein, as well as oil, from NS-B50027-4 seeds or progeny seeds derived from NS-B50027-4. Protein extraction from plant biomass can be accomplished by known methods. See, for example, Heney & Orr, 114 Anal. Biochem. 92 (1981). Crude flour from NS-B50027-4 can be shown to be particularly beneficial because it contains at least some DHA and other omega-3 fatty acids. Similarly, the protein fraction from NS-B50027-4 contains at least some beneficial DHA and other omega-3 fatty acids.

[0301] Despite having a lower oleic acid content than oils that claim to contribute stability to DHA and other LC-PUFAs through high oleic acid content, the LC-PUFA ω3 fatty acid oil from NS-B50027-4 seeds exhibits surprising stability. More specifically, LC-PUFA ω3 fatty acids are known to be unstable and particularly prone to oxidation. It is understood in the art that extending the shelf life of LC-PUFAs and LC-PUFA-containing foods requires encapsulation, blending with other oils, particularly high-oleic oils, or the addition of antioxidants. However, despite the lack of such treatments, some evidence suggests that crude oil extracted from crushed NS-B50027-4 seeds remains fresh for several months at room temperature.

[0302] Another aspect of this invention provides sources of DHA and LC-PUFA for use in nutritional supplements and diets for both humans and non-human animals. In particular, oil from the NS-B50027-4 seed provides a sustainable source of DHA and LC-PUFA for use in aquaculture. The importance of both marine and freshwater aquaculture is increasing due to high global demand for fish and the resulting marine overfishing (Betancor et al., 4 Sci. Rep. 8104 (2014)). For example, the farming and consumption of salmonids has increased dramatically over the past 20 years. However, the diets of wild-caught fish are very different from those of their aquaculture counterparts. Indeed, aquaculture remains highly dependent on marine fisheries for key dietary nutrients such as fishmeal and fish oil. In fact, fishmeal and fish oil are major sources of ω3-LC-PUFA in aquaculture. Because marine fish oil is a limiting factor for the robust growth (5% to 10% annually) of the fish farming industry, aquaculture diets incorporate many alternative plant-based ingredients such as legume seeds, oilseed cake, leaf meal, and increased proportions of vegetable oils. Replacing fish oil with traditionally low-LC-PUFA vegetable oils means fewer LC-PUFAs available in the fish diet, even though some oils, such as flaxseed oil, contain a certain amount of ALA, which can be converted into LC metabolites in fish (albeit to a limited extent). Generally, vegetable oils in current fish feeds may have a detrimental effect on FA distribution in fish, and they can alter the ω3 / ω6 ratio.

[0303] For example, typical vegetable oils contain high levels of ω6 PUFAs, primarily linoleic acid (C18:2ω6; LA). Oils from the parental line AV Jade lack DHA and therefore have no DHA:LA ratio; oils from NS-B50027-4 have a DHA:LA ratio of 1.048; in contrast, oils from farmed salmon have a DHA:LA ratio of 0.908. (Strobel et al., 11Lipids Health Dis. 144 (2012)). Interestingly, the ratio of ω3 FAs from NS-B50027-4 is more beneficial in terms of palmitic acid (a saturated fatty acid associated with cardiovascular disease and dyslipidemia). (Diet, Nutrition & Prevention of Chronic Dis., WHO Tech.Rep. Series 916, Report of a Joint WHO / FAO Expert Consultation, 88 (World Health Organization, Geneva, 2003)). Oil from the parental line AVJade does not contain DHA and therefore has no DHA:palmitic acid ratio; oil from NS-B50027-4 has a DHA:palmitic acid ratio of 2.122; in contrast, oil from farmed salmon has a DHA:palmitic acid ratio of 0.591; and oil from wild salmon has a DHA:palmitic acid ratio of 1.018. Strobel et al., 2012. The preparation of aquaculture feeds including LC-PUFAs is known in the art. See Betancor et al., 2014; Petrie et al., 9PLOS ONE1, 2014; Tocher, Aquaculture (2015). Therefore, the scope of embodiments of the present invention includes the use of oil from NS-B50027-4 as a source of ω3 fatty acids in aquaculture feeds and aquaculture feeds containing oil obtained from NS-B50027-4 and its progeny.

[0304] Identification of NS-B50027-4 and its offspring

[0305] Superior genetic events can be characterized by the location and conformation of the recombinant DNA molecule incorporated into the plant genome. The site in the plant genome where the recombinant DNA cassette is inserted is also called the "insertion site" or "target site." A "flanking region" or "flanking sequence" is a region of DNA in the plant genome located immediately upstream of and contiguous with the transgenic cassette, or immediately downstream of and contiguous with the transgenic cassette; for example, at least 20 base pairs, at least 50 base pairs, or up to 5,000 base pairs. Transformations that result in the random integration of exogenous DNA produce transformants with different flanking regions, which are characteristic and unique to each transformant (superior genetic events).

[0306] On the other hand, a method is provided for producing European rapeseed plants or portions thereof of NS-B50027-4, the method comprising hybridizing the aforementioned European rapeseed plants or portions thereof with a second plant to produce first-generation progeny seeds; allowing the first-generation progeny seeds to grow to produce F1 generation plants; optionally, repeating the hybridization and growth steps to obtain successive hybridization generations of the seeds to obtain European rapeseed seeds, plants, or portions thereof of the breeding line NS-B50027-4. Plants or plant parts (including any hybrids) produced by this method are also provided. In embodiments, genetic traits engineered into the genome of a particular rapeseed plant can be transferred to the genome of another cultivar using conventional breeding techniques well known in the field of plant breeding. For example, a backcross method can be used to transfer transgenes from a transformed rapeseed cultivar to an already developed rapeseed cultivar, and the resulting backcross transformed plants will then contain the transgenes.

[0307] Therefore, another aspect of the present invention provides compositions, methods, and kits for detecting NS-B50027-4. It would be advantageous to be able to detect the presence of a specific event to determine whether the offspring of a sexual hybridization contain the transgene of interest. Furthermore, methods for detecting specific events would be more helpful in complying with regulations, such as those requiring premarket approval and labeling of foods derived from recombinant crop plants. The presence of transgenes can be detected by any well-known nucleic acid detection method, such as polymerase chain reaction (PCR) or DNA hybridization using nucleic acid probes. These detection methods typically focus on commonly used genetic elements such as, for example, promoters, terminators, marker genes, etc. Therefore, such methods may not be able to distinguish between different events, especially those produced using the same DNA construct, unless the sequence of the chromosomal DNA adjacent to the inserted DNA (“flanking DNA”) is known. Event-specific PCR assays have been described. See, for example, Windels et al. (Med. Fac. Landbouww, Univ. Gent 64 / 5b:459-462, 1999) (identifying soybean glyphosate resistance events using a primer set comprising a sequence from the insert and a sequence from the flanking DNA via PCR). Furthermore, the 16-gene insert of NS-B50027-4 disrupted the expression of a Brassica gene encoding Pto-interacting protein (PTI), a serine-threonine kinase involved in hypersensitive response-mediated signal transduction on chromosome A05. Although no phenotypic changes were observed, this provides another marker for identifying NS-B50027-4 or progeny derived from NS-B50027-4.

[0308] The methods and kits described herein can be used to identify transgenic plant material specifically containing NS-B50027-4 in biological samples, as well as the presence of transgenic rapeseed plants, plant material, and seeds containing such an event. The superior species event NS-B50027-4 described herein can be identified by genotyping, which can be characterized by genetic marker profiles that can identify plants of the same or related cultivars or used to determine or verify pedigrees. Genetic marker profiles can be obtained using techniques such as restriction fragment length polymorphism (RFLP), random amplified polymorphic DNA (RAPD), arbitrary primer polymerase chain reaction (AP-PCR), DNA amplified fingerprint (DAF), sequence characteristic amplified region (SCAR), amplified fragment length polymorphism (AFLP), simple sequence repeats (SSR) (also known as microsatellites), and single nucleotide polymorphisms (SNPs).

[0309] For example, the superior species event NS-B50027-4 described herein can be identified by generating a genetic map from samples of plant material. Genetic maps can be generated by routine RFLP, polymerase chain reaction (PCR) analysis, or SSR analysis to identify the approximate chromosomal location of the integrated DNA molecule encoding the foreign protein. See Glick & Thompson, METHODS IN PLANT MOLEC. BIOL. & BIOTECHNOL. 269 (CRC Press, Boca Raton, FL, 1993). Mapping information regarding chromosomal location is useful for the proprietary protection of the tested transgenic plants. For example, the map of the integrated region can be compared with a similar map of a suspected plant to determine if the latter shares a common parentage with the tested plant. Map comparisons can involve hybridization, RFLP, PCR, SSR, and sequencing—all routine techniques.

[0310] Another aspect of the present invention provides kits and methods for determining whether a rapeseed plant is an inbred variety NS-B50027-4 or is related to the inbred variety NS-B50027-4, or is a rapeseed plant comprising at least a portion of a genetically superior event containing the variety NS-B50027-4. This document describes compositions and methods of simple and well-defined techniques for identifying the superior event NS-B50027-4 in biological samples.

[0311] For example, a kit may include at least one set of primers for identifying one or more genetic markers of NS-B50027-4, such as a set of sense (forward) primers and antisense (reverse) primers. See Table 2. Specific primer implementations include the following primers used in kits for performing KASP assays to detect the NS-B50027-4 genetic trait, particularly suitable for gene introgression studies and hybrid development. See Example 2. These primers can consist of nucleic acid molecules containing at least 10 consecutive nucleic acids with the following sequences: GAAGGTGACCAAGTTCATGCTCCAAGCACCGTAGTAAGAGAGCA (SEQ ID NO: 1, Micopu-Δ6D); GCTAAGAAGTGGGGACTCAACTACAA (SEQ ID NO: 2, Micopu-Δ6D); GAAGGTGACCAAGTTCATGCTGCTCTTGCTGGAACTCTTGG (SEQ ID NO: 3, Pyrco-Δ5E); GGGTTAGCCACATTGTAGGTAACGTA (SEQ ID NO: 4, Pyrco-Δ5E); GAAGGTGACCAAGTTCATGCTTAAGAGACACCCTGGTGGAAAGA (SEQ ID NO: 5, Pavsa-Δ5D); TAGCATCAGTTCCAACTTGGTAAGCAAT (SEQ ID NO: 1, Micopu-Δ6D ... GAAGGTGACCAAGTTCATGCTTAAGAGACACCCTGGTGGAAAGA (SEQ ID NO: 1, Micopu-Δ6D); GAAGGTGACCAAGTTCATGCTTAAGAGACACCCTGGTGGAAAGA (SEQ ID NO: 1, Micopu-Δ6D); GAAGGTGACCAAGTTCATGCTTAAGAGACACCCTGGAACTACAGCAAT (SEQ ID NO: 1, Micopu-Δ6D); GAAGGTGACCAAGTTCATGCTTAAGAGACACCCTGGAACTACAGCAAT (SEQ ID NO: 1, Micopu-Δ6D); GAAGGTGACC NO: 6, Pavsa-Δ5D); GAAGGTGACCAAGTTCATGCTGAACACGTAAGCAGACCAAGCAG (SEQ ID NO: 7, Picpa-ω3D); CCCTCTTCTCCCTAACGAATTCCTT (SEQ ID NO: 8, Picpa-ω3D); GAAGGTGACCAAGTTCATGCTGAGGAACCTGTTGCTGCTGATGA (SEQ ID NO: 9, Pavsa-Δ4D); GCGATCCTAGCACAAAGTTGAAGGTA (SEQ ID NO: 10, Pavsa-Δ4D); GAAGGTGACCAAGTTCATGCTGGATGGATCGCTTACCTCTTCGT (SEQ ID NO: 11, Lackl-Δ12D); CAGGGTAAGGTTGTCCTGTAACGTT (SEQ ID NO: 12, Lackl-Δ12D); GAAGGTGACCAAGTTCATGCTCTATTGGATGGGGACTCAAGC (SEQ ID NO: 13, Pyrco-Δ6E);GGGAGATCCTTAGTAGCAGAAGAGAT (SEQ ID NO: 14, Pyrco-Δ6E); GAAGGTGACCAAGTTCATGCTCCTGAGAGGCGTCCTGTTGAAAT (SEQ ID NO: 15, PAT); AACAGCAGCCATATCAGCAGCAGTA (SEQ ID NO: 16, PAT); GAAGGTGACCAAGTTCATGCTTGTTCTTGGGTGGGTCTGTCCTTC (SEQ ID NO: 17; A05 insert fragment link 1); GAAGGTCGGAGTCAACGGATTGTGTTCTTGGGTGGGTCTGTCCTTA (SEQ ID NO: 18, A05 insert fragment link 1); ATCCACTAGCAGATTGTCGTTTCCC (SEQ ID NO: 19, A05 insert fragment link 1); GTTGGCTAAGGTCACGGTGGAG (SEQ ID NO: 19; A05 insert fragment link 1); NO: 20, A05 insert fragment link 1); GAAGGTGACCAAGTTCATGCTCCGCCTTCAGTTTAAACTATCAGTGTT (SEQ ID NO: 21, A05 insert fragment link 1); GAAGGTCGGAGTCAACGGATTGGTCACGGTGGAGGTCACCA (SEQ ID NO: 22, A05 insert fragment link 1), GGTGTGTTCTTGGGTGGGTCTG (SEQ ID NO: 23, A05 insert fragment link 1); GAAGGTGACCAAGTTCATGCTACTTTTTTTTCAACTGTTGGCTAAGGTA (SEQ ID NO: 24, A05 insert fragment link 2); GAAGGTCGGAGTCAACGGATTACTTTTTTTTCAACTGTTGGCTAAGGTC (SEQ ID NO: 25, A05 insert fragment link 2), GTGTGTTCTTGGGTGGGTCTG (SEQ ID NO: 25, A05 insert fragment link 2), GTGTGTTCTTGGGTGGGTCTG (SEQ ID NO: 20, A05 insert fragment link 1); GAAGGTCGGAGTCAACGGATTACTTTTTTTTCAACTGTTGGCTAAGGTC ...0, A05 insert fragment link 2); GTGTGTTCTTGGGTGGGTCTG (SEQ ID NO: 20, A05 insert fragment link 1 NO: 26, A05 Insert fragment link 2); GTCGTTTCCCGCCTTCAGTTT (SEQ ID NO: 27, A05 Insert fragment link 2); GAAGGTGACCAAGTTCATGCTAAACTATCAGTGTTTGAACACCTCC (SEQ ID NO: 28, A02 Insert fragment link 1); GAAGGTCGGAGTCAACGGATTACAACTTGTCGTGCTACACACCT (SEQ ID NO: 29, A02 Insert fragment link 1);GGTTGTGTGAAAACGTGTGAGC (SEQ ID NO: 30, A02 insert fragment link 1); GAAGGTGACCAAGTTCATGCTCTTTTAGCTAAATAAGAGGTTCTGTATACT (SEQ ID NO: 31, A02 insert fragment link 2); GAAGGTCGGAGTCAACGGATTCTTTTAGCTAAATAAGAGGTTCTGTATACA (SEQ ID NO: 32, A02 insert fragment link 2); GATTGTGATTCCGGGCAGT (SEQ ID NO: 33, A02 insert fragment link 2); GTGTGAAAACGTGTGAGCAAT (SEQ ID NO: 34, A02 insert fragment link 2); GAAGGTGACCAAGTTCATGCTTTGTGATTCCGGGCAGTAG (SEQ ID NO: 35, A02 insert fragment link 2); GAAGGTCGGAGTCAACGGATTTGTGAGCAATTGTTGGAGGT (SEQ ID NO: 30, A02 insert fragment link 2); GAAGGTCGGAGTCAACGGATTTGTGAGCAATTGTTGGAGGT (SEQ ID NO: 30, A02 insert fragment link 2); NO: 36, A02 insert fragment link 2); TCTTATAACATTAAGAACATAATCTTTTAG (SEQ ID NO: 37, A02 insert fragment link 2); or its complementary sequence.

[0312] The present invention also provides a method for identifying rapeseed plants of the superior species event NS-B50027-4, the method comprising: (a) forming a biological sample containing rapeseed plant DNA and a mixture of a first nucleic acid primer and a second nucleic acid primer capable of amplifying a specific nucleic acid molecule of event NS-B50027-4; (b) reacting the mixture under conditions that allow the first and second nucleic acid primers to amplify the specific nucleic acid molecule of event NS-B50027-4; and (c) detecting the presence of amplified fragment nucleic acid molecules, wherein the presence of the specific nucleic acid molecule of rapeseed event NS-B50027-4 indicates that the rapeseed plant is NS-B50027-4 rapeseed plant.

[0313] Another embodiment provides a method for detecting a superior species event NS-B50027-4 nucleic acid molecule in a biological sample, the method comprising: (a) forming a mixture comprising a biological sample containing DNA and a nucleic acid probe capable of hybridizing with a specific nucleic acid molecule of event NS-B50027-4; (b) reacting the mixture under conditions that allow the probe to hybridize with the specific nucleic acid molecule of event NS-B50027-4; and (c) detecting the presence of the hybridized nucleic acid molecule, wherein the presence of the specific nucleic acid molecule of event NS-B50027-4 indicates that the sample contains the event NS-B50027-4 nucleic acid molecule.

[0314] Another embodiment provides a method for detecting the presence of an event NS-B50027-4 nucleic acid molecule in a biological sample, the method comprising: (a) forming a mixture comprising a biological sample containing DNA and a first primer capable of annealing to a region of an event NS-B50027-4 insert nucleic acid molecule and a second primer capable of annealing to a flanking nucleic acid molecule in a host cell genome; (b) reacting the mixture under conditions that allow the first and second nucleic acid primers to generate amplified nucleic acid molecules containing fragments of the event NS-B50027-4 insert nucleic acid molecule; and (c) detecting the presence of the amplified nucleic acid molecules, wherein the presence of fragments of the event NS-B50027-4 insert nucleic acid molecule indicates that the sample contains event NS-B50027-4 insert DNA.

[0315] Appropriate testing should detect any major defects and establish a level of advantage or improvement relative to current cultivars. In addition to demonstrating superior performance, new cultivars must be compatible with industry standards or create new markets. The introduction of new cultivars will incur additional costs for seed producers, growers, processors, and consumers for specialized advertising and marketing, changes in seed and commercial production practices, and the utilization of new products. Testing of new cultivars prior to release should consider research and development costs, as well as the final technical advantages of the cultivar. For seed-produced cultivars, easy and economical seed production must be feasible.

[0316] For example, the kit may include at least one set of sense (forward) primers and antisense (reverse) primers specific to the following: Δ6-desaturase from the microalga *Microcystis spp.*, Δ5-elongase from the microalga *Pyramimonas cordata*, Δ5-desaturase from the marine microalga *Haloxylon ammodendron*, Δ15 / ω3-desaturase from the yeast *Pichia pastoris*, Δ4-desaturase from *Haloxylon ammodendron*, or Δ12-desaturase from the yeast *Lachancea kluyveri* (see, for example, Table 2); and at least one set of primers specific to the 5' link between the insert and the natural *Brassica* chromosome A02 DNA, such as the link of nucleotides 2033 to 2132 of SEQ ID NO:40, comprising a 43 bp insert and a 57 bp *Brassica* chromosome A02. The following primers are used: a 100bp region of DNA, or at least a set of primers specific to the 3' link between the insert and the natural Brassica chromosome A02 DNA, such as the link of SEQ ID NO:40 from nucleotides 14156 to 14255, comprising a 46bp insert and a 54bp region of the Brassica chromosome A02 DNA; or at least a set of primers specific to the 5' link between the insert and the natural Brassica chromosome A05 DNA, such as the link of SEQ ID NO:41 from nucleotides 1110 to 1209, comprising a 50bp insert and a 50bp region of the Brassica chromosome A05 DNA, or at least a set of primers specific to the 3' link between the insert and the natural Brassica chromosome A05 DNA, such as the link of SEQ ID NO:41 from nucleotides 47724 to 47823, comprising a 50bp insert and a 50bp region of the Brassica chromosome A05 DNA. The 100bp region of DNA.

[0317] The amplification conditions for methods using DNA primers to generate amplicons for diagnosing the NS-B50027-4 event are within the general technical scope of this art. Additionally, a control primer pair for amplifying endogenous rapeseed genes is included as an internal standard for the reaction conditions, and it produces an amplicon of approximately 100-5000 nucleotides. Analysis of plant tissue samples from the NS-B50027-4 event should include a positive tissue control from the NS-B50027-4 event, a negative control from rapeseed plants not exhibiting the NS-B50027-4 event, and a negative control not containing template rapeseed DNA. Additional primers can be selected by those skilled in the art from the links shown in SEQ ID NO:47, SEQ ID NO:48, SEQ ID NO:49, and SEQ ID NO:50, and the amplicon generation conditions can be optimized to obtain any amplicon that may diagnose NS-B50027-4. The use of these modified DNA primer sequences is within the scope of the embodiments described herein. Amplicons generated using at least one primer sequence derived from SEQ ID NO:47, or at least one primer sequence derived from SEQ ID NO:48, or at least one primer sequence derived from SEQ ID NO:49, or at least one primer sequence derived from SEQ ID NO:50, when used in a PCR method, can be used in the described method and are one aspect of embodiments of the present invention. The generation of NS-B50027-4 event amplicons can be performed using a thermal cycler or by methods and apparatus known to those skilled in the art.

[0318] The present invention also provides a method for identifying rapeseed plants of the superior species event NS-B50027-4, the method comprising: (a) forming a biological sample containing rapeseed plant DNA and a mixture of a first nucleic acid primer and a second nucleic acid primer capable of amplifying a nucleic acid molecule specific to the event NS-B50027-4; (b) reacting the mixture under conditions that allow the first and second nucleic acid primers to amplify the nucleic acid molecule specific to the event NS-B50027-4; and (c) detecting the presence of amplified fragment nucleic acid molecules, wherein the presence of the nucleic acid molecule specific to the superior rapeseed species event NS-B50027-4 indicates that the rapeseed plant is NS-B50027-4 rapeseed plant.

[0319] Another embodiment provides a method for detecting a superior species event NS-B50027-4 nucleic acid molecule in a biological sample, the method comprising: (a) forming a mixture comprising a biological sample containing DNA and a nucleic acid probe capable of hybridizing with an event NS-B50027-4 specific nucleic acid molecule; (b) reacting the mixture under conditions that allow the probe to hybridize with the event NS-B50027-4 specific nucleic acid molecule; and (c) detecting the presence of the hybridized nucleic acid molecule, wherein the presence of the event NS-B50027-4 specific nucleic acid molecule indicates that the sample contains the event NS-B50027-4 nucleic acid molecule.

[0320] Another embodiment provides a method for detecting the presence of an event NS-B50027-4 nucleic acid molecule in a biological sample, the method comprising: (a) forming a biological sample containing DNA and a first primer capable of annealing to an event NS-B50027-4 insert nucleic acid molecule and a second primer capable of annealing to a host cell genome flanking nucleic acid molecule; (b) reacting the mixture under conditions that allow the first and second nucleic acid primers to generate amplified nucleic acid molecules containing fragments of the event NS-B50027-4 insert nucleic acid molecule; and (c) detecting the presence of the amplified nucleic acid molecules, wherein the presence of fragments of the event NS-B50027-4 insert nucleic acid molecule indicates that the sample contains event NS-B50027-4 insert DNA.

[0321] offspring

[0322] The strain NS-B50027-4 described herein can also be used to breed other strains. For example, the source material can be self-pollinated, crossbred, backcrossed, used to produce double haploids, used as source material for genetic transformation, subjected to genetic transformation, further mutagenesis, and used for other forms of breeding known to those skilled in the art. The methods and results of using the source material to breed other strains are also within the scope of these embodiments.

[0323] With the advent of molecular biology techniques that allow the isolation and characterization of genes encoding specific protein products, scientists in the field of plant biology have developed a strong interest in engineering plant genomes to include and express exogenous genes, or other versions or modified versions of natural or endogenous genes (possibly driven by different promoters), in order to alter plant traits in specific ways. Any DNA sequence introduced into the genome using transformation or various breeding methods, whether from different or the same species, is collectively referred to herein as a “transgenic”. Several methods for producing transgenic plants have been developed in the past fifteen to twenty years, and the present invention also relates in specific embodiments to transformed versions of the claimed strains.

[0324] Nucleic acids, oligonucleotides, or polynucleotides refer to linear or branched, single-stranded or double-stranded RNA or DNA molecules, or their hybrids—including RNA / DNA hybrids. These terms also include the 3'UTR and 5'UTR, typically a sequence of at least about 1000 nucleotides upstream of the 5' end of a gene coding region and at least about 200 nucleotides downstream of the 3' end of a gene coding region. Less common bases, such as inosine, 5-methylcytosine, 6-methyladenine, hypoxanthine, and others, can also be used for antisense, dsRNA, and ribozyme pairing. For example, polynucleotides containing C-5 propyne analogs of uracil and cytosine have been shown to bind RNA with high affinity and are effective antisense inhibitors of gene expression. Other modifications can also be made, such as modifications to the phosphodiester backbone or modifications to the 2'-hydroxyl group of the ribose group of RNA. Antisense polynucleotides and ribozymes can consist entirely of ribonucleotides or can contain a mixture of ribonucleotides and deoxyribonucleotides. The polynucleotides of the present invention can be produced by any means, including genome preparation, cDNA preparation, in vitro synthesis, RT-PCR, and in vitro or in vivo transcription.

[0325] Plant transformation involves constructing expression vectors that will function in plant cells. Such vectors contain genes that are controlled by regulatory elements (e.g., promoters) or are operatively linked to regulatory elements (e.g., promoters). Expression vectors may contain one or more such operatively linked gene / regulatory element combinations. Vectors may be in the form of plasmids and may be used alone or in combination with other plasmids to provide rapeseed plants transformed using methods known in the art for incorporating transgenes into the genetic material of rapeseed plants (including NS-B50027-4 rapeseed plants).

[0326] Genetic traits engineered into a specific rapeseed plant using transformation techniques can be transferred to another line using conventional breeding techniques well-known in the field of plant breeding. For example, plants carrying the superior species event NS-B50027-4 can be obtained from seeds preserved at the ATCC. Such plants can be further propagated or used in conventional breeding programs to introduce the superior species event NS-B50027-4 into other cultivars of the same plant species. The preserved seeds belong to the species *Raphanus chinensis*. However, methods for introducing alleles or transgenes located on the A or C genome from *Raphanus chinensis* into mustard are well-known in the art and include repeated backcrosses. Backcrossing can be used to transfer transgenes from transformed rapeseed plants to superior inbred lines, and the resulting offspring contain the transgene. Furthermore, if the inbred line is used for transformation, the transgenic plant can be hybridized with different lines to produce transgenic heterozygous rapeseed plants. As used herein, depending on the context, "hybridization" can refer to a simple X-Y hybridization or the process of backcrossing.

[0327] Various genetic elements can be further introduced into plant genomes using transformation. These elements include, but are not limited to, genes; coding sequences; inducible promoters, constitutive promoters, and tissue-specific promoters; enhancement sequences; and signaling and targeting sequences. The emergence of new molecular biology techniques has allowed for the isolation and characterization of genetic elements with specific functions, such as encoding specific protein products. Scientists in the field of plant biology have developed a strong interest in engineering plant genomes to include and express exogenous genetic elements, or other versions or modified versions of natural or endogenous genes, in order to alter plant traits in specific ways. Any DNA molecule inserted into the genome using transformation, whether from a different species or the same species, is collectively referred to herein as a “transgenic”. The process of “transformation” is the insertion of DNA into the genome. Several methods for producing transgenic plants have been developed, and this invention also relates in specific embodiments to a transformed version of the claimed rapeseed line NS-B50027-4.

[0328] Numerous methods have been developed for plant transformation, including biological and physical plant transformation protocols. Furthermore, expression vectors and in vitro culture methods for plant cell or tissue transformation and plant regeneration are available. See, for example, Miki et al., Procedures for introducing foreign DNA into plants, METH. PLANTMOLEC. BIOL. & BIOTECHNOL., p. 63 (edited by Glick & Thompson, CRC Press, Boca Raton, 1993); Gruber et al., Vectors for plant transformation, ibid., p. 89; Genetic transformation for the improvement of Canola, PROC. WORLD CONF. BIOTECHNOL. FATS & OILS INDUS., pp. 43-46 (Am. Oil. Chem. Soc., Champaign, IL, 1988).

[0329] The most common type of plant transformation involves the construction of expression vectors. Such vectors contain DNA molecules with coding regions controlled by regulatory regions (e.g., promoters) or coding regions operatively linked to regulatory regions (e.g., promoters). Expression vectors may contain one or more genes and one or more regulatory elements. At least one coding region and its respective regulatory element may be arranged in opposite directions within the vector, providing a binary vector. Theoretically, arranging genes sensitive to gene silencing in a binary manner can minimize gene silencing. Vectors may be in the form of plasmids and can be used alone or in combination with other plasmids to incorporate transgenes into the genetic material of NS-B50027-4 plants or plants derived from NS-B50027-4 using transformation methods known in the art, to provide transformed rapeseed plants.

[0330] For example, the initial transformation cassette pJP3416_GA7-modB includes seven genes that promote the accumulation of ω-3 fatty acids in rapeseed seeds and one selectable marker gene that promotes the selection of designated transgenic plants in vitro. See WO 2013185184; U.S. Patent Publication No. 2015 / 0374654; Petrie et al., 6 Plant Meth. 8 (2010). The expressed genes are all synthetic—codon-optimized and synthesized—so no transgenic DNA molecules have been found in any natural organism. The original sequences used as templates for codon optimization have been described. See Petrie et al., 12 Metab. Eng'g 233 (2010a); Petrie et al., 11 Plant Methods 6 (2010b); Petrie et al., 21 Transgenic Res. 139 (2012).

[0331] As is well known in the art, a functional gene promoter is a DNA region that is important for gene transcription but does not encode a functional product such as a peptide. For example, common promoters used for constitutive expression are derived from cauliflower mosaic virus. Kay et al., 236 Sci. 1299 (1987); Coutu et al., 16 Transgenic Res. 771 (2007). Promoters under developmental control include those that preferentially initiate transcription in certain tissues such as seeds, leaves, roots, fibers, xylem vessels, tracheids, or sclerenchyma tissues. Particularly relevant promoters are “seed-preferred” promoters that initiate transcription primarily or only in seeds. “Seed-preferred” promoters include both “seed-specific” promoters (those that are active during seed development, such as promoters of seed storage proteins) and “seed germination” promoters (those that are active during seed germination). See Thompson et al., 10 BioEssays 108 (1989). Preferred promoters for such seeds include, but are not limited to, Cim1 (cytokinin-induced signaling); cZ19B1 (maize 19kDa zeatin); and milps (inositol-1-phosphate synthase) (see WO 2000 / 11177 and U.S. Patent No. 6,225,529). For dicotyledonous crops, seed-specific promoters include, but are not limited to, soybean β-coumarin, rapeseed protein, β-conglycinin, soybean lectin, cruciferin, and conlinin. Seed-specific promoters used in GA7-modB have been previously described: Arabidopsis FAE1 (Rossack et al., 46 Plant Molec. Biol. 717 (2001)); Flax Cnl1 and Cnl2 (Chaudhary et al., WO 2001016340); and the truncated rapeseed protein promoter from European rapeseed (Stalberg et al., 23 Plant Molec. Biol. 671 (1993). See also WO 2013185184.

[0332] “Inducible” promoters are promoters under environmental control. Examples of environmental conditions that may affect inducible promoters include chemical control (induction in the presence of certain chemicals), anaerobic conditions, or the presence of light. Tissue-specific promoters, tissue-preferred (e.g., seed-specific) promoters, and inducible promoters constitute the “non-constitutive” promoter class. See Ward et al., 22 Plant Mol. Biol. 361 (1993); Meft et al., 90 PNAS 4567 (1993) (copper-inducible); Gastz et al., 243 Mol. Gen. Genet. 32 (1994) (inducible by herbicide safeners); Gastz et al., 227 Mol. Gen. Genet. 229 (1991) (tetracycline-inducible); Schena et al., 88 PNAS 10421 (1991) (glucocorticoid-inducible). See also WO 2001016340 and the promoters discussed therein.

[0333] "Constitutional" promoters are promoters that are active under most environmental conditions. Exemplary constitutive promoters include promoters from plant viruses, such as the 35S promoter from cauliflower mosaic virus (CMV) (Odell et al., 313 Nature 810 (1985)) and promoters from the following genes: rice actin (McElroy et al., 2 Plant Cell 163 (1990)); ubiquitin (Christensen et al., 12 Plant Mol. Biol. 619 (1989); Christensen et al., 18 Plant Mol. Biol. 6759 (1992)); pEMU (Last et al., 81 Theor. Appl. Genet. 581 (1991)); MAS (Velten et al., 3 EMBO J. 2723 (1984)) and maize H3 histone (Lepetit et al., 231 Mol. Gen. Genet. 276 (1992); Atanassova et al., 2 Plant J.291 (1992)). The ALS promoter, the XbaI / NcoI fragment (or a nucleotide sequence similar to the XbaI / NcoI fragment) at the 5' of the ALS3 structural gene in rapeseed provides another constitutive promoter. See also WO 1996 / 30530 and the promoters discussed therein. CMV promoters are also associated with useful enhancer regions. See WO 1996 / 30530 and WO 2013185184 and the promoters discussed therein.

[0334] Termination regions including polyadenylation signals are required for the production of intact and stable mRNA molecules. For example, the Agrobacterium tumefaciens carmine synthase (NOS) terminator provides a useful terminator. Bevan, 12 Nucl. Acid Res. 8711 (1984); Rogers et al., Biotechnol. PLANT SCI., p. 219 (Acad. Press, Inc., New York, NY, 1985); Sanders et al., 15 Nucl. Acids Res. 1543 (1987). A series of regulatory sequences are used in combination to drive and terminate transcription of various expression cassettes.

[0335] The transgenic protein is transported into subcellular compartments such as chloroplasts, vacuoles, peroxisomes, glyoxysomes, the cell wall, or mitochondria, or secreted into apoplasts, by means of operatively linking a nucleotide sequence encoding a signal sequence to the 5' or 3' region of the gene encoding the protein of interest. During protein synthesis and processing, the targeting sequence at the 5' or 3' end of the structural gene can determine the final compartmentalization location of the encoded protein.

[0336] The presence of a signal sequence directs a polypeptide to intracellular organelles or subcellular compartments or to the apoplast. Many signal sequences are known in the art. See, for example, Becker et al., 20 Plant Mol. Biol. 49 (1992); Knox et al., 9 Plant Mol. Biol. 3 (1987); Lerner et al., 91 Plant Physiol. 124 (1989); Fontes et al., 3 Plant Cell 483 (1991); Matsuoka et al., 88 PNAS 834 (1991); Creissen et al., 2 Plant J. 129 (1991); Kalderon et al., 39 Cell 499 (1984); Steifel et al., 2 Plant Cell 785 (1990).

[0337] Expression vectors typically include at least one genetic marker operatively linked to a regulatory element (e.g., a promoter), which allows transformed cells containing the marker to be recovered through negative selection (i.e., inhibiting the growth of cells not containing the selectable marker gene) or through positive selection (i.e., screening for products encoded by the genetic marker). Many commonly used selectable marker genes for plant transformation are well known in the field of transformation and include, for example, genes encoding enzymes that metabolically detoxify selective chemical agents (which may be antibiotics or herbicides), or genes encoding targets that are insensitive to inhibitors. Positive selection methods are known in the art.

[0338] A commonly used selectable marker gene for plant transformation is the neomycin phosphotransferase II (nptII) gene isolated from transposon Tn5, which confers kanamycin resistance when placed under the control of plant regulatory signals. (Fraley et al., 80 PNAS 4803 (1983)). Another commonly used selectable marker gene is the hygromycin phosphotransferase gene, which confers resistance to the antibiotic hygromycin. (Vanden Elzen et al., 5 Plant Mol. Biol. 299 (1985)). Other bacterial selectable marker genes that confer antibiotic resistance include gentamicin acetyltransferase, streptomycin phosphotransferase, aminoglycoside-3'-adenosyltransferase, and bleomycin resistance determinants. Hayford et al., 86 Plant Physiol. 1216 (1988); Jones et al., 210 Mol. Gen. Genet., 86 (1987); Svab et al., 14 Plant Mol. Biol. 197 (1990); Hille et al., 7 Plant Mol. Biol. 171 (1986). Other selectable marker genes confer resistance to herbicides such as glyphosate, glufosinate, or bromoxynil. Comai et al., 317 Nature 741 (1985); Gordon-Kamm et al., 2 Plant Cell 603 (1990); Stalker et al., 242 Sci. 419 (1988). Non-bacterial selectable marker genes for plant transformation include, for example, mouse dihydrofolate reductase, plant 5-enolpyruvate shikimate-3-phosphate synthase, and plant acetolactate synthase. Eichholtz et al., 13 Somatic Cell Mol. Genet. 67 (1987); Shah et al., 233 Sci. 478 (1986); Charest et al., 8 Plant Cell Rep. 643 (1990).

[0339] Another class of marker genes used for plant transformation requires screening for presumed transformed plant cells, rather than directly selecting for transformed cells resistant to toxic substances such as antibiotics. These genes are particularly useful for quantifying or visualizing spatial patterns of gene expression in specific tissues and are often referred to as reporter genes because they can be fused with genes or gene regulatory sequences for studying gene expression. Commonly used genes for screening for presumed transformed cells include α-glucuronidase (GUS), α-galactosidase, luciferase, and chloramphenicol, acetyltransferase. (Jefferson, RA, Plant Mol. Biol., 5:387 (1987); Teeri et al., EMBO J., 8:343 (1989); Koncz et al., PNAS, 84:131 (1987); and DeBlock et al., EMBO J., 3:1681 (1984). Some in vivo methods for visualizing GUS activity do not require destruction of plant tissue. Molecular Probes, Publication 2908, IMAGENE GREEN, 1-4 (1993); Naleway et al., 115 J. Cell Biol. 151a (1991). However, in vivo methods for visualizing GUS activity have problems, exhibiting low sensitivity, high fluorescence background, and limitations associated with using luciferase genes as selectable markers. Green fluorescent protein (GFP) can be used as a marker for gene expression in prokaryotic and eukaryotic cells. Chalfie et al., 263 Sci. 802 (1994). GFP and GFP mutants can be used as selectable markers.

[0340] NS-B50027-4 and its progeny can be further transformed to confer resistance to diseases or pests. For example, plant lines can be transformed with cloned resistance genes to engineer plants resistant to specific pathogen strains. See, for example, Jones et al., 266 Sci. 789 (1994) (cloning the tomato Cf-9 gene resistant to Cladosporium fulvum); Martin et al., 262 Sci. 1432 (1993) (the tomato Pto gene, a protein kinase, resistant to Pseudomonas syringae pv); Mindrinos et al., 78 Cell 1089 (1994) (the Arabidopsis RSP2 gene resistant to Pseudomonas syringae); Geiser et al., 48 Gene 109 (1986) (the Bacillus thuringiensis δ-endotoxin gene); Van Damme et al., 24 Plant Mol. Biol. 25 (1994) (Clivia miniata). (miniata) mannose-binding lectin; Sumitani et al., 57 Biosci. Biotech. Biochem. 1243 (1993) (amylase inhibitor); Abe et al., 262 J. Biol. Chem. 16793 (1987) (cysteine ​​protease inhibitor); Huub et al., 21 Plant Mol. Biol. 985 (1993) (tobacco protease inhibitor I); Regan, 269 J. Biol. Chem. 9 (1994) (insect diuretic hormone receptor); Pratt et al., 163 Biochem. Biophys. Res. Comm. 1243 (1989) (allostatin); Tomalski et al., US Patent No. 5,266,317 (insect-specific paralytic neurotoxin); Scott et al., WO1993 / 02197 (callase gene); Kramer et al., 23 Insect Biochem.Mol.Biol.691 (1993) (Tobacco hawk moth chitinase); Kawalleck et al., 21 Plant Mol.Biol.673 (1993) (Parsley ubi4-2 polyubiquitin gene); WO1995 / 16776 (Limulus amebocyte lysate derivatives inhibiting fungi); WO 1995 / 18855 (Synthetic antimicrobial peptides); Jaynes et al., 89 Plant Sci.43 (1993) (Silkworm antimicrobial peptide-β, cleavage peptide confers resistance to *Pseudomonas solanacearum* in transgenic tobacco plants); Botella et al., 24 Plant Mol. Biol., 24:757 (1994) (Mung bean calmodulin); Griess et al., 104 Plant Physiol. 1467 (1994) (Maize calmodulin); Taylor et al., Abstract #497, 7th Int'l Symp. Molec. Plant-Microbe Interactions (Edinburgh, Scotland) (1994) (Enzymatic inactivation in tobacco via transgenic single-chain antibody); Tavaldoraki et al., 366 Nature 469 (1993) (Viral resistance via transgenic antibody); Lamb et al., 10 Bio Technol. 1436 (1992) (Fungal endonuclease fragments promote fungal colonization and release plant nutrients through the dissolution of plant cell walls by homo-α-1,4-D-galacturonase; Toubart et al., 2 Plant J. 367 (1992) (Soybean polygalacturonase inhibitor); Logemann et al., 10 Bio / technology 305 (1992) (Transgenic plants expressing barley ribosome inactivation genes exhibit increased resistance to fungal diseases).

[0341] As mentioned above, herbicide resistance is another useful trait that can be introduced through genetic modification. For example, resistance to herbicides that inhibit growth points or meristems (such as imidazolinones or sulfonylureas) can be conferred by mutant ALS and AHAS enzymes. See, for example, Lee et al., 7EMBO J.1241 (1988); Miki et al., 80Theor.Appl.Genet.449 (1990); glyphosate resistance is conferred by aroA and mutant 5-enolpyruvate-shikimate-3-phosphate synthase (EPSPS) genes; glufosinate resistance is conferred by glufosinate-acetyltransferase genes; and resistance to pyridoxypropionic acid or phenoxypropionic acid and cyclohexanone is conferred by ACC enzyme inhibitor encoding genes.See, for example, U.S. Patent No. 4,940,835 (EPSPS conferring resistance to glyphosate); the mutant aroA gene, ATCC accession number 39256, see Comai, U.S. Patent No. 4,769,061; also see Umaballava-Mobapathie, 8 Transgenic Research 33 (1999) (resistance to glufosinate in lettuce (Lactuca sativa)); Kumada et al., EP 0 333 033; Goodman et al., U.S. Patent No. 4,975,374 (EPSPS conferring resistance to herbicides such as L-glufosinate); Leemans et al., EP 0 242 246 (glufosinate-acetyltransferase); DeGreef et al., 7 Bio / technol. 61 (1989) (chimeric bar gene encoding glufosinate-acetyltransferase); Marshall et al., 83 Theor. Appl. Genet. 435 (1992) (Acc1-S1, Acc1-S2, and Acc1-S3 genes confer resistance to phenoxypropionic acid and cyclohexanone such as haloxyfop-methyl and fluopyram); Przibilla et al., 3 Plant Cell169 (1991) (PsbA and gs+ genes confer triazine resistance); Stalker, US Patent No. 4,810,648 (Nitrile hydrolase gene confers phenyl nitrile resistance); Hayes et al., 285 Biochem. J. 173 (1992) (glutathione S-transferase); Hattori et al., 246 Mol. Gen. Genet. 419 (1995) (acetylhydroxyl synthase confers resistance to multiple herbicides); Shiota et al., 106 Plant Physiol. 17 (1994) (yeast NADPH-cytochrome P450 oxidoreductase); Aono et al., 36 Plant Cell Physiol. 1687 (1995) (glutathione reductase and superoxide dismutase); Datta et al., 20 Plant Mol. Biol. 619 (1992) (various phosphotransferases); WO 2001 / 12825; US Patent Nos. 6,288,306, 6,282,837, and 5,767,373; (Plants with altered protoporphyrinogen oxidase activity are resistant to herbicides targeting protoporphyrinogen oxidase).

[0342] The offspring derived from NS-B50027-4 and NS-B50027-4 can be further modified to endow any number of value-added traits known in the art. See, for example, Goto et al., 521 Acta Horticulturae 101 (2000) (soybean ferritin gene); Curtis et al., 18 Plant Cell Rep. 889 (1999) (nitrate reductase); Knultzon et al., 89 PNAS 2625 (1992) (stearoyl-ACP desaturase); Shiroza et al., 170 J. Bacteriol. 810 (1988) (nucleotide sequence of the fructosyltransferase gene of Streptococcus mutans); Steinmetz et al., 20 Mol. Gen. Genet. 220 (1985) (Bacillus subtilis L-sucrase gene); Pen et al., 10 Bio / technol. 292 (1992) (transgenic plants expressing Bacillus licheniformis α-amylase); Elliot et al., 21 Plant Mol.Biol.515(1993) (Tomato invertase gene); Fisher et al., 268 J. Biol. Chem. 22480 (1993) (site-directed mutagenesis of barley α-amylase gene); Fisher et al., 102 Plant Physiol. 1045 (1993) (maize endosperm starch branching enzyme II).

[0343] The rapeseed line NS-B50027-4 can also be manipulated to be male-sterile by any of a variety of methods known in the art, including the use of mechanical methods, chemical methods, self-incompatibility (SI), cytoplasmic male sterility (CMS, Ogura, or another system), or nuclear male sterility (NMS). The term "manipulated to be male-sterile" means using any available technique to produce a male-sterile version of the rapeseed line NS-B50027-4. Male sterility can be partial or complete. See, for example, WO 2001 / 29237 (introduction of deacetylase genes under the control of tapetum-specific promoters and application of the chemical substance N-Ac-PPT); WO 1992 / 13956, WO1992 / 13957 (stamen-specific promoters); Paul et al., 19 Plant Mol. Biol. 611 (1992) (introduction of Bacillus RNase and Bacillus RNase inhibitor genes); also see U.S. Patent Nos. 5,859,341; 6,297,426; 5,478,369; 5,824,524; 5,850,014; 6,265,640; Hanson et al., 16 Plant Cell S154 (2004).

[0344] Numerous methods have been developed for plant transformation, including biological and physical plant transformation protocols. See, for example, WO 2013185184; Miki et al., METHS. PLANT MOLEC. BIOL. BIOTECHNOL., pp. 67-88 (edited by Glick & Thompson, CRC Press, Inc., Boca Raton, FL, 1993). Furthermore, in vitro culture methods for expression vector and plant cell or tissue transformation and regeneration are available. See, for example, WO 2013185184; Gruber et al., METHS. PLANT MOLEC. BIOL. BIOTECHNOL., pp. 89-119 (edited by Glick & Thompson, CRC Press, Inc., Boca Raton, FL, 1993). One method for introducing expression vectors into plants is to use natural transformation systems of Agrobacterium, see Horsch et al., 227 Sci. 1229 (1985); Curtis et al., 45 J.Exper.Botany 1441 (1994); Torres et al., 34 Plant Cell Tissue Organ Culture 279 (1993); Dinant et al., 3 Molec.Breeding 75 (1997); Kado, 10 Crit.Rev.Plant Sci. 1 (1991) (Ti and Ri plasmids of Agrobacterium tumefaciens and Agrobacterium rhizogenes carry genes responsible for genetic transformation in plants); Gruber et al.; Miki et al.; Moloney et al., 8 Plant Cell Rep. 238 (1989) (Agrobacterium vector systems for Agrobacterium-mediated gene transfer); U.S. Patent No. 5,591,616.

[0345] Several plant transformation methods, collectively known as direct gene transfer, have been developed as alternatives to Agrobacterium-mediated transformation. A commonly applicable plant transformation method is particle-mediated transformation, in which DNA is carried on the surface of particles ranging from 1 μm to 4 μm in size. The expression vector is introduced into plant tissue via a biolistic device that accelerates the particles to speeds of 300 m / s to 600 m / s, sufficient to penetrate plant cell walls and membranes. Russell et al., 12 Plant Cell Rep. 165 (1993); Aragao et al., 20 Plant Mol. Biol. 357 (1992); Aragao et al., 12 Plant Cell Rep. 483 (1993); Aragao, 93 Theor. Appl. Genet. 142 (1996); Kim & Minamikawa, 117 Plant Sci. 131 (1996); Sanford et al., 5 Part. Sci. Technol. 27 (1987); Sanford, 6 Trends Biotech. 299 (1988); Klein et al., 6 Bio / technol. 559 (1988); Sanford, 7 Physiol. Plant 206 (1990); Klein et al., 10 Bio / technol. 268 (1992).

[0346] Methods for physically delivering DNA into plants are also known in the art. See, for example, Zhang et al., 9 Bio / technol. 996 (1991) (ultrasound); Deshayes et al., 4 EMBO J., 2731 (1985) (liposomes); Christou et al., 84 PNAS 3962 (1987) (protoplasts NHW11915); Hain et al., 199 Mol. Gen. Genet. 161 (1985) (CaCl2 precipitation); Draper et al., 23 Plant Cell Physiol. 451 (1982) (polyvinyl alcohol or poly-L-ornithine); Saker et al., 40 Biologia Plantarum, 507 (1997 / 98) (protoplast electroporation). Other methods include, but are not limited to, introducing expression vectors into plant tissues using direct gene transfer methods, such as microparticle-mediated delivery with shotgun devices, DNA injection, electroporation, etc. Following transformation, the expression of the selectable marker genes described above can allow for preferential selection of transformed cells, tissues, and / or plants using regeneration and selection methods well-known in the art. See, for example, WO 2013185184.

[0347] The transformation methods described above are typically used to produce transgenic lines. These transgenic lines can then be crossed with another (untransformed or transformed) line to produce new transgenic rapeseed lines. Alternatively, genetic traits engineered into a specific rapeseed or Brassica genus using well-known transformation techniques can be introduced into another line using traditional backcrossing techniques also well-known in the field of plant breeding. For example, backcrossing can be used to transfer engineered traits from a common, non-superior inbred line to a superior inbred line, or from an inbred line containing a foreign gene in its genome to an inbred line or line that does not contain that gene. As used herein, depending on the context, "hybridization" can refer to a simple X-Y cross or backcross process.

[0348] When the term "NS-B50027-4 plant" is used in the context of embodiments of this invention, it also includes any gene conversion of that line. The term "gene-converted plant" refers to those NS-B50027-4 plants developed through backcrossing, genetic engineering, or mutation, in which substantially all desired morphological and physiological characteristics are acquired, except for one or more genes transferred to a line derived from NS-B50027-4 through backcrossing, genetic engineering, or mutation. Backcrossing methods can be used in conjunction with embodiments of the invention to improve varieties or introduce traits into varieties. As used herein, the term "backcross" refers to repeatedly crossing hybrid offspring back to a recurrent parent, i.e., backcrossing with a recurrent parent 1, 2, 3, 4, 5, 6, 7, 8, 9, or more times. The parent Brassica plant that contributes genes to the desired trait is referred to as the "non-recurrent parent" or "donor parent." This term refers to the fact that the non-recurrent parent is used only once in the backcrossing scheme and therefore does not recur. A Brassica parent in which one or more genes from a non-recurrent parent are transferred is called a recurrent parent because it uses several cycles in the backcross scheme. (Poehlman & Sleper, 1994; Fehr, 1993). In a typical backcross scheme, the original variety of interest (recurrent parent) is crossed with a second variety (non-recurrent parent) carrying the genes of interest to be transferred. The offspring from this cross are then crossed again with the recurrent parent, and this process is repeated until rapeseed plants are obtained, in which virtually all the desired morphological and physiological characteristics of the recurrent parent are acquired in the transformed plant, except for the genes transferred from the non-recurrent parent.

[0349] Selecting a suitable recurrent parent is a crucial step in a successful backcross procedure. The goal of a backcross is to alter or replace traits or characteristics in the original line. To achieve this, genes in the recurrent cultivar are modified or replaced with the desired genes from a non-recurrent parent, while retaining virtually all other desired genotypes and thus preserving the desired physiological and morphological characteristics of the original line. The selection of a specific non-recurrent parent will depend on the purpose of the backcross. One primary objective is to add commercially desirable and agronomically important traits to the plant. The exact backcross protocol will depend on the trait or characteristic to be altered to determine the appropriate testing protocol. While the backcross method is simplified when the transferred trait is a dominant allele, recessive alleles can also be transferred. In this case, it may be necessary to introduce testing in the offspring to determine whether the desired trait has been successfully transferred.

[0350] Genetic traits that are not frequently selected in the development of new lines but can be improved through backcrossing can be identified. These traits may be transgenic or non-transgenic. Examples of such traits include, but are not limited to, male sterility, altered carbohydrate metabolism, herbicide resistance, resistance to bacterial, fungal, or viral diseases, insect resistance, enhanced nutritional quality, industrial use, yield stability, and yield improvement. These genes are typically inherited through the cell nucleus. See, for example, U.S. Patent Nos. 5,969,212 and 7,164,059.

[0351] Further propagation of the inbred strain NS-B50027-4 can occur through tissue culture and regeneration. The term "tissue culture" refers to a composition or collection of such cells comprising isolated cells of the same or different types, constituting a plant part. Exemplary types of tissue cultures include protoplasts, callus, meristematic cells, and plant cells that can generate complete tissue cultures in plants or plant parts such as leaves, pollen, embryos, roots, root tips, anthers, pistils, flowers, seeds, petioles, haustoria, etc. Means for preparing and maintaining plant tissue cultures are well known in the art. Tissue cultures of various tissues of rapeseed and regenerated plants from them are well known. See, for example, Teng et al., 27 Hort Sci. 1030 (1992); Teng et al., 28 Hort Sci. 669 (1993); Zhang et al., 46 J. Genet. Breeding 287 (1992); Webb et al., 38 Plant Cell Tissue Organ Cult. 77 (1994); Curtis et al., 45 J. Exp. Bot. 1441 (1994); Nagata et al., 125 J. Am. Soc'y Hort. Sci. 669 (2000); Ibrahim et al., 28 Plant Cell Tissue Organ Cult. 139 (1992); U.S. Patent Nos. 5,959,185, 5,973,234, and 5,977,445. Tissue culture and microspore culture for rapeseed plant regeneration can be successfully performed. See Chuong et al., 4 Plant Cell Rep. 4 (1985); Barsby et al., 5 Plant Cell Rep. 101 (1986); Kartha et al., 31 Physiol. Plant 217 (1974); Narasimhulu et al., 7 Plant Cell Rep. 104 (1988); Swanson, 6 Meth. Molec. Biol. 159 (1990); Cell Culture Tech. & Canola Improvement, 66 J. Am. Oil Chem. Soc. 455 (1989). It is clear from the literature that the state of the art allows these methods for obtaining plants to be used conventionally with a high success rate. Therefore, another aspect of the present invention provides cells that, upon growth and differentiation, produce rapeseed plants with the physiological and morphological characteristics of the inbred transgenic line NS-B50027-4.

[0352] Typically, when a transgene is introduced into a plant via conventional hybridization, its insertion site and flanking regions in the plant genome remain unchanged. An "insertion region" refers to a region corresponding to at least 40 base pairs, such as at least 100 base pairs or up to more than 10,000 base pairs, which is surrounded by upstream and downstream flanking regions of the transgene in the (untransformed) plant genome and includes the insertion site (and possibly target site deletions). Given the small differences due to mutations within a species, the insertion region can maintain at least 85%, such as 90%, 95%, or 100%, sequence identity with upstream and downstream flanking regions of the exogenous DNA in a given plant of that species. However, transgene cassette insertion into the plant genome can sometimes be accompanied by deletions of plant DNA known as "target site deletions." However, additional transgenesis or other genetic manipulations can be performed with NS-B50027-4 without extensive experimentation; and plants derived from NS-B50027-4 can be identified as described herein.

[0353] If the source material NS-B50027-4 is backcrossed with a cytoplasmic male-sterile source or some other source used to make inbred lines female-sterile, the source material NS-B50027-4 can be used to produce lines for hybrid seed production. Alternatively, the lines can be used directly. For example, the European rapeseed line NS-B50027-4 can be hybridized with another rapeseed plant to form a population of first-generation F1 plants. The population of first-generation F1 plants produced by this method is also an embodiment. This population of first-generation F1 plants contains the essentially complete allele genome of the rapeseed line NS-B50027-4. Typically, F1 hybrids are considered to possess all the alleles of each parent. Those skilled in the art can use breeding manuals or molecular methods to identify specific F1 plants produced using the rapeseed line NS-B50027-4, and any such individual plants are also included in this invention. These embodiments also cover the use of these methods for transgenic or single-gene conversion of the line NS-B50027-4.

[0354] Another embodiment of the invention is a method for using the rapeseed line NS-B50027-4 in breeding, comprising repeatedly backcrossing the rapeseed line NS-B50027-4 an arbitrary number of times. Using the transgenic method described herein, the backcross method, or other breeding methods known to those skilled in the art, it is possible to develop individual plants and plant populations that retain at least 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 99.5% of the genetic spectrum of the rapeseed line NS-B50027-4. The percentage of genetic material retained in offspring can be measured through pedigree analysis or by using genetic techniques such as molecular markers or electrophoresis. In pedigree analysis, on average 50% of the initial germplasm is passed to the offspring lines after one cross with another strain, 25% after another cross with a different strain, and so on. Molecular markers can also be used to confirm and / or determine the pedigree of offspring lines.

[0355] The specific method for preparing a line derived from the rapeseed cultivar NS-B50027-4 is as follows. Those skilled in the art cross the rapeseed cultivar NS-B50027-4 with another rapeseed plant (e.g., a superior variety). The F1 seeds from this cross are allowed to grow to form a homologous population. The F1 seeds contain 50% alleles from the rapeseed cultivar NS-B50027-4 and 50% alleles from the other plant. The F1 seeds are allowed to grow and self-pollinate to form F2 seeds. On average, the F2 seeds have acquired 50% alleles from the cultivar NS-B50027-4 and 50% from the other rapeseed plant, but the alleles of the various individual plants from the population have a greater percentage of alleles derived from the cultivar NS-B50027-4. Wang et al., 40 Crop Sci. 659 (2000); Bernardo et al., 102 Theor. Appl. Genet. 986 (2001). As used herein, the term population refers to a statistically representative sample. F2 seeds were grown and plants were selected based on visual observation or phenotypic measurements. The phenotypic used for selection could be the rapeseed line NS-B50027-4, which produces high DHA in rapeseed seeds. F2 progeny exhibiting the desired NS-B50027-4-derived phenotypic traits were selected, and each plant was harvested separately. F3 seeds from each plant were grown in separate rows and allowed to self-pollinate. Selected rows or plants from selected rows were harvested and threshed separately. Selection was also based on visual observation of plant phenotypes or detection of desired traits in plants, such as those from the desired NS-B50027-4-derived phenotypic traits. The growth and selection process is repeated as many times as possible until rapeseed plants of the inbred NS-B50027-4 source are obtained.

[0356] Rapeseed plants derived from NS-B50027-4 contain desired traits derived from the rapeseed line NS-B50027-4, some of which may not be expressed by another rapeseed plant hybridized with the rapeseed line NS-B50027-4 and some of which may be expressed by both rapeseed lines but are currently at levels equal to or greater than the expression level in NS-B50027-4.

[0357] F1 rapeseed or Brassica plants derived from NS-B50027-4 have an average of 50% of their genes derived from NS-B50027-4, but individual plants from this population have an even higher percentage of alleles from NS-B50027-4. A breeding process involving repeated hybridization, self-pollination, and selection was used to produce another population of rapeseed plants derived from NS-B50027-4, which has an average of 25% of its genes derived from the rapeseed line NS-B50027-4, but individual plants from this population have an even higher percentage of alleles from NS-B50027-4. Another embodiment of the invention is inbred rapeseed plants derived from NS-B50027-4, which have acquired the desired NS-B50027-4 trait of high DHA.

[0358] The preceding embodiments can be modified in various ways, for example, selection may or may not occur in each self-pollinating generation, may occur before or after the actual self-pollination process, or individual selection may be carried out by harvesting individual pods, plants, rows, or points at any point during the described breeding process. Furthermore, the double haploid breeding method can be used at any step of the process. The plant populations generated in each generation and in any generation of self-pollination are also embodiments of the present invention, and each such population will consist of plants containing approximately 50% of their genes from the rapeseed line NS-B50027-4, 25% of their genes from the rapeseed line NS-B50027-4 in the second round of hybridization and selection, 12.5% ​​of their genes from the rapeseed line NS-B50027-4 in the third round of hybridization and selection, and so on.

[0359] Another implementation method is to obtain homozygous rapeseed plants derived from NS-B50027-4, which is carried out by crossing the rapeseed line NS-B50027-4 with another rapeseed plant and applying a double haploid method to F1 seeds or F1 plants, or by self-pollinating the rapeseed line NS-B50027-4 obtained from this cross. Line breeding is commonly used to improve inbred lines of self-pollinating or cross-pollinating crops. Two parents with favorable, complementary traits are crossed to produce F1. The F2 population is produced by self-pollinating one or more F1 plants or by crossing two F1 plants with each other (sib crossing). Selection of the best individuals typically begins in the F2 population. Then, starting from F3, the best individuals from the best families are selected. Repeated testing of families or hybrid combinations involving individuals from these families are typically carried out in the F4 generation to improve the effectiveness of selection for traits with low heritability. During the advanced stages of inbreeding (i.e., F6 and F7), the best lines or mixtures of phenotypic similar lines are tested as potential releases of new cultivars.

[0360] Furthermore, embodiments of the present invention relate to a method for producing rapeseed plants derived from NS-B50027-4, the method comprising: hybridizing the rapeseed line NS-B50027-4 with rapeseed plants and allowing the progeny seeds to grow, and repeating the hybridization and growth steps 1 to 2 times, 1 to 3 times, 1 to 4 times, or 1 to 5 times with rapeseed plants derived from NS-B50027-4, and self-pollinating any number of times after the first, second, third, fourth, or fifth hybridization. Quality and recurrent selection can be used to improve populations of self-pollinating or cross-pollinating crops. Populations of genetic variation of heterozygous individuals are identified or generated by hybridizing several different parents. Optimal plants are selected based on individual strengths, outstanding progeny, or superior combinatorial ability. Selected plants are hybridized to produce new populations, in which further selection cycles continue.

[0361] Backcrossing has been used to transfer genes for easily inherited, highly heritable traits into a desired homozygous cultivar or line that serves as a recurrent parent. The source of the trait to be transferred is called the donor parent. The resulting plant is expected to possess the attributes of the recurrent parent (e.g., a cultivar) and the desired trait transferred from the donor parent. After initial hybridization, individuals with the donor parent phenotype are selected and repeated hybridization (backcrossing) is performed on the recurrent parent. The resulting plant is expected to possess the attributes of the recurrent parent (e.g., a cultivar) and the desired trait transferred from the donor parent.

[0362] Strictly speaking, the single-seed descent procedure involves planting a segregating population, harvesting a sample of one seed from each plant, and using this single-seed sample to propagate the next generation. As the population progresses from F2 to the desired breeding level, plants from the derived lines will each be traced back to different F2 individuals. Because some seeds fail to germinate or some plants do not produce at least one seed, the number of plants in the population decreases with each generation. Consequently, when the succession is complete, not all F2 plants initially sampled in the population will appear in the offspring.

[0363] Another implementation provides single-gene conversion of NS-B50027-4. Gene conversion occurs when a DNA sequence is introduced via conventional (non-transformation) breeding techniques, such as backcrossing. The DNA sequence, whether naturally occurring or transgenic, can be introduced using these conventional breeding techniques. Desired traits transferred via this method include, but are not limited to, alterations in fertility, fatty acid profile modification, other nutritional enhancements, industrial enhancements, disease resistance, insect resistance, herbicide resistance, and yield increase. The trait of interest is transferred from a donor parent to a recurrent parent, in this case, the rapeseed plant disclosed herein. Single-gene traits may result from the transfer of dominant or recessive alleles. Selection of progeny containing the trait of interest is performed by directly selecting for the trait associated with the dominant allele. Selection of progeny for traits transferred via recessive alleles requires allowing the first backcross to grow and self-pollinate to determine which plants carry the recessive allele. Recessive traits may require further progeny testing in successive backcross generations to determine the presence of the gene of interest. Selection is performed on the recurrent parent's phenotype in offspring for the trait of interest. It should be understood that additional polynucleotide sequences or genes may occasionally be transferred along with the single-gene transforming trait of interest. Offspring containing at least 90%, 95%, 96%, 97%, 98%, 99%, or 99.5% of the genes from the recurrent parent (the rapeseed plant disclosed herein), plus offspring containing the transforming trait, are considered to be NS-B50027-4 of the transforming trait. When the trait is controlled by two genes (e.g., some disease resistance), selection can be performed on both genes simultaneously, and so on.

[0364] Mutation breeding is another method for introducing new traits into rapeseed varieties. For plant breeders, spontaneously occurring or artificially induced mutations can be a useful source of variation. The goal of artificial mutagenesis is to increase the mutation rate of the desired trait. Mutation rates can be increased through many different means, including temperature, long-term seed storage, tissue culture conditions, radiation (such as X-rays, gamma rays, neutrons, beta radiation, or ultraviolet radiation), chemical mutagens (such as base analogs like 5-bromouracil), antibiotics, alkylating agents (such as sulfur mustard, nitrogen mustard, epoxides, ethylamine, sulfates, sulfonates, sulfones, or lactones), azides, hydroxylamines, nitrites, or acridine. Once the desired trait is observed through mutagenesis, it can be incorporated into existing germplasm using conventional breeding techniques. See, for example, Fehr, PRINCIPLES CULTIVAR DEVEL. (Macmillan Pub'l Co., 1993).

[0365] It should be understood that the rapeseed lines of the embodiments of the present invention can be produced in a male-sterile form through conventional manipulation of cytoplasmic genes, nuclear genes, or other factors, as described in the foregoing references. Such embodiments are also within the scope of the claims. The embodiments of the present invention therefore provide F1 hybrid seeds and plants produced using the rapeseed line NS-B50027-4.

[0366] Many laboratory techniques can be used for the analysis, comparison, and characterization of plant genotypes; these include isoenzyme electrophoresis, restriction fragment length polymorphism (RFLP), random amplified polymorphic DNA (RAPD), arbitrary primer polymerase chain reaction (AP-PCR), DNA amplified fingerprinting (DAF), sequence characteristic amplified region (SCAR), amplified fragment length polymorphism (AFLP), simple sequence repeats (SSR, also known as microsatellites), and single nucleotide polymorphisms (SNPs).

[0367] Isozyme electrophoresis and RFLP have been widely used to determine gene composition. Shoemaker & Olsen (Molecular Linkage Map of Soybean (Glycine max), S. J. Bren (ed.) Genetic Maps: Locus Maps of Complex Genomes, pp. 6.131-6.138, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1993) developed a molecular genetic linkage map consisting of 25 linkage groups with approximately 365 RFLPs, 11 RAPDs, 3 classical markers, and 4 isozyme loci. See also Shoemaker, RC, RFLP Map of Soybean, pp. 299-309, Phillips, RL and Vasil, IK (ed.), DNA-Based Markers in Plants, Kluwer Academic Press, Dordrecht, the Netherlands (1994).

[0368] SSR technology is currently an effective and practical marker technology; more marker loci can be routinely used, and compared to RFLP, SSR can find more alleles per marker locus. See, for example, Diwan & Cregan, 95 Theor. Appl. Genet. 22 (1997). SNPs can also be used to identify the unique genetic makeup of the present invention and progeny varieties that retain this unique genetic makeup. Various molecular marker technologies can be used in combination to enhance overall resolution. Molecular markers can be used in plant breeding, including markers identified by using techniques such as isozyme electrophoresis, RFLP, RAPD, AP-PCR, DAF, SCAR, AFLP, SSR, and SNP. One use of molecular markers is quantitative trait locus (QTL) mapping. QTL mapping uses markers known to be closely linked to alleles that have a measurable effect on quantitative traits. Selection in the breeding process is based on the accumulation of markers linked to positive-effect alleles from the plant genome or the elimination of markers linked to negative-effect alleles from the plant genome.

[0369] Molecular markers can also be used during the breeding process to select for qualitative traits. For example, markers closely linked to alleles or containing sequences within the actual allele of interest can be used during backcross breeding procedures to select plants containing the allele of interest. These markers can also be used for genomic selection toward the recurrent parent and for discarding the donor parent. This process attempts to minimize the amount of genome from the donor parent retained in the selected plants. It can also be used to reduce the number of backcrosses required to the recurrent parent in a backcross procedure. The use of molecular markers in the selection process is often referred to as marker-assisted selection or marker-enhanced selection. By providing a means of tracing the genetic spectrum through hybridization, molecular markers can also be used to identify and exclude the origin of certain germplasm as the ancestor of parental varieties or plants.

[0370] Therefore, it is clear that the technical state of these methods for obtaining plants is "conventional" because they are routinely used and have a high success rate. The applicability of the rapeseed line NS-B50027-4 also extends to hybridization with other species. Typically, suitable species belong to the Brassicaceae family. Therefore, embodiments of the invention include any and all methods of breeding using the rapeseed line NS-B50027-4, including self-pollination, pedigree breeding, backcrossing, hybridization, and hybridization with populations. All plants and plant populations produced using the rapeseed line NS-B50027-4 as a parent are within the scope of these embodiments, including those developed from varieties derived from the rapeseed line NS-B50027-4. Those skilled in the art can identify progeny lines or populations derived from the rapeseed line NS-B50027-4 using unique molecular marker profiles or breeding records. Example

[0371] Example 1. Characterization and selection of strain NS-B50027-4 in field trials

[0372] A challenging task in plant breeding is identifying individual plants with genetic advantages, because for most traits, the true genotypic value can be masked by other confounding plant traits or environmental factors. One method for identifying superior plants is to observe their performance relative to other experimental plants and one or more widely cultivated standard cultivars. If the results of a single observation are uncertain, repeated observations provide a better estimate of genetic value.

[0373] The plant initially identified as B0050-027-18 was selected based on single-seed selection, by harvesting a sample of one seed from each plant and planting the next generation using the single-seed sample. Typically, the number of plants in the population decreases with each generation because some seeds fail to germinate or some plants do not produce at least one seed. As a result, not all plants initially sampled in the population will be present in the offspring when the succession is complete. Moreover, the original transgenic events add genetic complexity, making it impossible to predict the genotype or phenotype of the offspring. Therefore, plants are self-pollinated and selected for several generations until a specific line becomes homozygous, exhibiting selective traits with superior agronomic characteristics, and producing a homogeneous population of truly breeding generations. More specifically, test lines were selected at the Nuseed Innovation Center (NIC) in Horsham (Victoria, Australia) according to a breeding reselection procedure. The selection and development of candidate lines were based on:

[0374] (a) Copy number of the T-DNA insert;

[0375] (b) Separation pattern of DHA expression;

[0376] (c) Homozygosity; (based on fatty acid phenotype and genotype);

[0377] (d) Production of LC-ω3-DHA; and

[0378] (e) Agronomic traits suitable for crop production based on offspring tests at different locations in winter and summer.

[0379] In Australia, canola is grown in the southern dryland regions and primarily in winter-rainy environments. Australian production mainly comes from spring-growing canola cultivars with lower vernalization requirements. Generally, Australian cultivars typically have a slightly delayed flowering start and relatively high plant vigor or biomass yield during the winter months. Australian canola crops are usually sown in April or May after the first major rainfall event and harvested from October to December. Yield is primarily influenced by water availability during the growing season and the cultivar's water use efficiency. Resistance to the main pathotype genes for blackleg caused by *Leptosphaeria maculans* can differentiate cultivars in terms of seedling survival and stem canker, but Australian cultivars are generally considered highly resistant when grown under recommended agronomic practices. Seed development occurs after the five- to seven-month growing season and in late spring or early summer. Besides water availability, yield can be significantly affected by extreme temperatures (<0°C to >35°C), which can lead to seed and pod abortion.

[0380] As described in this paper, rapeseed germplasm transformation was performed using an eight-gene construct that induced seed-specific accumulation of LC-ω3 fatty acids, particularly DHA. More broadly, although plants carry marker genes (MGs), phenotypes are characterized by product quality (PQ) (the amount of ω-3 fatty acids produced). Further selection of transformation materials is based on locus homozygosity, DHA expression in seeds, and agronomic traits and yield potential suitable for commercial production.

[0381] A range of key agronomic and seed traits were compared between three sister plants (sibs) from three T2 generations of transgenic events at eight test sites (locations) and eight other rapeseed cultivars (lines). In 2015 in Victoria, growing season rainfall was below the long-term average, and the growing season was shortened. The eight Australian test sites represent a wide range of environmental yield potentials, as indicated by the range of site-average yields (i.e., AV Garnet: 0.7 to 2.4 t / ha). The transgenic line B0050-027-18-X was represented by three transgenic lines: B0050-027-18-20 (T3), B0050-027-18-36-13 (T4), and B0050-027-18-105-13 (T4). Variations in agronomic traits in the test lines were comparable to those in commercial cultivars assessed across all test settings. This conclusion is supported by the following findings: Based on cross-site analysis (MET-REML), the grain yield of the highest-yielding test lines was statistically comparable to that of the highest-yielding commercial cultivars. Furthermore, for each site, the highest-yielding test lines had significantly higher yields than at least one cultivar, except for one site where no significant difference was observed. The test lines produced seeds with a slightly lower percentage of seed oil and altered fatty acid composition; however, this did not affect yield or agronomic traits. The expression of LCω3DHA fatty acids was highly stable in the test environment.

[0382] The test strain was derived from transformed plantlets (AV Jade variety). Seeds were bulked by allowing isolated plants to self-pollinate (i.e., through insect-proof canopies).

[0383] The control cultivars used for comparison (commercial breeding lines) provide a range of agronomical diversity (e.g., plant habits, phenology) of well-adapted cultivars (i.e., high-yielding but variable yield potential and oil content) that are widely grown in the planting area. These cultivars are all open-pollinated and are described and extensively evaluated in, for example, the Australian National Variety Testing Scheme and regional annual crop reports. See the “nvtonline” website. Furthermore, for black shank in Australia, variations in plant disease resistance are described in detail. Van De Wouw et al., 67Crop & Pasture Sci. 273 (2015). In Australia, black shank can cause yield losses of up to 90%. Marcroft & Bluett, Agricul. Notes, AG1352, Victoria, Dept. Primary Indus. (2008). Genetic variation in specific seed fatty acid composition and seed oil content in commercial cultivars has been documented over time. See Seberry et al., Quality of Australian canola 2011 (Australian Oilseeds Fed., 2012). Plants from the cultivar AV Jade were transformed to produce transgenic T0, and therefore AV Jade can be considered as the untransformed isoline of the transgenic event described herein.

[0384] Phenotypic variation in the test lines was characterized by plant germination, plant vigor, flowering time, flowering duration, plant height, seed drop, lodging resistance, black shank severity, plant harvest count, grain yield, grain moisture, seed oil percentage, and fatty acid content, particularly seed LC-ω3 polyunsaturated fatty acid (LC-PUFA) content (specifically involving the yield of EPA, DPA, and DHA). For all measured traits, finite likelihood estimation was performed using ASREML in the statistical software GenStat. Gilmour et al., ASREML User Guide, release 3.0, Biometric Bulletin (3) (VSV Int'l, Waterhouse Stm Hemel Hempstead, UK, 2009). Linear mixed model statistical methods were used to explain field spatial variation, as extensively described, and for field plant breeding and genetic studies. Cullis & Gleeson, 47 Biometrics 1449 (1991); Smith et al., 57 Biometrics 1138 (2001); Welham et al., Analysis of linear mixed models by ASReml-R with Applications in Plant Breeding: Course Notes (VSVInt'l, Waterhouse Stm Hemel Hempstead, UK, 2013). Further meta-REML cross-location analysis was performed on grain yield (t / ha) to determine the best cross-location linear unbiased prediction (BLUP) for the tested lines.

[0385] Regarding plant germination, this count was performed approximately 12 days after sowing, at two 1-square-meter plots in each of the eight locations. 2 The number of germinating plants in each quadrant is counted to estimate the number of germinating plants per square meter. The average of the two quadrants is used to estimate the number of germinating plants per square meter and is analyzed as a trait variable. For each plot at all locations, a plant emergence score is recorded based on a visual estimate of the average plant density in each plot and is analyzed as a trait variable (e.g., 1 = low = 0-5 plants / m²). 2 5 = Medium = 25-30 plants / m² 2;9 = height = 45-50 plants / m2). Plant germination and plant germination scores based on the number per square meter varied significantly among the line treatments at all eight sites. Statistical variation in plant germination of transgenic lines was significant within the range represented by the cultivars in all experiments. Observations of plant vigor at the cabage stage (i.e., from the six-leaf stage) in each plot at all sites, ranging from 1 to 9, were used to predict early growing season plant vigor and analyzed as a trait variable.

[0386] Flowering time was recorded as the number of days from sowing to when 50% of the plants in the plot had at least one open flower. This was recorded for each plot in all trials and analyzed as a trait variable. The onset of flowering (days from sowing) based on 50% of the plants being in bloom varied significantly among line treatments at all locations. The site-mean flowering time varied from 99 to 110 days and indicates environmental differences in this trait across experimental sites. The statistical variation in flowering time of transgenic lines was significant within the range represented by cultivars in all experiments.

[0387] Flowering duration is the calculated difference (expressed in days) between flowering time and the end of flowering. This was calculated for each plot in all trials and analyzed as a trait variable: Flowering duration = Flowering end date - Flowering time (50%). The flowering start (days from sowing) based on 50% of plants flowering varied significantly among lines at all locations. The site-mean flowering time varied from 99 to 110 days, reflecting environmental differences in the trait across experimental sites. Statistically, the variation in flowering time of transgenic lines was significant within the range expressed for cultivars across all experiments. The flowering end (days from sowing) based on 90% of plants not flowering varied significantly among lines at all eight locations. The site-mean flowering end time ranged from 128 to 139 days, reflecting environmental differences in the trait across experimental sites. Statistically, the variation in flowering end of transgenic lines was significant within the range expressed for cultivars across all locations.

[0388] Plant count at harvest per square meter varied significantly among all eight locations. Statistically, the variation in plant count at harvest time for transgenic lines was significant across the range represented by cultivars at all plantings and locations. Plant count at germination was significantly correlated with the number of plants recorded at harvest. Some calculated survival percentages exceeded 100%, reflecting the slow seedling germination of the two cultivars (ATR Wahoo and AV Jade): not all germinating seedlings were recorded at plant germination counts.

[0389] Plant height at dry seed maturity was measured from the base to the tip of the plant at the center of the plot. The plot center was used to avoid confounding effects (edge ​​effects) that might be associated with inter-plot spatial regions. The trait was recorded for each plot in all trials and analyzed as a trait variable. Mature plant height (cm) varied significantly among line treatments at all locations. The site mean plant height varied from 63 cm to 105 cm, indicating environmental differences in this trait across experimental sites. Statistically, the variation in mature plant height of transgenic lines was significant within the range represented by cultivars in all experiments.

[0390] Seed drop at maturity (sometimes called pod drop) was analyzed using seed drop counts recorded per 1 / 8 square meter over a two-week period. This was done by placing two trays under the canopy between the seed rows in each plot at all locations and analyzing them as a trait. Seed drop scores (based on grades 1 (zero) to 9 (high: +40)) were also recorded at each site based on the number of seeds observed on the ground before adjacent harvest and analyzed as a trait. Seed drop based on the number of seeds on the ground at harvest varied significantly among line treatments in four of the eight sites. The site mean seed drop number varied from 3 to 15 (per 1 / 8 square meter) and indicated a low level of seed drop at all sites. Seed drop scores at one site also varied significantly among lines and were strongly correlated with the mean seed drop count across sites. This suggests that recording seed drop as a score is a good predictor of seed drop. Statistically, the variation in seed drop based on seed counts and scores for transgenic lines was significantly within the range represented by cultivars in all experiments.

[0391] Lodging resistance was scored based on the angle of the plant tilted from its base at maturity, and was recorded as 1 (resistant) to 9 (susceptible). There was no statistically significant variation in lodging. The lack of variation in this trait may be related to below-average rainfall during the later stages of pod filling.

[0392] At five sites, black shank severity symptoms representing *Leptosphaeria biglobosa* and *Leptosphaeria spp.* were recorded on scores ranging from 1 (low <5%) to 9 (high >40%). Not all plots were scored due to a lack of observable variation. No symptoms associated with canker and stem breakage were observed. Black shank leaf symptoms were observed at very low levels at all eight sites. One site was sown with naked seeds (untreated seeds). There was no relative difference in plant germination between lines tested at this site and at other sites treated with seed fungicides. Leaf symptoms do not always predict the severity of stem canker caused by *Leptosphaeria biglobosa* (a major cause of yield loss and a basis for resistance rating in Australia, see Sosnowski et al., 33 Australian Plant Pathol. 401 (2004)). Several studies have assessed black shank resistance based on pathogen infection on cotyledons, leaves, stems (canker), and plant survival under field conditions. Due to the absence of ulceration and stem breakage, rapeseed varieties can be considered resistant to existing disease stress for the purposes described herein.

[0393] Plant harvest counts were estimated by counting plants in two one-square-meter quadrants in each plot at all eight sites. The mean of the two quadrants was then used to estimate the number of plants per square meter and analyzed as a trait variable. Plant survival rate (%) was calculated by expressing the site mean of plant counts as a percentage of the site mean of plant germination counts: Plant survival rate % = (Plant harvest counts × 100) / Plant germination counts.

[0394] Grains were harvested when the seeds were physiologically mature and dried using a plot harvester (~7%). For each trial, the harvesting direction was kept consistent (i.e., the front and back ranges of each row) to avoid directional errors. The dry grain weight for each plot was determined and converted to t / ha based on plot area and analyzed as a trait variable.

[0395] Grain moisture content at harvest and in laboratory samples was recorded and analyzed as a trait variable. Large numbers of samples were analyzed directly at field harvest using a handheld moisture meter. Moisture percentage was also determined using an oven drying method based on Australian Oilseed Combined (AOF) Method 4-1.5. This method involves drying 5 g samples in an open container at 130°C for 1 hour in an oven. The samples were then cooled in a desiccator for 40 minutes and weighed, and the moisture percentage was determined as a percentage of mass loss. Grain moisture content (%) at harvest varied significantly among line treatments at all eight locations. The site-average grain moisture content at harvest varied from 9% to 12%, indicating that seeds were harvested at similar grain stages. Statistically, for transgenic lines, the variation in grain moisture content at harvest was significant within the range represented by all experimental cultivars. Grain moisture content at harvest (%) was also correlated with flowering time, with late-flowering lines (i.e., ATR Wahoo and Monola 515TT) exhibiting significantly higher grain moisture content (%) at harvest time across all locations. Laboratory seed moisture content varied significantly among lines across all locations. However, the differences between lines and cross-sites were very low, averaging about 7%. This suggests that there is no confusion effect from seed storage. In the laboratory, the variation in seed moisture of transgenic lines was significantly within the range expressed by non-transgenic lines (P<0.05).

[0396] Seed oil content (%) was analyzed in seeds adjusted to 6% moisture using spin-lock nuclear magnetic resonance (NMR) spectroscopy. Briefly, samples of 5 to 10 grams of seeds were weighed into NMR tubes and analyzed using an NMR spectrometer. Seed oil results were determined using software calibration initially created with 20 reference samples of known oil content percentages, as determined by the weight of the extracted oil. Seed oil content varied significantly among lines at all eight locations (P < 0.05). The site-average seed oil % varied from 37.0% to 41.5%, generally below the site average and likely a result of below-average rainfall and above-average temperatures experienced during grain filling. Relative line differences were very consistent across locations. Variation in seed oil content in transgenic lines at all locations was slightly lower than in non-transgenic lines—averaging about 2%, which may provide a target for genetic improvement. Lower oil content may not be genetically linked to transgenic events but could be a result of transformation into a lower-oil-content cultivar, AV Jade.

[0397] A summary of the characterization of the agronomic traits of event NS-B50027-4 compared to the agronomic traits of the non-GMO cultivar is shown in Table 4 (analytical REML; F pr < 0.001 Sig for all traits).

[0398]

[0399] Fatty acids were determined using solvent extraction, followed by simultaneous saponification and methylation, and analyzed by GC-FID. In short, this involves crushing seed samples and extracting the oil from the crushed seed samples into a solvent. The solvent is evaporated under nitrogen, and the oil sample is diluted in fresh solvent. Aliquots are reacted with Meth Prep II (a saponification / methylation reagent). The samples are heated to 40°C to accelerate the reaction and then injected into a GC-FID using a BPX-70 column for fatty acid determination. Fatty acids are calculated as a percentage of the oil composition, where the area of ​​each fatty acid peak is determined as a percentage of the sum of all fatty acid peaks in the chromatogram. These estimates are analyzed separately as phenotypic variables. The following specific fatty acid percentages were assessed: palmitic acid; stearic acid; oleic acid and cis-vaccenic acid; linoleic acid; alpha-linolenic acid (ALA); arachidonic acid (also known as eicosanoic acid) and octadecanoic acid (SDA); eicosapentaenoic acid, eicosa-11-enoic acid, and eicosa-9-enoic acid; erucic acid and eicosapentaenoic acid (ETA); eicosapentaenoic acid (EPA); docosapentaenoic acid (DPA); and docosahexaenoic acid (DHA). Table 5 shows the cross-site analysis of seed fatty acid content (all values ​​are percentages; analytical REML; for all traits, F pr < 0.001 Sig):

[0400]

[0401] The percentage of fatty acids present as stearic acid in seeds, as analyzed by GC-FID, varied significantly among lines at all eight locations. The site-average % stearic acid showed very small variation, ranging from 1.6% to 2.2%. Statistically, the variation in % stearic acid for transgenic lines was significant within the range expressed for non-transgenic lines at all locations.

[0402] The percentage of fatty acids as oleic acid and cis-isooleic acid in seeds, analyzed by GC-FID, varied significantly among lines at all eight locations. The site-average percentages of oleic acid and cis-isooleic acid ranged from 51% to 58%. Statistically, the variation in the percentages of oleic acid and cis-isooleic acid in transgenic lines was significantly lower than the range represented by non-transgenic lines at all locations. This result is relevant to the transgenic insert and does not affect commercial agronomic traits or grain production.

[0403] The percentage of fatty acids present as linoleic acid in seeds, as analyzed by GC-FID, varied significantly among lines at all eight locations. The mean percentage of linoleic acid at each location ranged from 13.4% to 14.7%. The variation in linoleic acid percentage in the transgenic sister line (sib line) derived from a T2 event (plant B0050-027-18) was significantly lower (P<0.05) than that represented by cultivars at all locations and sister lines derived from other events. The significant difference in linoleic acid percentage may be associated with transgenic expression. The reduction in linoleic acid percentage may be associated with transgenic inserts but does not affect agronomic traits or commercial-scale grain production.

[0404] The percentages of fatty acids present as ALA, arachidic acid, and SDA varied significantly among lines at all eight sites. Site-average ALA, arachidic acid, and SDA percentages ranged from 5% to 11%. The variation in ALA, arachidic acid, and SDA percentages in transgenic lines was significantly higher (P<0.05) than that expressed in all non-transgenic cultivars tested. This significant difference in traits observed at some sites was associated with transgenic expression. This result was associated with the transgenic insert and did not affect commercial agronomic traits or grain production. Due to the SNP in the Fad gene, the high-oleic cultivar (Monola515TT) produced significantly lower ALA percentages compared to other cultivars (P<0.05).

[0405] The percentages of fatty acids present as eicosapentaenoic acid (EPA), eicosapentaenoic acid (EPA), and eicosapentaenoic acid (EPA) varied significantly among lines at all eight locations. The location mean values ​​of EPA, EPA, and EPA ranged from 2.0% to 2.5%. The variation in EPA, EPA, and EPA percentages in transgenic lines was significantly higher (P<0.05) than that expressed in non-transgenic cultivars in all experiments. This result is associated with transgenic inserts and does not affect commercial agronomic traits or grain production.

[0406] The percentages of fatty acids present as erucic acid and ETA were recorded at five sites, and the variation was generally close to 0%. Results associated with the transgenic insert did not commercially affect agronomic traits or grain production.

[0407] Seed LC-ω3 polyunsaturated fatty acids (LC-PUFA), particularly EPA, DPA, and DHA, were calculated as percentages for each plot and analyzed as trait variation, where LC-PUFA = EPA% + DPA% + DHA%. For each plot, the predicted DHA was calculated in kg / ha and analyzed as a trait variable: DHA kg / ha = (oil% x 0.01) x (DHA% x 0.01) x grain yield (t / ha) x 1000. For each plot, the predicted LC-PUFA was calculated in kg / ha and analyzed as a trait variable: DHA kg / ha = (oil% x 0.01) x (LC-PUFA% x 0.01) x grain yield (t / ha) x 1000.

[0408] The percentage of fatty acids as EPA varied significantly (P<0.05) across all eight locations. The variation in the percentage of transgenic lines was significantly higher (P<0.05) than that expressed in non-transgenic cultivars. This result, associated with the transgenic insert, did not affect agronomic traits or grain production, but it did make the grain more valuable.

[0409] The percentage of fatty acids as DPA varied significantly (P<0.05) among lines at all locations. The variation in the percentage of transgenic lines was significantly (P<0.05) higher than that expressed by non-transgenic cultivars at all locations. This result is associated with the transgenic insert and will not commercially affect agronomic traits or grain production.

[0410] The percentage of fatty acids as DHA varied significantly among lines at all eight locations. The variation in the percentage of transgenic lines was significantly higher (P<0.05) than that expressed by non-transgenic cultivars at all locations. This result was associated with the transgenic insert and did not affect commercial agronomic traits or grain production. Variance between transgenic sister lines was used as the basis for selection. The percentage of DHA across locations and comparisons of the superior variety event NS-B50027-4 with non-transgenic cultivars (as determined by GC-FID) are shown in Table 6 (analytical REML; F pr<0.001 Sig for all locations).

[0411]

[0412] Predicted DHA, expressed in kg / ha and calculated based on fatty acid profiles, seed oil % and grain yield, varied significantly among lines at all locations (P < 0.05). The variability in % of transgenic lines was significantly higher (P < 0.05) than that expressed in non-transgenic lines at all locations. This result is associated with the transgenic insert and, apart from making the grain more valuable, does not affect commercial agronomic traits or grain production. Variance among transgenic sister lines was used as the basis for selection. High stability of DHA yield per unit area (kg / ha) is attributed to low cross-location variability in seed oil and DHA % produced in seeds. Predicted yields of DHA across locations (kg / ha) and comparisons of the superior cultivar NS-B50027-4 with non-transgenic cultivars are shown in Table 7 (analytical REML; F pr < 0.001 Sig for all locations):

[0413]

[0414] Regarding the percentages of seed LC-PUFAω3—EPA, DPA, and DHA—the percentages of LC-PUFA varied significantly across lines at all eight sites (P<0.05). The variation in the percentages for transgenic lines was significantly higher (P<0.05) than that expressed for cultivars in all trials. This result is associated with the transgenic insert and, apart from increasing grain value, does not affect agronomic traits or commercial grain production. Variation among transgenic sister lines was used as a basis for selection. Trace levels of LC-PUFA observed in non-transgenic lines may be associated with pollen flow, seed migration, or GC-FID error.

[0415] Table 8 shows the percentage values ​​determined by GC-FID (analytical REML; for all locations, F pr < 0.001 Sig).

[0416]

[0417]

[0418] The predicted LC-PUFA, expressed as kg / ha and calculated based on fatty acid profiles, seed oil % and grain yield, varied significantly among different treatment lines at all locations. Statistically, the variability in % of transgenic lines was significantly higher than the variability expressed in cultivars across all experiments. This result is associated with the transgenic insert and does not commercially affect agronomic traits or grain yield. Variance among transgenic sister lines was used as the basis for selection. Trace levels in cultivar seeds may be related to pollen flow, seed migration, or GC-FID error. LC-PUFA exhibits high stability in terms of yield per unit area (kg / ha) due to the low cross-site variability in % DHA produced in seed oil and seeds. Table 9 shows the predicted kg / ha LC-PUFA values ​​(F pr < 0.001 at all locations).

[0419]

[0420]

[0421] For each cultivation site, seed oil content determined by NMR will be tabulated and shown in Table 10 (units are percentages; analytical REML; for all sites, Fpr < 0.001 Sig):

[0422] Further analysis of the fatty acid content of NS-B50027-4 seeds is shown in Table 11:

[0423]

[0424]

[0425]

[0426]

[0427]

[0428] The data in Table 11 confirm that NS-B50027-4 seeds contain substantially more ALA than conventional rapeseed varieties, in addition to LC-ω3 fatty acids. See also Table 5. Although ALA is not LC-PUFA, it is an ω3 fatty acid. The ω3 / ω6 fatty acid ratio in NS-B50027-4 seed oil in Table 11 is approximately 3.59 to approximately 6.12; the ω3 / ω6 fatty acid ratio in conventional rapeseed oil is approximately 0.5. Patterson et al., J. Nutr. Metab. (2012).

[0429] Table 12 shows data on the percentages of DHA and LC-PUFA in seeds of the NS-B50027-4, a superior variety grown in experimental culture in Australia over 16 generations. Additional field trials conducted in Australia produced a large number of seeds with 9.6% DHA and 10.1% LC-PUFA.

[0430]

[0431] Furthermore, the ability of NS-B50027-4 to grow in Canada was tested under controlled experimental conditions at two different locations in 2016. Table 13 shows the agronomic traits and yield data of NS-B50027-4 compared with several non-GMO rapeseed lines:

[0432]

[0433] Because the rapeseed strain NS-B50027-4 is basically homogeneous, it can be propagated by planting seeds of this strain, allowing the resulting rapeseed plants to grow under conditions of full separation and self-pollination or close pollination, and harvesting the seeds using conventional agronomic methods.

[0434] Example 2. Detection of competitive allele-specific PCR (KASP)

[0435] The phenotypic expression of transgenes in rapeseed is determined by both the structure of the transgene cassette itself and its insertion site in the plant genome: the presence of a transgene at a specific location in the plant genome can influence transgene expression and overall phenotype. Incorporation of recombinant DNA molecules into the plant genome is typically induced by cell or tissue transformation (or by another genetic manipulation). The specific incorporation site can be random or predetermined (if targeted integration methods are used). The successful agronomical or industrial introduction of commercially interesting traits through genetic manipulation can be a lengthy process dependent on various factors. The actual transformation and regeneration of genetically transformed plants is only the first step in a series of selection steps involving extensive genetic characterization, breeding, and field trial evaluation, ultimately leading to the selection of superior varieties.

[0436] NS-B50027-4 is a line developed through extensive selection breeding and field trials, and provides a rapeseed cultivar that produces at least approximately 7%–15% DHA. Genetic analysis shows that NS-B50027-4 has a transgenic insert on chromosome A02 and another transgenic insert on chromosome A05. The insert on A05 contains two complete, head-to-head (RB-LB:LB-RB) boxes of eight genes bounded by T-DNA (Micpu-Δ6D, Pyrco-Δ5E, Pavsa-Δ5D, Picpa-ω3D, Pavsa-Δ4D, Lack1-Δ12D, Pyrco-Δ6E, and the PAT marker). The insert on chromosome A02 contains a set of four genes: Micpu-Δ6D, Pyrco-Δ5E, Pavsa-Δ5D, and Picpa-ω3D. Surprisingly, the segregation hybridization showed that the inserts on both chromosomes A02 and A05 were the necessary to achieve approximately 11% DHA production.

[0437] Approximately 1200 progeny cells from eight different BC and F2 populations of DHA-introduced rapeseed were used for DNA extraction using the LGC Octopure SOP developed by Woodland's Nuseed Molecular Lab. Briefly, two 0.25-inch diameter lyophilized leaf discs were homogenized in 300 μL of DNA extraction buffer (100 mM Tris-HCl, pH 8.0; 25 mM EDTA, pH 8.0; 0.5% SDS, 1.5 M NaCl) at 1400 rpm for 5 minutes using a GenoGrinder. After incubation at 55°C for 45 minutes and centrifugation at 4500 rpm for 30 minutes, 50 μL of the supernatant was transferred to 100 μL of LGC binding buffer with magnetic Sbeadex beads. After binding and washing, the DNA was eluted into 80 μL of LGC DNA elution buffer.

[0438] DNA concentrations were measured using a NanoDrop 8000 (Thermo Scientific) and ranged from 5.0 ng / μL to 20.0 ng / μL, with an average of 10.0 ng / μL. DNA samples were diluted 1-fold. For each reaction, 2.0 μL (~5.0 ng / μL) of genomic DNA sample and 2 μL of the master mixture with primers were dispensed into 384-well plates for KASP genotyping.

[0439] In addition to progeny from the DHA-introgression population in rapeseed, eight controls were included in the genotyping. These included two non-GMO controls (Dwarf and AV Jade), two hemizygous controls (2.5 ng Av Jade or 2.5 ng dwarf + 2.5 ng B0050-027-18-20-12-19), two event-positive controls (B0050-027-18-20-12-19), and four non-template controls (NTC). The positive control (T5 plant B0050-027-18-20-12-19) was previously used to characterize DHA-introgression events in rapeseed by sequencing.

[0440] KASP assays were developed to provide a simple, economical, high-throughput, and flexible method for detecting and monitoring 8 transgenic and 4 NS-B50027-4 specific linkages, and to further facilitate NS-B50027-4 gene introgression in breeding programs. KASP was performed according to a standard protocol from the manufacturer with modifications (LGC Ltd., Middlesex, UK). TM Genotyping chemistry, assay design, genotyping and scoring.

[0441] Sequence information was uploaded to LGC Kraken Workflow Manager, and the KASP assay was designed using its assay design program, Primer Picker. A typical KASP assay includes two allele-specific primers (primer_alleleX for transgenic alleles and primer_alleleY for non-transgenic, wild-type alleles) and one common locus-specific primer (primer_common). Primer_alleleX associates with fluorescent FAM, and primer_alleleY associates with fluorescent HEX.

[0442] Most assays targeting ligation are of this type, using three primers (Table 14). To detect DHA in rapeseed, in addition to the conventional three-primer assays mentioned above, four-primer assays have been developed. The four-primer assay uses primers specific to the transgene allele X, primers specific to the wild-type allele Y, primers specific to the ω3 gene _common, and primer _common2 specific to the wild-type. To detect the eight genes in the ω3 cassette, only two primers are used in each assay: primer _allele X and primer _common (two-primer assay); both primers are ω3 gene specific (Table 14).

[0443]

[0444]

[0445] The KASP genotyping system requires two components: an assay mixture and a master mixture. The assay mixture is a mixture of the required primers, and the master mixture contains all other required components, including PCR buffer, a universal fluorescent reporter system, and Taq polymerase.

[0446] The KASP reaction was performed in a 4.0 μL volume, comprising 2.0 μL (10.0 ng) of genomic DNA, 2.0 μL of 2x KASP master mixture, and 0.06 μL of assay (primer) mixture. For two-primer assays, the assay (primer) mixture was a combination of 12 μM allele-specific primer_allele X and 12 μM primer_common; for three-primer assays, the assay (primer) mixture was a combination of 12 μM allele-specific primer_allele X, 12 μM allele-specific primer_allele Y, and 30 μM primer_common; and for four-primer assays, the assay (primer) mixture was a combination of 12 μM allele-specific primer_allele X, 12 μM allele-specific primer_allele Y, 12 μM primer_common, and 12 μM primer_common2.

[0447] The reaction was performed in 384-well plates in an LGC Hydrocycler 16 with the following cycling parameters: one cycle at 94°C for 15 minutes, followed by eight cycles at 94°C for 30 seconds and 64°C–57°C (decreasing by 1.0°C per cycle) for 60 seconds, and then thirty cycles at 94°C for 30 seconds and 57°C for 60 seconds. If clear genotypic clusters were not yet obtained, the plates were further thermally cycled with three additional cycles at 94°C for 30 seconds and 57°C for 60 seconds.

[0448] After the KASP reaction, transgenic alleles were labeled with FAM using primer_allele X, and non-transgenic wild-type alleles were labeled with HEX using primer_allele Y. Fluorescence signals were read using a PheraStar microplate reader with an excitation wavelength of 485 nm, and the emission wavelengths for FAM and HEX were 535 nm / 556 nm. Data were analyzed using the LGCKraken database.

[0449] Gene-specific dominant (NBN01–NBN08; one assay / gene) markers were developed for the detection of eight genes in the construct cassette. Insertion-specific, co-dominant KASP assays were developed for upstream links (NBN57, NBN68, NBN58, NBN85, and NBN14) and downstream links (NBN16, NBN62, and NBN64) targeting inserts on A02, and for upstream links (NBN52, NBN51, NBN09, NBN50, NBN48, and NBN10) and downstream links (NBN83, NBN82, NBN84, NBN66, NBN41, and NBN43) targeting inserts on A05, and validated using 1200 progeny from the NS-B50027-4 gene introgression population (Table 14). Genotyping of over 10,000 samples has been performed using these markers.

[0450] Thirty competing allele-specific PCR (KASP) assays were developed and validated targeting eight genes and four ligations of two inserts in the DHA rapeseed event NS-B50027-4. These assays provide a simple, cost-effective, high-throughput, and flexible method for detecting and monitoring NS-B50027-4 in breeding programs.

[0451] Example 3. Detailed comparison of NS-B50027-4 and non-GMO rapeseed

[0452] Data on rapeseed seed yield from experimental plots from 2014 to 2016 were tabulated. Ranges for DHA and total EPA+DPA+DHA are based on observations from several experimental plots. The content of major fatty acids in NS-B50027-4 and non-GMO “control” rapeseed varied by several percentage points depending on growth conditions. In Table 15 below, “0.0” can refer to trace amounts identified as below the amount required for accurate component determination.

[0453]

[0454]

[0455] Oil was obtained by crushing and cold pressing seeds harvested from the experimental culture of NS-B50027-4. Seeds harvested from the parental isogene line AV Jade underwent similar treatment, and the content of each oil is compared as shown in Table 16.

[0456]

[0457]

[0458] In accordance with the Budapest Treaty, the applicant has deposited at least 2,500 seeds of rapeseed NS-B50027-4 at the American Center for Type Culture Collection, located at 10801, 20110-2209, University of Manassas, Virginia, USA. Login ID PTA-123186, and the seed's viability is determined by... Confirmed. During the pending period of this application, the Commissioner may be requested to obtain the invention; upon grant of the patent, all restrictions on public availability shall be irrevocably lifted; the deposit of strain NS-B50027-4 shall continue for a period of 30 years at the ATCC Depository (a public depository), or 5 years after the most recent request, or the duration of the patent, whichever is later; and if it becomes inviable during this period, it shall be replaced. Seed viability was tested at the time of deposit. The applicant has met all the requirements of 37C.FR §§1.801-1.809. The applicant has not restricted the availability of the deposited material from the ATCC; however, the applicant has no right to waive any legal restrictions on the transfer or commercial transport of biological material. The applicant shall not be exempt from any infringement under this patent or the Plant Variety Protection Act (7U.SC §2321 et seq.).

[0459] Although the foregoing embodiments have been described in detail by way of illustration and examples for purposes of clarity and understanding, those skilled in the art will recognize that certain variations and modifications, such as single-gene modifications and mutations, somatic cell clonal variants, variant individuals from large populations of plants selected from the inbred lines of the present invention, etc., may be implemented within the scope of the present invention, the scope of which is defined only by the appended claims. sequence list <110> Newside Nutrition Australia Pte Ltd <120> Superior variety of rapeseed NS-B50027-4 <130> 87376.0002 <150> 62 / 351,246 <151> 2016-06-16 <160> 66 <170> PatentIn version 3.5 <210> 1 <211> 44 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 1 gaaggtgacc aagttcatgc tccaagcacc gtagtaagag agca 44 <210> 2 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 2 gctaagaagt ggggactcaa ctacaa 26 <210> 3 <211> 41 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 3 gaaggtgacc aagttcatgc tgctcttgct ggaactcttg g 41 <210> 4 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 4 gggttagcca cattgtaggt aacgta 26 <210> 5 <211> 44 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 5 gaaggtgacc aagttcatgc ttaagagaca ccctggtgga aaga 44 <210> 6 <211> 28 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 6 tagcatcagt tccaacttgg taagcaat 28 <210> 7 <211> 44 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 7 gaaggtgacc aagttcatgc tgaacacgta agcagaccaa gcag 44 <210> 8 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 8 ccctcttctc cctaacgaat tcctt 25 <210> 9 <211> 44 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 9 gaaggtgacc aagttcatgc tgaggaacct gttgctgctg atga 44 <210> 10 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 10 gcgatcctag cacaaagttg aaggta 26 <210> 11 <211> 44 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 11 gaaggtgacc aagttcatgc tggatggatc gcttacctct tcgt 44 <210> 12 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 12 cagggtaagg ttgtcctgta acgtt 25 <210> 13 <211> 42 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 13 gaaggtgacc aagttcatgc tctattggat ggggactcaa gc 42 <210> 14 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 14 gggagatcct tagtagcaga agagat 26 <210> 15 <211> 44 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 15 gaaggtgacc aagttcatgc tcctgagagg cgtcctgttg aaat 44 <210> 16 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 16 aacagcagcc atatcagcag cagta 25 <210> 17 <211> 45 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 17 gaaggtgacc aagttcatgc ttgttcttgg gtgggtctgt ccttc 45 <210> 18 <211> 46 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 18 gaaggtcgga gtcaacggat tgtgttcttg ggtgggtctg tcctta 46 <210> 19 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 19 atccactagc agattgtcgt ttccc 25 <210> 20 <211> twenty two <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 20 gttggctaag gtcacggtgg ag 22 <210> twenty one <211> 48 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> twenty one gaaggtgacc aagttcatgc tccgccttca gtttaaacta tcagtgtt 48 <210> twenty two <211> 41 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> twenty two gaaggtcgga gtcaacggat tggtcacggt ggaggtcacc a 41 <210> twenty three <211> twenty two <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> twenty three ggtgtgttct tgggtgggtc tg 22 <210> twenty four <211> 49 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> twenty four gaaggtgacc aagttcatgc tacttttttt tcaactgttg gctaaggta 49 <210> 25 <211> 49 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 25 gaaggtcgga gtcaacggat tacttttttt tcaactgttg gctaaggtc 49 <210> 26 <211> twenty one <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 26 gtgtgttctt gggtgggtct g 21 <210> 27 <211> twenty one <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 27 gtcgtttccc gccttcagtt t 21 <210> 28 <211> 46 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 28 gaaggtgacc aagttcatgc taaactatca gtgtttgaac acctcc 46 <210> 29 <211> 44 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 29 gaaggtcgga gtcaacggat tacaacttgt cgtgctacac acct 44 <210> 30 <211> twenty two <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 30 ggttgtgtga aaacgtgtga gc 22 <210> 31 <211> 51 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 31 gaaggtgacc aagttcatgc tcttttagct aaataagagg ttctgtatac t 51 <210> 32 <211> 51 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 32 gaaggtcgga gtcaacggat tcttttagct aaataagagg ttctgtatac a 51 <210> 33 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 33 gattgtgatt ccgggcagt 19 <210> 34 <211> twenty one <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 34 gtgtgaaaac gtgtgagcaa t 21 <210> 35 <211> 40 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 35 gaaggtgacc aagttcatgc tttgtgattc cgggcagtag 40 <210> 36 <211> 41 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 36 gaaggtcgga gtcaacggat ttgtgagcaa ttgttggagg t 41 <210> 37 <211> 31 <212> DNA <213> Artificial Sequence <220> <223> KASP primers <400> 37 tcttatcaac attaagaaca taatctttta g 31 <210> 38 <211> 15 <212> DNA <213> Artificial Sequence <220> <223> Insertion / deletion on chromosome A02 of the genus Brassica <400> 38 gtagcacgac aagtt 15 <210> 39 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> Insertion / deletion of Brassica chromosome A05 <400> 39 cacggtggag gtcaccatgt 20 <210> 40 <211> 15004 <212> DNA <213> Artificial Sequence <220> <223> Transgenic insert fragment and Brassica flanking region <400> 40 gagccttgag tgctactttg ggaacaaaaa cttggtttga tgctatccta gtctttttct 60 cttttataaa ctattattag ataaaaacta aaaaatagta tttatgagat ttgtcttttt 120 ttcacaatat aaattatttt aggtataaaaaata gattagtat tattagatat 180 aaaataca tttattaa tattaatat aactgtaag daddy tattacaata 240 tctaataat aaaaatttg tattaaaata tgggaaaaca atattattatt ttaaagcgat 300 cttactcgat ctctctttga tccaaagtt ttcattcctt ttaattatat tgttgcaga 360 atattaaaac cagtgatttc tggggtttga taggattag acacgatcgc agagaagta 420 gatcaatcg tggaggaa gggatattcg aaaccctaat ttcgatcgta tcccatctt 480 ctacgaaagc atcgatcgac tttttctga ttcagtgaga gtttgaatc aaagtttgat 540 tttttcgacc tgatggttt cttaaagaag ttaacgggga tttcggtt cggggcacaac 600 gatggtgggc acggagctgc tgcgagagac gagatggtg aagggataa cactggatca 660 gtctctgagg acggagata acgccgggag ggtaatcagg caggttccg tgaaccgga 720 cttccaagga ggggttttgg agttccggtt caagtagccg tcgaacggtc tagtccttggt 780 cctattctc agccttgtgc tgcttctgac ggtggagttc aggtttgtct ttcttcatg 840 gttgtgattt taactgtgta gaagtctagg gactgaagaa attaatgaga atttgagggt 900 tgctagttt gattctgatc ttgtaatgtg gctacagtgt tgtacttgtc ttgttgcagg 960 atcgttaaat ccatttgttt ggttccgatc atcctatgtt agttggtaaa attggtcttg 1020 tgagtttgtt taagttgttt ttgtgtcttc attcattttc taagcttagc attgatgaac 1080 agttgaattt agaatctttg ttctaagctt aacattaatg aatatcgaat ctttgttcta 1140 ctcagtcctt tctttgtttt tggttgtgat atgttctcgt ttcaacgtag tttatgttct 1200 tcttgtgatt ggctttacat tctgcacggt ttccgcttta gttaggtgtc tgcattatag 1260 ttagttcatt gctatcttaa attctctgtt cattcatctc tatatatcaa attaaagagt 1320 ggcagtgaag tttatgacag gacacgatat atgttttagc ttgattagtt gcggttaaag 1380 caaaaagttt ttgtttcact ctgtctgcta cagaacctgt aatttagaaa tgatgatgga 1440 tctcatgtct taacggtttc gtattcatca tgagtcacga ggctgctata gagtttgaat 1500 cttaattggt tctgttgttg gggaaagaca ataatccagt ctttaagaag ctagtggggt 1560 tgattcatcc ccaagactat tcgattgtcc aaacgcattg atatgttttt tttaatcaag 1620 tttttgttga tggcaataaa ctaacatccc agcatagtta ttgactcgac ttagttttac 1680 cattagggac tacgatggta ctcaatgcgg ctaaggattg atgaagatgg agatgttgca 1740 gatgagttct tggaagatga taactgtaag actttgccca gaaaatgcaa aacaaaagct 1800 gcaaaagtga gaggtttagt gatatcttct gatgggaaac ttcagccatt aatgcattga 1860 gcagtgaaca ccaaggataa atatttactg attagtgtgt gattgaatca aagaaaggtt 1920 agaatctggt tttcatttag ccattcaatc tcgatgtaaa atcggttaga ttctggttgt 1980 tgatacttga gaacttgaaa tgttttgtaa ctgtgaattt tgttttgaaa atagacaagt 2040 gaatctgttt ggggttgtgt gaaaacgtgt gagcaattgt tggaggtgtt caaacactga 2100 tagtttaaac tgaaggcggg aaacgacaat ctgctagtgg atctcccagt cacgacgttg 2160 taaaacgggc gccccgcgga aagcttgcgg ccgcggtacc gcccgttcga ctcagatctt 2220 ccaaggcctc gtctccgagt ccgctgcttc tcgccgcgcc gatcacttct ccgccgccaa 2280 caaggcttgt agttaatagg aatcattcag ggattgtgat tccgggcagt agtaattaat 2340 aatatagtat tagtatagat aatatgtttc gtttgggatc tttggaacgt tgctctgttc 2400 cttgttgttc atttaaagc ttttgaggga tagttgcaga actgttcggt gatgcttcat 2460 cctctcaaga actagatttg ggtaaagaaa catccatgca tggatatgga atgttgttct 2520 tccgattgga gattatttta taaatttaa aattcatgat ttaaaaaaac acataaaaac 2580 cacaaaattc atgatttatt gacaatacga tacaaaatta gcaccaccgg ctactggctc 2640 attacacatt tccccttccc ctcattctca cttgtggct ttattattat tattattaca 2700 tatattttac cgttattatt tcacgtcaca tagacttgtt aattaatcat tagtgagcct 2760 tctcagcctt tccgttaacg tagtagtgct gtcccacctt atcaaggtta gagaaagtag 2820 ccttccaagc accgtagtaa gagagcacct tgtagttgag tccccacttc ttagcgaaag 2880 gaacgaatct tctgctaacc tcaggctgtc tgaattgagg catatcaggg aagaggtggt 2940 ggataacctg acagttaagg tatcccataa gccagttcac gtatcctcta gaaggatcga 3000 tatcaacggt gtgatcaaca gcgtagttaa cccaagaaag gtgcttatca gatggaaca 3060 cagggaggtg agtatgagaa gtagagaagt gagcgaaaag gtacatgtaa gcgatccagt 3120 ttccgaaagt gaaccaccag tagcaacag gccaagagta tccagtagca agcttgataa 3180 3240 3300 taaaaggaac gaaagtccaa gcttgaagtc tagcccaagc tctagagaat cctctaggtc 3360 tgttatcctc aacagcagtg ttgaagaaag ccacagcagg agtggtatca agatccatat 3420 cgtgtctaac cttttgaggg gtagcatggt gcttgttatg catctggttc cacatctcac 3480 3540 atccggtaag agagttatgt ccaccctcat gttgaaccca tccacatcta gctccgaaga 3600 aagcaccgta aacaacagaa ccaatgatag ggtatccagc gtacataaga gcagttccaa 3660 3720 agaatccatc tctctcaagc tcagcacgcc atctagcgaa atcctcaagc ataggagcat 3780 cctcagactc agatctcttg atctcagcag gtctagaagg caaagctcta agcatcttcc 3840 aagccttgag agaacgcatg tggaattctt tgaaagcctc agtagcatca gcaccagtgt 3900 tagcaagcat gtagagaatc acagatccac cagggtgctt gaagttagtc acatcgtact 3960 caacgtcctc aactctaacc catctagtct cgaaagtagc agcaagctca tgaggctcaa 4020 gagtcttaag atcaacagga gcagtagaag catccttagc atcaagagcc tcagcagaag 4080 atttagacct ggtaagtgga gatctaggag aagatcttcc atcagtctta ggagggcaca 4140 tggtatggta attgtaaatg taattgtaat gttgtttgtt gtttgttgtt gttggtaatt 4200 gttgtaaaat taattaagtg ggtatctttt ggatggataa gcaagtagtg atgatgttct 4260 aggtgaagtg atggggtgt tttatagcgg gagatggtga aatggatggt cgccacataa 4320 gaaatggagg ggaagggttc ttgcgccatt cttcagtttg catggatgca tgggtttcat 4380 tttgtaacac gtaataagga caatgaagtg caggtgtctc tcaagtttca gaggggatat 4440 gtggacagaa gagaacggc gatgatattg atggaatgg ccatctagtg tgaatctatt 4500 cggttgataa tactagtgca ttttggccgt taatccctc aattaactgc acaaacttca 4560 gttgagtatt gattatttga ttataggttc tgtaaacaca attackagtt tattagagg 4620 ggagacatac aaatagttttc gattaaata atagagtggt taaacttagt tattaaaact 4680 atatataag tctaaaagtt aaattatttt ttatattgca atatataaa gtctaaaggg 4740 gttacattat ttcttagag atgtactct gttggaatct gacttaatcc gtctcatcac 4800 tctggtttcc agttctaatc taatgaattg ttttctgcca aagaatttga agcaagaagt 4860 aaattgatca atgccgtcaa cccaccaa accgtcacc cactaccacc gccgcggaga 4920 cccccaaact cacctccac ccatcggtaa gaagcacagg gcagcccgca ccaccacca 4980 tttggcgtgc atgacaccta gggacttggc acgggaggcg gcgcacgtgg atgcaatga 5040 cgggatatca gatgacagga aacgacgttg agagaccata cgatgtagaa tatgagctca 5100 ccatcaacga gaaactagga aaatcacaaaaaaaacaact ctcgtaattg tacgagtggc 5160 acagatgggt ctgcctcaac atatctctaa tacggcgaag cctgcccaac acgtagttgc 5220 cggaatccgg tgtggagctc acgactctga aagataggcg cttcctgttt cgtttcgctc 5280 acccactgga cgtccgtcat gtgatggatt tcggtcattg gtttgctgac aaccacattc 5340 tgaagctcca tgagatgagt cttcacaata ggtcctgctc aataccgtgg agttatggtt 5400 gcaagtccat aacttgccgt tcgaatattt tgcggagcca gtcggacggg aattggcgag 5460 ctcggctgac acctataaag gccatgacaa gaagaaccaa aagttcttcc ctaatgcttt 5520 catgaggctt cgggtcgtta tggatgtcgg aaaacccctc ttgaaggaac gagacgttat 5580 tatgcatgac ggtaagacta ttacttgtca gtataagtat gaaagattac ctgtcttctg 5640 ctttgtttgt ggattgattg gacacgttga aaaaaaaatgt gcacttcgat ttcaatactc 5700 agagatcgac ttcccttttc tctaggagta ttcgatcaag gcattaacat ggaaggaagc 5760 tcaagctcta aaggcttcac aatggaacct gaaaaatttc aacaagccta aactgaaatc 5820 gaagtcaaat cacccaaccg ggagctctaa atcagcaaac actcctcctc cacagtatcc 5880 aatcatcgtg cacgatgctc caggtattgc aagccaggta ttgcaagcta ggagtaggat 5940 agagacctta aacgtcgttg gtgtgaagag tcatcttcag acctaatgga gatagatgta 6000 gacggcggca cgaagactct gaaacaccag aaaggctagt ccaggataag gatctgctat 6060 cccaactgac ctctcgttag tcccaaggcc tctcaactag agcaggagga aggatggtca 6120 caagactagg ataatgatgt ttccaatatg aacctgaatg tccatagcta atttttttag 6180 tcttgcttct gcactttttg tttatgtgt tctggtgact atgttattta cccttgtccg 6240 tatgcttgag ggtaccctag tagattggtt ggttggttc catgtaccag aaggcttacc 6300 ctattagttg aaagttgaaa ctttgttccc tactcaattc ctagttgtgt aaatgtatgt 6360 atatgtaatg tgtataaaac gtagtactta aatgactagg agtggttctt gagaccgatg 6420 agagatggga gcagaactaa agatgatgac ataattaaga acgaatttga aaggctctta 6480 ggtttgaatc ctattcgaga atgtttttgt caaagatagt ggcgattttg aaccaaagaa 6540 aacatttaaa aaatcagtat ccggttacgt tcatgcaaat agaaagtggt ctaggatctg 6600 attgtaattt tagacttaaa gagtctctta agattcaatc ctggctgtgt acaaaactac aaatatata ttttagacta tttggcctta actaaacttc cactcattat ttactgaggt tag acttgcgaat aaacacattc ccgagaaata ctcatgatcc cataattagt cagagggtat gccaatcaga tctaagaaca cacattccct caaattttaa tgcacatgta atcatagttt agcacaattc aaaataatg tagtattaaa gacagaatt tgtagacttt tttttggcgt taaagaaga ctaagtttat acgtacattt tattttaagt ggaaaaccga aattttccat cgaaatatat gaatttagta fathertttc tgcaatgtac tattttgcta ttttggcaac tttcagtgga ctactacttt attackgt gtatggatgc atgagtttga gtatacacat gtctaatgc atgctttgta aaacgtaacg gaccacaaaa gaggatccat 7200. ctcatagctt cctccattat tttccgacac aaacagagca ttttacaaca attack acaacaaaca acaaacaaca ttacaattac attackt accataccat ggcctctatc gctatccctg ctgctcttgc tggaactctt ggatacgtta cctacaatgt 7320 ggctaaccct gatatcccag cttctgagaa agttcctgct tacttcatgc aggttgagta 7380 ctggggacct actatcggaa ctattggata cctcctcttc atctacttcg gaaagcgtat 7440 catgcagaac agatctcaac cttcggact caagaacgct atgctcgttt acaacttcta 7500 ccagaccttc ttcaacagct actgcatcta cttttcgtt acttctcata gggctcaggg 7560 acttaaggtt tggggaaaca tccctgatat gactgctaac tcttggggaa tctctcaggt 7620 tatctggctt cactacaaca acaagtacgt tgagcttctc gacaccttct tcatggtgat 7680 gaggaagaag ttcgaccagc tttctttcct tcacatctac caccacactc ttctcatctg 7740 gtcatggttc gttgttatga agcttgagcc tgttggagat tgctacttcg gatcttctgt 7800 taacaccttc gtgcacgtga tcatgtactc ttactacgga cttgctgctc ttggagttaa 7860 ctgtttctgg aagaagtaca tcacccagat ccagatgctt cagttctgta tctgtgcttc 7920 tcactctatc tacaccgctt acgttcagaa taccgctttc tggcttcctt accttcaact 7980 ctgggttatg gtgaacatgt tcgttctctt cgccaacttc taccgtaaga ggtacaagtc 8040 taagggtgct agaagcagt gataagccgc gcggcgcgcc gggccgccgc catgtgacag 8100 atcgaaggaa gaagtgtaa taagacgact ctcactactc gatcgctagt gattgtcatt 8160 gttatata ataatgttat ctttcacaac ttatcgtaat gcatgtgaaa ctataacaca 8220 ttaatcctac tgtcatatg atacactct ccccattaa aactctgtc aatttaaaga 8280 tataagattc ttataatgat taaaaaaaat atattattaa ttcaatcact cctactaata 8340 Attattaat tattattat tgattaaaaaatacttata ctaatttagt ctgaatagaa 8400 taattagatt ctagtctcat ccccttttaa accaacttag taaacgtttt ttttttaat 8460 tttatgaagt taagtttttta ccttgttttt aaaagaatc gttcataaga tgccatgcca 8520 gaacattagc tacacgttac acatagcatg cagccgcgga gattgtttt tctcgccac 8580 ttgtcactcc cttcaacac ctaagagctt ctctctcaca gcacacacat acatcacat 8640 gcgtgcatgc attack gtgatcgcca tgcaatctc ctttatagcc tataaattaa 8700 ctcatccgct tcactcttta ctcaaccaa aactcatcga tacaacaag attaaaaca 8760 tacacgagga tcttttacaa caattaccaa caacaacaaa caacaaacaa cattacaatt 8820 acatttacaa ttaccatacc atgcctccaa gggactctta ctcttatgct gctcctcctt 8880 ctgctcaact tcacgaagtt gatactcctc aagagcacga caagaaagag cttgttatcg 8940 gagatagggc ttacgatgtt accaacttcg ttaagagaca ccctggtgga aagatcattg 9000 cttaccaagt tggaactgat gctaccgatg cttacaagca gttccatgtt agatctgcta 9060 aggctgacaa gatgcttaag tctcttcctt ctcgtcctgt tcacaaggga tactctccaa 9120 gaagggctga tcttatcgct gatttccaag agttcaccaa gcaacttgag gctgagggaa 9180 tgttcgagcc ttctcttcct catgttgctt acagacttgc tgaggttatc gctatgcatg 9240 ttgctggtgc tgctcttatc tggcatggat acactttcgc tggaatcgct atgcttggag 9300 ttgttcaggg aagatgtgga tggcttatgc atgagggtgg acattactct ctcactggaa 9360 acattgcttt cgacagagct atccaagttg cttgttacgg acttggatgt ggaatgtctg 9420 gtgcttggtg gcgtaaccag cataacaagc accatgctac tcctcaaaag cttcagcacg 9480 atgttgatct tgataccctt cctctcgttg ctttccatga gagaatcgct gctaaggtta agtctcctgc tatgaaggct tggctttcta tgcaagctaa gcttttcgct cctgttacca ctcttcttgt tgctcttgga tggcagcttt accttcatcc tagacacatg ctcaggacta 9660 agcacga tgagcttgct atgctcgga tcagatacgg acttgttgga taccttgctg ctaactacgg tgctggatac gttctcgctt gttaccttct ttacgttcag cttggagcta 9780 tgtacatctt ctgcaacttc gctgtttctc atactcacct ccctgttgtt gagcctaacg 9840 9900. agcatgctac ttgggttgag accacactac taactgttct ccatcttggt ggtgtgattg gtggatgtct taccttaact accagatcga gcaccacctt tacccttcta tgcctcaatt cagacaccct aagatcgctc ctagagttaa gcagcttttc gagaagcacg gacttcacta cgatgttaga ggatacttcg aggctatggc tgatactttc gctaaccttg 10080 aatacgttgc ccatgctcct gagaagaaa tgcagtaatg agatcgttca aacatttggc father cttaagattg fathercctgttg ccggtcttgc gatgattatc fatheratttc tgttgaatta cgttaagcac gtataatta acatgtaatg catgacgtta tttatgagat 10260 gggttttt gattagagtc ccgcaattat accattata cgcgatagaa aaaaaat 10320 agcgcgcaaa ctaggataaa ttacgcgcg cggtgtcatc tatgttacta gatcggtcga 10380 ttaaaaatcc caattatatt tggtctaatt tagttttggta tgagtaaaa caattcgaa 10440 ccaaaccaaa ataataat atagtttta tatatatgcc tttaagactt tttatagaat 10500 tttctttaaa aaatatctag aaatatttgc gactctctg gcatgtataa tttcgttaaa 10560 tatgaagtgc tccatttta ttactttaa atattggtt gtacgatcac tttcttatca 10620 agtgttacta aaatgcgtca atctctttgt tcttccatat tcatatgtca aaatctatca 10680 aaattcttat atatctttt cgaatttgaa gtgaatttc gataattta aattaatag 10740 aacatatcat tatttaggta tcatattgat tttatactt aattactaaa ttggttaac 10800 tttgaaagtg tacatcaacg aaaaattagt caacgacta aaaaata atatcatgtg 10860 ttattagaa attctccta taagaatatt ttaatagatc atatgttgt aaaaaaatt 10920 aatttttact aacacatata tttacttc aaaaatttga CAagtaaga ttaaataat 10980 attcatctaa CAaaaaaaaa accagaaaat gctgaaaacc cggcaaacc gaaccaatcc 11040 aaaccgatat agttggttg gttttgattt gattaacc gaaccactc ggtccatttg 11100 cacccctaat cataatagct ttaatattc agatattat taagttaacg ttgtcaat 11160 cctggaaattt ttgcaaatg atcaagcct atatggctgt atatgaatt taaaagcagc 11220 tcgatgtggt gtaatatgt atttacttg attctaaaaa atatcccaa gtattaataa 11280 tttctgctag gagaaggtt agctacgatt tacagcaag ccagaataca aagaaccata 11340 aagtgattga agctcgaat atacgaagga acaataattt ttaaaaaat acgcaatgac 11400 ttggaacaaa agaaagtgat atattttg ttctttaaaca agcatcccct ctaaagaatg 11460 gcagttttcc tttgcatgta actattatgc tccctcgtt acaaaaattt tggactacta 11520 ttgggaactt cttctgaaaa tagtgataga acccacacga gcatgtgctt tccatttaat 11580 tttaaaaacc aagaaacata catacataac attccatcag cctctctctc ttttattac 11640 ggttaatgac ttaaaacaca tcttattatc ccatccttaa cacctagcag tgtctttata 11700 cgatctcatc gatcaccact tcaaaaccat gcagactgct gctgcccctg gagctggcat 11760 cggctaggct gggtgccgca ctgtcccgga aggtccctag cgacttgttt agattgatgg 11820 gaccacctct caacttcctg ctgctgtccc tgctgctgga tgtcctgcct catctggccg 11880 attgcacgct ccagtcccct gcatgtgcac tcgctcctca attgcttaag atcatcgcag 11940 cagctatcga agtgctggct ctgttgccct cctccacggc cttggttgta gtagtagctg 12000 ccgccgccct tctggacttt ttcccacagg aaccgccgaa taattcgata gaaccacacg 12060 agcatgtgct ttcatttatt ttaaaaacca agaaacatac ataacatttc atcagcctct 12120 ctctctct ctctctct ctctctct ctctctct ctctcttt attacagctg 12180 ttacactaac ttaaaacaca ttcatctcat tattattatt attatccatc cttaacacct 12240 agcagtgtct ttgtacgatc tcataatcga tcaccccttc atcaggtatc cttaggcttc 12300 actccaacgt tgttgcagtt acggaacatg tacacaccat catggttctc aacgaactgg 12360 caagatctcc aagttttcca aaggctaacc cacatgttct catcggtgtg tctgtagtgc 12420 tctcccataa ctttcttgat gcactcggta gcttctctag catggtagaa tgggatcctt 12480 gaaacgtagt gatggagcac atgagtctcg atgatgtcat ggaagatgat tccgaggatt 12540 ccgaactctc tatcgatagt agcagcagca cccttagcga aagtccactc ttgagcatcg 12600 taatgaggca tagagaaatc ggtgtgctga aggaaggtaa cgaaaacaag ccagtggtta 12660 acaaggatcc aagcacagaa ccatgtgatg aaagtaggcc agaatccgaa aaccttgtaa 12720 gcggtgtaaa cagaagtgag ggtagcaagg attccaagat cagaaagaac gatgtaccag 12780 tagtccttct tatcgaaaac agggctagaa ggccagtagt gagacttgaa gaacttagaa 12840 acaccagggt aaggttgtcc agtagcgtta gtagcaaggt aaagagaaag tcctccaagc 12900 tgttggaaca agagagcgaa aacagagtag ataggagttt cctcagcgat atcgtgaagg 12960 ctggtaactt ggtgcttctc tttgaattc tcggcggtgt aaggaacgaa aaccatatct 13020 ctggtcatgt gtccagtagc cttatggtgc ttagcatgag agaacttcca gctgaagtaa 13080 ggaaccataa caagagagtg gagaacccat ccaacggtat cgttaaccca tccgtagtta 13140 gagaaagcag aatgtccaca ctcatgtcca aggatccaga ttccgaatcc gaaacaagag 13200 atagagaaca cgtaagcaga ccaagcagcg aatctaagga attcgttagg gagaagaggg 13260 atgtaggtaa gtccaacgta agcgatagca gagatagcca cgatatctct caccacgtaa 13320 gacatagact tcacgagaga tctctcgtaa cagtgcttag ggatagcgtc aaggatatcc 13380 ttgatggtgt aatctggcac cttgaaaacg tttccgaagg tatcgatagc ggtcttttgc 13440 tgcttgaaag atgcaacgtt tccagaacgc ctaacggtct tagtagatcc ctcaaggatc 13500 tcagatccag acacggtaac cttagacatg gtatggtaat tgtaaatgta attgtaatgt 13560 tgtttgttgt ttgttgttgt tggtaattgt tgtaaaattt ttggtggtga ttggttcttt 13620 aaggtgtgag agtgagttgt gagttgtgtg gtgggtttgg tgagattggg gatggtgggt 13680 ttatatagtg gagactgagg aatggggtcg tgagtgttaa ctttgcatgg gctacacgtg 13740 ggttcttttg ggcttacacg tagtattatt catgcaaatg cagccaatac atatacggta 13800 ttttaataat gtgtgggaat acaatatgcc gagtatttta ctaatttttgg caatgacaag 13860 tgtacatttg gattatctta cttggcctct cttgctttaa tttggattat ttttattctc 13920 ttaccttggc cgttcatatt cacatcccta aaggcaagac agaattgaat ggtggccaaa 13980 aattaaaacg atggatatga cctacatagt gtaggatcaa ttaacgtcga aggaaaatac 14040 tgattctgcc cgttcgactc agatcttcca aggcctcgtc tccgagtccg ctgcttcg 14100 ccgcgccgat cacttctccg ccgccaacaa ggcttgtagt tataggaat cattcaggga 14160 ttgtgattcc gggcagtagt attaataat atagtattag tatacagaac ctcttattta 14220 gctaaaagat tatgttctta atgttgataa gaagtttgag aaacaaatat aattgagctt 14280 ctgattagtt gatcgtaatt ggtcattaat aattgtatct aaccagtgca gtataagagc 14340 gtataagagc atcttcaaaa agactttatt ttagagttaa tcagtgcagt ataagagcat ctctaaaaaa actctaatta taggttttg caaactctat atttgaagtt ttaaggtgtt tttttttcaa aagcaaaact tcaaatttaa cttcaaaatt atttgtaatt tacactatgc tctttatatt tatcataatt fatheraggg ggtgttagtg ggacttagat ttctatagag tttgttgatt ttaaagttg agagatttgt taaatttaga aagagatgta gagaattttg tctattgtga aaatctatga aaatagagta atgtaatgat tctaagaatt caaagtaaac atgtagtatt ctcaaaatct aaatttgtga aacagtggtc ccagattttc aagactcaga ctaaaggcta tggaggaagc tagggttttg gcgattggcg acactagggt ttcgagtacg gcagatttgg atgaaactat gatggatgtg ggggagagag ggagaccgcc aggagatccg 14880. ccagataagt taacctcatg ggtagcgaag gtggtggaga cggctgaggg agggatgcca gtaccggagg ttttgattgc agattctttt gtgtcggaga gggtacgggt agaatttccg aatg 15004 <210> 41 <211> 49789 <212> DNA <213> Artificial Sequence <220> <223> 16 chimeric transgenes inserted into the Brassica genus <400> 41 aaaaaataca accaaagaaa aatataccag aaggttgtga tttggtccat tatataaaaa 60 ttacgaaatg aatttcttta tccttttatc tcaaatttta ttgaagactt ttgtaggatt 120 atagttgact ttatgctcac atatatatac actgatcaaa actttttaaa aacataaaga 180 aattgtgaaa caataaaaat aaaatgaaat gagtaattaa tgagtagatt aagacattgg 240 accctccaca ggcgataaag taaaataatc agaagttgca ggaggcaaag gaggactact 300 actaatactt ggaacttgga agtagctatc gtgcgcatct gcctccaagt ccaacacctt 360 ataacaaatt tccgccggga agaaagaaaa gtctctctgc cctctcttct ttagcctcca 420 gcttctgcaa accatacgta caaacaagat agacacaatc ctccctacct ccttcttcta 480 tcttcatcga aagattcaac caccactcaa gtcttctctc tctttttttgg aaagaaaaaa 540 ggtaaaagct ttcttctttc tgagcaaact cccatgaatt tcccttttgg gggtttaggg 600 tctttccttt tatgttccta cttcggtata attcgatttc atgcgaactt agattaaa aatttgatct tttttttgtg gggtttgaaa ttgaatcca ttttaggggt taccatcgtt 720. gaccaaatgt ctcgactttg ttcgaatcat gatgttactt aatcatggag gagaagaagg atttttataa ccatgtctct gttgcttgct gcttaaaccc tatataattg gaaacttttt gttttagtct gtgtctgaaa gtttctatat tcgtattgtc tattttgtaa agactaaaac aaaaatgcct atttttagtt tgttcttgtt ccgcaacacc gttactgaac tcttcgttca 960 cttaaacagt ttgtgtgtgt gagaaacagc gtaatgagct gctttggttg ttgtggtggt gacgattttc gtcgagttgc tgaaactgga cccaagccag tgtacggcgc aggaggtact 1080 ttaagcttat aacccttgt ctatcctttg gctagcggct aatgttgatg aactttttta ttcaaccgtt ggctaaggta acactgatag tttaaactga aggcggggaa cgacaatctg ctagtggatc tcccagtcac gacgttgtaa aacggggcgcc ccgcggaag cttgcggccg cggtaccgcc cgttcgactc agatcttcca aggcctcgtc tccgagtccg ctgcttctcg 1320 ccgcgccgat cacttctccg ccgccaacaa ggcttgtagt tataggaat cattcaggga 1380 ttgtgattcc gggcagtagt attaataat atagtattag tatagataat atgtttcgtt 1440 tgggatcttt ggaacgttgc tctgttcctt gttgttcatt ttaaagcttt tgagggatag 1500 ttgcagaact gttcggtgat gcttcatcct ctcaagaact agatttgggt aaagaaacat 1560 ccatgcatgg atatggaatg ttgttcttcc gattggagat tattttataa aatttaaaat 1620 tcatgattta aaaaaaca taaaaaccac aaaattcatg atttattgac atacgatac 1680 aaaattagca ccaccggcta ctggctcatt acacatttcc ccttcccctc attctcactt 1740 tgtggcttta ttattattat tattacatat atttaccgt tattattca cgtcacataa 1800 gcttgttaat taatcattag tgagccttct cagccttttcc gttaacgtag tagtgctgtc 1860 ccaccttatc aaggttagag aaagtagcct tccaagcacc gtagtaagag agcaccttgt 1920 agttgagtcc ccacttctta gcgaaaggaa cgaatcttct gctaacctca ggctgtctga 1980 attgaggcat atcagggaag aggtggtgga taacctgaca gttaaggtat cccataagcc 2040 agttcacgta tcccttagaa ggatcgatat caacggtgtg atcaacagcg tagttaaccc 2100 aaaaaggtg cttatcagat ggaagacag ggaggtgagt atgaagagagagagagtgag 2160 cgaaaaggta catgtaagcg atccagtttc cgaaagtgaa ccaccagtaa gcaacaggcc 2220 2280 aagaagcctc ttcgtagttc ttcttacgga gaacttgtct agggtggaga acgtagatcc 2340 2400 cccaagctct agagaatcct ctaggtctgt tatcctcaac agcagtgttg aagaaagcca 2460 cagcagggt ggtatcaaga tccatatcgt gtctaacctt ttgaggggta gcatggtgct 2520 tgttatgcat ctggttccac atctcaccag agtagaaag tccgaatcca caagtcatag 2580 cctgaagtct cttgtccacg taaacagatc cggtaagaga gttatgtcca ccctcatgtt 2640 gaacccatcc acatctagct ccgaagaaag caccgtaaac aacagaagca atgatagggt 2700 atccagcgta cataagagca gttccaagag cgaatgtagc aagaagctcg agaagtctgt 2760 aagccacatg ggtgatagaa ggcttgaaga atccatctct ctcaagctca gcagccatc 2820 tagcgaaatc ctcaagcata ggagcatcct cagactcaga tctcttgatc tcagcaggtc 2880 tagaaggcaa agctctaagc atcttccaag ccttgagaga acgcatgtgg aattctttga 2940 aagcctcagt agcatcagca ccagtgttag caagcatgta gaagatcaca gatccaccag 3000 ggtgcttgaa gttagtcaca tcgtactcaa cgtcctcaac tctaacccat ctagtctcga 3060 aagtagcagc aagctcatga ggctcaagag tcttaagatc aacaggagca gtagaagcat 3120 ccttagcatc aagagcctca gcaagagatt tagacctggt aagtggagat ctaggagaag 3180 atcttccatc agtcttagga gggcacatgg tatggtaatt gtaaatgtaa ttgtaatgtt 3240 gtttgttgtt tgttgttgtt ggtaattgtt gtaaaattaa ttaagtgggt atcttttgga 3300 tggataagca agtagtgatg atgttctagg tgaagtgatg ggggtgtttt atagcgggag 3360 atggtgaaat ggatggtcgc cacataagaa atggagggga agggttcttg cgccattctt 3420 cagtttgcat ggatgcatgg gtttcatttt gtaacacgta ataaggacaa tgaagtgcag 3480 gtgtctctca agtttcagag gggatatgtg gagagaa gaacggcgat gatttgag 3540 gaaatggcca tctagtgtga atctattcgg ttgataac tagtgcattt tggccgttaa 3600 tccttcaat taactgcaca aacttcagtt gagtattgat tatttgatta taggttctgt 3660 aaacacaata ccaagtttta ttagagggga gatacaa tagttcgat attaata 3720 gagtggttaa acttagttat taaaactata tataaagtct aaagttaaa ttatttttt 3780 aattgcaat ataataagtc taaaggggtt acattattc ttaagagatg taactctgtt 3840 ggaatctgac ttaatccgtc tcatcactct ggtttccagt tctaatcta tgaattgttt 3900 tctgccaaag aatttgaagc aagaagtaaa ttgatcaatg ccgtcaaccc acaccaaacc 3960 gtcaaccac taccatcgcc gcggagaccc gccaaccca cctccaccca tcggtaagaa 4020 gcacagggca gcccgcacca ccaccaattt ggcgtgcatg acacctaggg acttggcacg 4080 ggaggcggcg cacgtgtg aaatgacgg gatcagat gaggaac gacgttgaga 4140 gaccatacga tgtagaat gagctcacca tcaacgaa actaggaaaa tcacaaaaaa 4200 aacaactctc gtaattgtac gagtggcaca gatgggtctg cctcaacata tctctaaatac 4260 ggcgaagcct gcccaacacg tagttgccgg aatccggtgt ggagctcacg actctgaaag 4320 ataggcgctt cctgtttcgt ttcgctcacc cactggacgt ccgtcatgtg atggatttcg 4380 gtcattggtt tgctgacaac cacattctga agctccatga gatgagtctt caaataggt 4440 cctgctcaat accgtggagt tatggttgca agtccataac ttgccgttcg aatattttgc 4500 ggagccagtc ggacgggaat tggcgagctc ggctgacacc tataaaggcc atgacaagaa 4560 gaaccaaaag ttcttcccta atgctttcat gaggcttcgg gtcgttatgg atgtcggaaa 4620 accccctcttg aaagcaacgag acgttatat gcatgacggt aagactatta cttgtcagta 4680 tagtatgaa agattacctg tcttctgctt tgtttgtgga ttgattggac acgttgaaaa 4740 aaaatgtgca cttcgatttc aatactcaga gatcgacttc ccttttctct aggagtattc 4800 gatcaaggca ttaacatgga aggaagctca agctcaaag gcttcacaat ggaacctgaa 4860 aaatttcaac aagcctaaac tgaaatcgaa gtcaaatcac ccaaccggga gctctaaatc 4920 agcaacact cctcctccac agtatccaat catcgtgcac gatgctccag gtattgcaag 4980 ccaggtattg caagctagga gtaggataga gaccttaaac gtcgttggtg tgaagagtca 5040 tcttcagacc taatggagat agatgtagac ggcggcacga agactctga acaccagaaa 5100 ggctagtcca ggataggat ctgctatccc aactgacctc tcgttagtcc caagcctct 5160 caactagagc aggaggaagg atggtcacacacatagata atgatgttttc caatgaac 5220 ctgaatgtcc atagctatt tttttagtct tgctctgca ctttttgttt attatgttct 5280 ggtgactatg ttatttacc ttgtccgtat gcttgaggggt acctagtag attggttggt 5340 tggtttccat gtaccagaag gcttacccta ttagttgaaa gttgaaactt tgttccctac 5400 tcaatttccta gttgtgtaaa tgtatgtata tgtaatgtgt ataaacgta gtacttaaat 5460 gactaggagt ggttcttgag accgatgaga gatgggagca gactaaga tgatgacata 5520 attagaacg aatttgaaag gctcttaggt ttgaatccta tcgagaatg ttttgtca 5580 agatagtggc gattttgaac caaaaaac atttaaaaa tcagtatccg gttacgttca 5640 tgcaataga aagtggtcta ggatctgatt gtaatttag acttaaag tctcttaaga 5700 ttcaatcctg gctgtgtaca aaactacaa taatatattt tagacttt ggccttaact 5760 aaacttccac tcattatta ctgaggttag agatagact tgcgataaa cacattcccg 5820 agaaatactc atgatcccat attagtcag agggtagcc aatcagatct aagaacacac 5880 attccctcaa attttaatgc acatgtaatc atagtttagc acaatcaa aaatgtag 5940 tattaaagac agaatttgt agacttttt ttggcgttaa aagagacta agtttatacg 6000 tacattttat tttaagtgga aaccgaaat ttccatcga atatatgaa tttagtatat 6060 atatttctgc aatgtactat ttgctatt tggcacttt cagtggacta ctactttatt 6120 acaatgtgta tggatgcatg agtttgagta tacacatgtc taaatgcatg ctttgtaaaa 6180 cgtaacggac cacaaagag gatccataca atacatctc atagcttcct ccattatttt 6240 ccgacacaaa cagagcattt acaacatt accaacaaaaaacaaaaacaatta 6300 caattacatt tacattacc ataccatggc ctctatcgct atccctgctg ctcttgctgg 6360 aactcttgga tacgttacct aaatgtggc taaccctgat atcccagctt ctgagaaagt 6420 tcctgcttac ttcatgcagg ttgagtactg gggacctact atcggacta ttggatacct 6480 cctcttcatc tacttggaa agcgtatcat gcaagaagaga tctcaacctt tcggactcaa 6540 gaacgctatg ctcgtttaca acttctacca gaccttcttc aacagctact gcatctacct 6600 tttcgttact tctcataggg ctcagggact taaggtttgg ggaaacatcc ctgatatgac 6660 tgctaactct tggggaatct ctcaggttat ctggcttcac tacaacaa agtacgttga 6720 gcttctcgac accttcttca tggtgatgag gaagaagttc gaccagcttt ctttccttca 6780 catctaccac cacactcttc tcatctggtc atggttcgtt gttatgaagc ttgagcctgt 6840 tggagattgc tacttcggat cttctgttaa caccttgtg cacgtgatca tgtactctta 6900 ctacggactt gctgctcttg gagttaactg tttctggaag aagtacatca cccagatcca 6960 gatgcttcag ttctgtatct gtgcttctca ctctatctac accgcttacg ttcagaatac 7020 cgctttctgg cttccttacc ttcaactctg ggttatggtg aacatgttcg ttctcttcgc 7080 caacttctac cgtaagaggt acaagtctaa gggtgctaag aagcagtgat aaggcgcgcg 7140 gcgcgccggg ccgccgccat gtgacagatc gaaggaagaa agtgtaataa gacgactctc 7200 actactcgat cgctagtgat tgtcattgtt atatataata atgttatctt tcacaactta 7260 tcgtaatgca tgtgaacta taacacatta atcctacttg tcatatgata acactctccc 7320 catttaaaac tcttgtcaat ttaaaagatat aagattcttt aaatgattaa aaaaaatata 7380 ttataaattc aatcactcct actataataat tattaattat tatttattga ttaaaaaaaat 7440 acttatacta atttagtctg aatagaataa ttagattcta gtctcatccc cttttaaacc 7500 aacttagtaa acgttttttt ttttaatttt atgaagttaa gtttttacct tgtttttaaa 7560 aagaatcgtt cataagatgc catgccagaa cattagctac acgttacaca tagcatgcag 7620 ccgcggagaa ttgtttttct tcgccacttg tcactccctt caaacaccta agagcttctc 7680 tctcacagca cacacataca atcacatgcg tgcatgcatt attacacgtg atcgccatgc 7740 aaatctcctt tatagcctat aaattaactc atccgcttca ctctttactc aaaccaaaac 7800 tcatcgatac aaacaagatt aaaaacatac acgaggatct tttacaacaa ttaccaacaa 7860 caacaaacaa caaacaacat tacaattaca tttacaatta ccataccatg cctccaaggg 7920 actcttactc ttatgctgct cctccttctg ctcaacttca cgaagttgat actcctcaag 7980 agcacgacaa gaaagagctt gttatcggag atagggctta cgatgttacc aacttcgtta 8040 agagacaccc tggtggaaag atcattgctt accaagttgg aactgatgct accgatgctt 8100 acaagcagtt ccatgttaga tctgctaagg ctgacaagat gcttaagtct cttccttctc 8160 gtcctgttca caagggatac tctccaagaa gggctgatct tatcgctgat ttccaagagt 8220 tcaccaagca acttgaggct gagggaatgt tcgagccttc tcttcctcat gttgcttaca 8280 gacttgctga ggttatcgct atgcatgttg ctggtgctgc tcttatctgg catggataca 8340 ctttcgctgg aatcgctatg cttggagttg ttcagggaag atgtggatgg cttatgcatg 8400 agggtggaca ttactctctc actggaaaca ttgctttcga cagagctatc caagttgctt 8460 gttacggact tggatgtgga atgtctggtg cttggtggcg taaccagcat aacaagcacc 8520 atgctactcc tcaaaagctt cagcacgatg ttgatcttga tacccttcct ctcgttgctt 8580 tccatgagag aatcgctgct aaggttaagt ctcctgctat gaaggcttgg ctttctatgc 8640 ...

Claims

1. A method for detecting the presence of event NS-B50027-4 or its progeny in a sample containing plant DNA, wherein characteristic seeds of NS-B50027-4 have been deposited with ATCC accession number PTA-123186, wherein the method comprises: (a) Identify at least one transgenic locus selected from chromosome A02 of: SEQ ID NO:43 (5' flanking linker sequence of the transgenic locus on chromosome A02) or its complementary sequence, and SEQ ID NO:44 (3' flanking linker sequence of the transgenic locus on chromosome A02) or its complementary sequence; and (b) Identify at least one transgenic locus selected from chromosome A05 of the following: SEQ ID NO:45 (5' flanking link sequence of the transgenic locus on chromosome A05) or its complementary sequence, and SEQ ID NO:46 (3' flanking link sequence of the transgenic locus on chromosome A05) or its complementary sequence.

2. An in vitro method for detecting the presence of at least one transgenic locus in a sample containing plant DNA, wherein the method is based on genotyping using competitive allele-specific PCR, and wherein the method comprises: (a) Contact the sample with the following: A set of primers for diagnosing the first linker region of the chromosome A05 transgenic locus, wherein the primer set is SEQ ID NO:24-SEQ ID NO:27, and / or a set of primers for diagnosing the second linker region of the chromosome A05 transgenic locus, wherein the primer set is SEQ ID NO:17-SEQ ID NO:20; and A set of primers for diagnosing the first linker region of the chromosome A02 transgenic locus, wherein the primer set is SEQ ID NO:28-SEQ ID NO:30; and / or a set of primers for diagnosing the second linker region of the chromosome A02 transgenic locus, wherein the primer set is selected from (i) SEQ ID NO:31-SEQ ID NO:34 or (ii) SEQ ID NO:35-SEQ ID NO:37; (b) subjecting the sample to a polymerase chain reaction; and (c) Determine the amplicon generated between the primers. The generated amplicon identifies the presence or absence of the chromosome A02 transgenic locus and chromosome A05 transgenic locus of the superior species event NS-B50027-4. The characteristic seeds of the superior species event NS-B50027-4 have been deposited with ATCC accession number PTA-123186.

3. The method according to claim 2, further comprising: The step of contacting the sample with at least one additional primer pair, which binds to the transgenic sequence to generate an amplicon identifying the chromosome A05 transgenic locus, wherein the at least one additional primer pair is selected from the group of primers described below: SEQ ID NO:1-SEQ ID NO:2 (Microcystis aeruginosa ( Micromonas pusilla Δ6-desaturase), SEQ ID NO:3-SEQ ID NO:4 ( Pyramimonascordata Δ5 elongase), SEQ ID NO:5-SEQ ID NO:6 (Haloxylon ammodendron ( Pavlova salina Δ5-desaturase), SEQ ID NO:7-SEQ ID NO:8 (Pichia pastoris ( Pichia pastoris ) Δ15 / ω3 desaturase); SEQ ID NO:9-SEQ ID NO:10 (Haloxylon ammodendron Δ4 desaturase), SEQ ID NO:11-SEQ ID NO:12 ( Lachancea kluyveri Δ12-desaturase), SEQ ID NO:13-SEQ ID NO:14 ( Pyramimonas cordata Δ6 elongase).

4. The method according to claim 2, further comprising: The step of contacting the sample with at least one additional primer pair, which binds to the transgenic sequence to generate an amplicon identifying the chromosome A02 transgenic locus, wherein the at least one additional primer pair is selected from the group of primers described below: SEQ ID NO:1-SEQ ID NO:2 (Microcystis Δ6-desaturase), SEQ ID NO:3-SEQ ID NO:4 ( Pyramimonas cordata Δ5-elongation enzyme), SEQ ID NO:5-SEQ ID NO:6 (Haloxylon ammodendron Δ5-desaturase), SEQ ID NO:7-SEQ ID NO:8 (Pichia pastoris Δ15 / ω3 desaturase).

5. A method for detecting the presence of NS-B50027-4 or its progeny in a sample containing plant DNA, wherein characteristic seeds of NS-B50027-4 have been deposited with ATCC accession number PTA-123186, the method comprising: (a) Select a first primer and a second primer to provide a forward primer and a reverse primer, the first primer containing at least 11 consecutive nucleotides or a complementary sequence thereof from a portion of SEQ ID NO:47, and the second primer containing at least 11 consecutive nucleotides or a complementary sequence thereof from another portion of SEQ ID NO:47, wherein when used together in a nucleic acid amplification reaction, the forward primer and the reverse primer produce an amplicon containing SEQ ID NO:43; (b) Contact the selected primers with the sample containing plant DNA; (c) Perform nucleic acid amplification reaction; (d) Detect the presence or absence of an amplicon containing SEQ ID NO:43; (e) Selecting a third primer and a fourth primer to provide a forward primer and a reverse primer, the third primer containing at least 11 consecutive nucleotides or a complementary sequence thereof from a portion of SEQ ID NO:48, and the fourth primer containing at least 11 consecutive nucleotides or a complementary sequence thereof from another portion of SEQ ID NO:48, wherein when used together in a nucleic acid amplification reaction, the forward primer and the reverse primer produce an amplicon containing SEQ ID NO:44; (f) Contact the selected primers with the sample containing plant DNA; (g) Perform nucleic acid amplification reaction; (h) Detect the presence or absence of an amplicon containing SEQ ID NO:44; (i) Select a fifth primer and a sixth primer to provide a forward primer and a reverse primer, wherein the fifth primer contains at least 11 consecutive nucleotides or a complementary sequence thereof from a portion of SEQ ID NO:49, and the sixth primer contains at least 11 consecutive nucleotides or a complementary sequence thereof from another portion of SEQ ID NO:49, wherein when used together in a nucleic acid amplification reaction, the forward primer and the reverse primer produce an amplicon containing SEQ ID NO:45; (j) Contact the selected primer with the sample containing plant DNA; (k) Perform nucleic acid amplification reaction; (l) Detect the presence or absence of an amplicon containing SEQ ID NO:45; (m) Select a seventh primer and an eighth primer to provide a forward primer and a reverse primer, wherein the seventh primer contains at least 11 consecutive nucleotides or a complementary sequence thereof from a portion of SEQ ID NO:50, and the eighth primer contains at least 11 consecutive nucleotides or a complementary sequence thereof from another portion of SEQ ID NO:50, wherein when used together in a nucleic acid amplification reaction, the forward primer and the reverse primer produce an amplicon containing SEQ ID NO:46; (n) Contact the selected primer with the sample containing plant DNA; (o) Perform nucleic acid amplification reaction; and (p) Detect the presence or absence of an amplicon containing SEQ ID NO:46; The presence of SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45 and SEQ ID NO:46 identifies NS-B50027-4 or its progeny.

6. The method of claim 5, wherein the first primer comprises at least 11 consecutive nucleotides of nucleotides 1 to 235 or their complementary sequences from the 5' Brassica flanking genomic region of SEQ ID NO:47, and the second primer comprises at least 11 consecutive nucleotides of the transgenic region of nucleotides 236 to 470 or their complementary sequences from SEQ ID NO:47, wherein when used together in a DNA amplification reaction, the primer pair of the DNA molecule produces an amplicon comprising SEQ ID NO:

43.

7. The method according to claim 5, wherein (i) the first primer is nucleotide 22-46 of SEQ ID NO:28 or a complementary sequence of nucleotide 22-46 of SEQ ID NO:28; or (ii) The first primer is SEQ ID NO:30 or its complementary sequence; or (iii) The first primer is SEQ ID NO:51 or its complementary sequence and the second primer is SEQ ID NO:52 or its complementary sequence.

8. The method of claim 5, wherein the third primer comprises at least 11 consecutive nucleotides or their complementary sequences from nucleotides 1 to 235 of the transgenic region of SEQ ID NO:48, and the fourth primer comprises at least 11 consecutive nucleotides or their complementary sequences from nucleotides 236 to 470 of the 3' Brassica flanking genomic DNA region of SEQ ID NO:48, wherein when used together in a DNA amplification reaction, the primer pair of the DNA molecule produces an amplicon comprising SEQ ID NO:

44.

9. The method of claim 5, wherein the fifth primer comprises at least 11 consecutive nucleotides of nucleotides 1 to 235 from the 5' Brassica flanking genomic region of SEQ ID NO:49, or their complete complementary sequence, and the sixth primer comprises at least 11 consecutive nucleotides of the transgenic region of nucleotides 236 to 470 from SEQ ID NO:49, or their complete complementary sequence, wherein when used together in a DNA amplification reaction, the primer pair of the DNA molecule produces an amplicon comprising SEQ ID NO:

45.

10. The method of claim 5, wherein the seventh primer comprises at least 11 consecutive nucleotides of nucleotides 1 to 235 from the transgenic region of SEQ ID NO: 50 or their complete complementary sequence, and the eighth primer comprises at least 11 consecutive nucleotides of nucleotides 236 to 470 from the 3' Brassica flanking genomic DNA region of SEQ ID NO: 50 or their complete complementary sequence, wherein when used together in a DNA amplification reaction, the primer pair of the DNA molecule produces an amplicon comprising SEQ ID NO:

46.

11. A method for detecting the presence of NS-B50027-4 or its progeny in a sample containing plant DNA, wherein the characteristic seeds of NS-B50027-4 have been deposited with ATCC accession number PTA-123186, the method comprising: (a) Select a first primer and a second primer to provide a forward primer and a reverse primer, the first primer containing at least 11 consecutive nucleotides or a complementary sequence thereof from a portion of SEQ ID NO:47, and the second primer containing at least 11 consecutive nucleotides or a complementary sequence thereof from another portion of SEQ ID NO:47, wherein when used together in a nucleic acid amplification reaction, the forward primer and the reverse primer produce an amplicon containing SEQ ID NO:43; (b) Selecting a third and a fourth primer to provide a forward and a reverse primer, the third primer comprising at least 11 consecutive nucleotides or a complementary sequence thereof from a portion of SEQ ID NO:48, and the fourth primer comprising at least 11 consecutive nucleotides or a complementary sequence thereof from another portion of SEQ ID NO:48, wherein when used together in a nucleic acid amplification reaction, the forward and reverse primers produce an amplicon comprising SEQ ID NO:44; (c) Select a fifth primer and a sixth primer to provide a forward primer and a reverse primer, the fifth primer containing at least 11 consecutive nucleotides or a complementary sequence thereof from a portion of SEQ ID NO:49, and the sixth primer containing at least 11 consecutive nucleotides or a complementary sequence thereof from another portion of SEQ ID NO:49, when used together in a nucleic acid amplification reaction, the forward primer and the reverse primer produce an amplicon containing SEQ ID NO:45; and (d) Select a seventh primer and an eighth primer to provide a forward primer and a reverse primer, wherein the seventh primer contains at least 11 consecutive nucleotides or a complementary sequence thereof from a portion of SEQ ID NO:50, and the eighth primer contains at least 11 consecutive nucleotides or a complementary sequence thereof from another portion of SEQ ID NO:50, wherein when used together in a nucleic acid amplification reaction, the forward primer and the reverse primer produce an amplicon containing SEQ ID NO:46; (e) Contact the selected primers with the sample containing plant DNA; (f) Perform nucleic acid amplification reactions; and (g) Detect the presence or absence of the amplicon containing SEQ ID NO:43, the amplicon containing SEQ ID NO:44, the amplicon containing SEQ ID NO:45 and the amplicon containing SEQ ID NO:46; The presence of SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45 and SEQ ID NO:46 identifies NS-B50027-4 or its progeny.

12. The method according to claim 11, wherein the first primer is nucleotide 22-46 of SEQ ID NO:28 or a complementary sequence of nucleotide 22-46 of SEQ ID NO:

28.

13. The method according to claim 11, wherein the first primer is SEQ ID NO:30 or its complementary sequence.

14. The method of claim 1, wherein the first primer comprises at least 11 consecutive nucleotides of nucleotides 1 to 235 or their complementary sequence from the 5' Brassica flanking genomic region of SEQ ID NO:47, and the second primer comprises at least 11 consecutive nucleotides of the transgenic region of nucleotides 236 to 470 or their complementary sequence from SEQ ID NO:47, wherein when used together in a DNA amplification reaction, the primer pair of the DNA molecule generates a diagnostic amplicon for Brassica event NS-B50027-4 or its progeny, the diagnostic amplicon comprising SEQ ID NO:

43.

15. The method of claim 11, wherein the third primer comprises at least 11 consecutive nucleotides or their complementary sequences from nucleotides 1 to 235 of the transgenic region of SEQ ID NO:48, and the fourth primer comprises at least 11 consecutive nucleotides or their complementary sequences from nucleotides 236 to 470 of the 3' Brassica flanking genomic DNA region of SEQ ID NO:48, wherein when used together in a DNA amplification reaction, the primer pair of the DNA molecule generates a diagnostic amplicon for Brassica event NS-B50027-4 or its progeny, the diagnostic amplicon comprising SEQ ID NO:

44.

16. The method of claim 11, wherein the fifth primer comprises at least 11 consecutive nucleotides of nucleotides 1 to 235 from the 5' Brassica flanking genomic region of SEQ ID NO:49, or their complete complementary sequence, and the sixth primer comprises at least 11 consecutive nucleotides of the transgenic region of nucleotides 236 to 470 from SEQ ID NO:49, or their complete complementary sequence, wherein when used together in a DNA amplification reaction, the primer pair of the DNA molecule generates a diagnostic amplicon for Brassica event NS-B50027-4 or its progeny, the diagnostic amplicon comprising SEQ ID NO:

45.

17. The method of claim 11, wherein the seventh primer comprises at least 11 consecutive nucleotides of nucleotides 1 to 235 of the transgenic region of SEQ ID NO: 50 or their complete complement, and the eighth primer comprises at least 11 consecutive nucleotides of the 3' Brassica flanking genomic DNA region of nucleotides 236 to 470 of SEQ ID NO: 50 or their complete complement, wherein when used together in a DNA amplification reaction, the primer pair of the DNA molecule generates a diagnostic amplicon for Brassica event NS-B50027-4 or its progeny, the diagnostic amplicon comprising SEQ ID NO: 46.

Citation Information

Patent Citations

  • Plant cells resistant to glutamine synthetase inhibitors, made by genetic engineering

    EP0242246A1

  • Glutamine synthesis gene and glutamine synthetase

    EP0333033A1

  • Lipid comprising long chain polyunsaturated fatty acids

    US20150166928A1

  • Lipid comprising docosapentaenoic acid

    US20150374654A1

  • Processes for producing industrial products from plant lipids

    US20160002566A1